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ABSTRACT 
THE RELATIONSHIP BETWEEN CANCER-RELATED FATIGUE AND UPPER 

EXTREMITY FUNCTION IN BREAST CANCER SURVIVORS 

Meryl Marger Picard 

Seton Hall University 

2012 

Chair: Dr. Genevieve Pinto-Zipp 

Background: Cancer-related fatigue (CRF) and arm morbidity constitute the two most 
common symptom complexes impacting breast cancer survivors (BCS) following 
surgery and adjuvant treatment, but these multifaceted entities have traditionally been 
researched as if they were separately occurring events in the survivor's recovery. 
Objective: This study examined the relationship between breast cancer survivors' 
perceptions of CRF and upper extremity function one to six years post-diagnosis. The 
study further investigated the impact of multiple adjuvant therapies, node dissection 
procedures, caring for dependent children, and physical aspects of employment on CRF 
and upper extremity function. 
Methods: One hundred fifty-eight BCS responded to an exploratory internet-based 
cross-sectional demographic survey, the FACIT-F and the DASH. Descriptive statistics, 
correlation and simple linear regression were used for data analysis. 
Results: An analysis revealed a moderate statistically significant relationship between 
CRF and upper extremity function, r = -.661, P < .001, such that BCS with higher levels 
of fatigue also exhibited higher levels of arm morbidity. In addition, 22.3% reported 
persistent fatigue symptoms, consistent with the criteria for a diagnosis of CRF, with 
14 
45.5% of the fatigued subset also reporting significant limitations in upper body function. 
BCS demonstrated significantly higher levels of fatigue when compared to prior 
research on a nationally representative sample of adults (p = .037). Women who were 
caregivers of at least one dependent child demonstrated higher levels of fatigue than 
women without dependent children (p =0.38). The BCS reported high levels of function 
overall indicating that many survivors are functioning well in the years that follow 
treatment, however a subset of women reported persistent problems that interfere with 
daily function and participation, and the overall sample was more fatigued than the 
general population. 
Conclusions: The results from this exploratory study document preliminary evidence 
that a relationship exists between CRF and upper extremity morbidity. It also adds 
support for persistent fatigue in a subset of BCS long after surgery and adjuvant 
therapies conclude. Further research is indicated in order to meet the long term 
survivorship needs of this growing population. 
15 
CHAPTER I 
Introduction 
Survivorship 
Increased longevity for many individuals diagnosed with cancer has served to 
refocus the research community and government agencies on the phase of the cancer 
trajectory that begins after acute medical interventions conclude. Survivorship, even 
when measured well beyond the calculated five-year survival rates, may be 
accompanied by a myriad of physical, psychosocial and economic consequences of 
living with the late effects of the disease process and treatment modalities (NCI, 2006; 
Hausman, Ganz, Sellers, & Rosenquist, 2011). A national panel, convened to study 
issues of survivorship, concluded that survivorship research and intervention is a priority 
for all cancer patients in order to enhance quality of life for this growing population 
(Centers for Disease Control [CDC], 2005). The results of this CDC study signify a 
paradigm shift in cancer care that envisions and defines the long-term post-intervention 
needs of cancer survivors as a chronic disease state that must be monitored 
longitudinally, rather than viewed as an acute medical condition (2005). Survivorship 
can thus be conceptualized as a distinct stage in the continuum of the life experience of 
the person living with cancer, one that requires an equivalent amount of attention as 
afforded the acute management experience (NCCN, 2006). Defining the breadth and 
scope of the problem, understanding key symptomatology, better identification and 
follow-up of at-risk individuals, and the development of targeted interventions are 
therefore indicated for this population. 
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Zebrack (2000) defined cancer survivorship as "the state or process of living after 
a diagnosis of cancer, regardless of how long the person lives" (p. 239). Family and 
friends of diagnosed individuals are also included within the definition of survivorship 
due to the impact of cancer on roles and socialization (National Cancer Institute [NCll, 
2006). The term survivor is accepted by most national cancer organizations and 
governmental agencies, although some individuals with a cancer diagnosis object to the 
use of this label (Twombly, 2004; Jennings, 2010). A unified concept of survivorship has 
yet to be established rendering attempts to develop survivorship theories to support 
clinical practice and research agendas more difficult (Doyle, 2008). The term BCS 
(Breast Cancer Survivor) will be used throughout this document for consistency and 
readership ease to refer to women living with breast cancer, unless individuals living 
with other forms of cancer are discussed. 
Definitions of Survivor and Survivorship 
National Cancer Institute (n.d., para. 1) 
"In cancer, survivorship covers the physical, psychosocial, and economic issues 
of cancer, from diagnosis until the end of life. It focuses on the health and life of a 
person with cancer beyond the diagnosis and treatment phases. Survivorship 
includes issues related to the ability to get health care and follow-up treatment, 
late effects of treatment, second cancers, and quality of life. Family members, 
friends, and caregivers are also part of the survivorship experience." 
National Coalition for Cancer Survivorship (n.d., para. 2 - 3) 
"The term survivorship, as defined by the founders of NCCS, is the experience of 
living with, through and beyond a diagnosis of cancer. The founders of NCCS 
also extended the term survivor to apply to an individual's friends and 
caregivers. " 
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American Cancer Society (2012) 
"The American Cancer Society believes that each individual has the right to 
define his or her own experience with cancer and considers a cancer survivor to 
be anyone who defines himself or herself this way, from the time of diagnosis 
throughout the balance of his or her life." 
In the United States, 2010 prevalence statistics for persons living with a history of 
cancer or a cancer diagnosis with treatment are estimated at 13.8 million persons 
(Centers for Disease Control, 2011; Mariotto, Yabroff, Shao, Feuer, & Brown, 2011). If 
current trends prevail, the estimated population of cancer survivors will rise to 18.1 
million by 2020 (Mariotto et aI., 2011). Female breast cancer survivors comprise the 
largest segment of this growing population, estimated at 22% of all cancer diagnoses 
(NCI, 2011). According to the National Cancer Institute (2010) one in eight American 
women will be diagnosed with breast cancer during her lifetime. The prevalence 
estimate for breast cancer survivors in the United States is 2.6 million women with over 
200,000 women diagnosed annually (NCI, 2010; Howlader et aI., 2010). Further 
expansion of this population is anticipated as 5 and 10 year survival rates continue to 
improve (NCI, 2010). Earlier detection has resulted in more positive five-year survival 
outcomes for Caucasian BCS (91 %); African-American BCS still have a disturbingly 
lower percentage of survival for the same time period than other ethnic or racial groups 
(79%) (NCI SEER Statfact, 2011). 
Background of the Problem 
A robust body of literature suggests that select cancer-related sequelae may not 
resolve after surgical and adjuvant therapy interventions conclude, subtly or overtly 
impeding functional capacity in everyday activities as well as negatively impacting 
18 
quality of life (Sadler et aI., 2002; Portenoy & Itri, 1999; Vogelzang et aI., 1997). A 
recent qualitative study exploring BCS survivorship needs found that there was not a 
clearly defined path or consistent quality of care to help women address post-treatment 
transitional needs, including residual symptoms (Roundtree, Giordano, Price, & Suarez­
Almazor, 2010). 
As the information that follows will clarify, the most common and noteworthy of 
these potentially prolonged symptom complexes for breast cancer survivors are cancer­
related fatigue (CRF) and upper extremity morbidity. 
Cancer-Related Fatigue 
Cancer-related fatigue (CRF) has been long-recognized as a side effect during 
adjuvant cancer therapies or potentially due to the cancer disease process itself (Piper 
& Cella, 2010; Portenoy & Itri, 1999). There is evidence to indicate that fatigue 
symptoms resolve following intervention for many survivors, but studies repeatedly 
identify a subset of BCS for whom CRF will become a chronic fatigue condition creating 
difficulties completing daily tasks, employment responsibilities and socialization (Stone, 
Richardson, Ream, Smith, Kerr, & Kearney, 2000; Servaes, Verhagen, S., & 
Bleijenberg, 2002). CRF has also been identified as one of the most likely causes of 
decreases in perceived quality of life (CDC, 2005; National Institutes of Health State-of­
the-Science Panel, 2003; Curt, Breitbart, Cella, Groopman, Horning, Itri et aI., 2000; 
Andrykowski, Curan, & Lightner, 1998; Broeckel, Jacobson, Horton, Balducci, & Lyman, 
1998). This fatigue complex can persist for years or decades after treatment concludes, 
despite achievement of remission or disease-free status (Bower et aI., 2006; Servaes, 
Verhagen, S., & Bleijenberg, 2002; Andrykowski, Curan, & Lightner, 1998). 
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Estimates from NCI (2011) and the National Institutes of Health [NIH] State-of­
the-Science Panel (2003) place the prevalence rate of fatigue in individuals with all 
forms of cancer at 14 - 96% of the total cancer population. Other research findings 
report prevalence rates from diagnosis through the varying phases of intervention as 
high as 100% (Ream & Richardson, 1999). Inconsistencies may be due to differences in 
study deSigns, fatigue measurement tool selection, defining cancer fatigue terminology, 
and the heterogeneous nature of the fatigue experience for each survivor. Despite 
these disparities in consensus, it is widely agreed that CRF is the most commonly 
experienced symptom of patients across the cancer trajectory which negatively impacts 
the lives of survivors. 
CRF is a complex multi-dimensional symptom construct that comprises a distinct 
entity from acute complaints of fatigue or exhaustion experienced by busy adults due to 
high daily task demands, over-exertion, or stress-related daily events (Stasi, Abriani, 
Beccaglia, Terzoli, & Amadori, 2003; Wu & McSweeney, 2001). CRF is not resolvable 
by a temporary reduction in daily activities or rest and is more closely aligned with the 
quality of fatigue experienced by individuals with chronic fatigue syndrome (Young & 
White, 2006). The National Comprehensive Cancer Network [NCCN] defines CRF as a 
"distressing, persistent, subjective sense of physical, emotional and/or cognitive 
tiredness or exhaustion related to cancer or cancer treatment that is not proportional to 
recent activity and interferes with usual functioning" (2012, p. FT-1). 
Although the exact etiology is as yet unknown, contributing factors to CRF 
include experiences of pain, side effects of chemotherapy and radiation, anemia, 
metabolic disorders, immune function disturbances, sleep dysfunction, inactivity, 
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medication use, psychological distress and additional disease comorbidities (Mortimer, 
Barsevick, Bennett, Berger, Cleeland, DeVader, & Escalante et aI., 2010; Portenoy & 
Itri, 1999; Yellen, Cella, Webster, Blendowski, & Kaplan, 1997). One recent study 
examining the role of several biomarkers suggested that elevated C-Reactive Protein 
levels, as one measurement of underlying inflammatory cell activity, may have a 
potential contributory role in CRF (Alexander, Minton, Andrews, & Stone, 2009). 
Depression, frequently correlated with fatigue symptoms in mental health diagnosis, has 
been implicated as a co-morbid factor in CRF, but there are conflicting research study 
results as to whether depression exists as a pre-existing psychiatric comorbidity or 
results from living with a chronic fatigue-based condition (Bower et aI., 2006; Sadler et 
aI., 2002; Broeckel et aI., 1998). The sheer scope ofthese factors presents difficulties 
when designing and interpreting fatigue study outcomes. Mortimer et al. (2010) 
identified the conundrum faced by researchers since a clearly articulated conceptual 
framework and definition of CRF must currently be defined by each study's parameters, 
further limiting comparisons and generalizability. 
Instrumentation design and choice to measure the variability and extent of the 
fatigue experience remains elusive owing to the multidimensional nature of this 
construct. CRF, as it is experienced during different stages of cancer treatment and its 
aftermath, cannot necessarily be measured by a single assessment tool or assumed to 
be a static state. Similar to accepted beliefs regarding the assessment of pain, the 
assessment of fatigue is acknowledged to be a subjective experience with the National 
Institutes of Health State of the Science Panel (2003) stating that reporting of fatigue 
symptoms are "best assessed by the patient" (p. 1111), identified as a self-perceived 
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state (NCI, 2011). Patient self-perception is increasingly recognized in research and 
medical outcomes studies as a viable indicator of quality of life. In one longitudinal 
study, self-ratings of fatigue by breast cancer patients were found to be predictive of risk 
of cancer recurrence (Groenvald, Peterson, Idlen, Bjoourner, Fayers et al., 2007). 
Numerous fatigue questionnaires have been developed and researched to 
establish psychometric properties with multiple instruments receiving support from 
researchers and clinicians. However, there has been no consensus as to which of the 
fatigue assessment tools currently available constitutes the gold standard for fatigue 
assessment (National Institutes of Health State of the Science Panel, 2003). Brief, 
single-item CRF assessment tools have been found to be advantageous for use in 
clinical settings where time is often at a premium, but these tools are often limited to 
unidimensional aspects of fatigue, such as daily fatigue level or disturbance in daily 
routines (Butt, Wagner, Beaumond, Paice, Peterman, & Shevrin et aI., 2008; Schwartz, 
Meek, Nail, Linquist, & Donofrio et aI., 2002). Lengthier, more cumbersome multi­
dimensional tools provide the breadth of knowledge of the extent of the fatigue 
experience, but can be time consuming for the respondent and therefore are often 
relegated to research studies and not in general use in clinical settings (Schwartz & 
Meek et aI., 2002). More than 25 CRF tools were identified by an expert panel with no 
single tool emerging as the standard for this construct, although the NCCN committee 
recently charged with this task developed a consensus-based screening tool for clinical 
use (Mortimer et aI., 2010). The new tool, focused on contributory influences, activity 
levels and exercise, does not include questions about the impact of fatigue on daily 
functional performance in the spheres of self-care, home and community activities or 
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employment, outcomes of significant importance to cancer survivors. It is derived from 
expert opinion and not from quantitative outcomes from randomized controlled trials. 
Attempts to define the CRF construct in recent years resulted in a compilation of 
clinical findings by fatigue experts for a proposed diagnostic category for CRF in the 
International Classification of Disease, 10th edition, Clinical Modification (ICD-10 CM) 
(Sadler et aI., 2002; Portenoy & Itri, 1999). The goal of the criteria was to provide 
clinicians with a defined symptom list to assist in identification of patients experiencing 
CRF. The proposed criteria have been used in research studies to validate the symptom 
list and determine prevalence rates (young & White, 2006). Post-intervention cancer 
fatigue prevalence estimates are reduced to 17-25% of the survivor population when the 
proposed ICD-10 criteria for CRF are applied (Gerber et aI., 2010; Young & White, 
2006; Sadler et aI., 2002; Cella, Davis, Breitbart & Curt, 2001). Conservative estimates, 
using the proposed ICD-10 CM criteria for inclusion, therefore approximates the 
severely fatigued BCS population at 391,000 - 483,000 women living in the United 
States. However, recent actions by the NCCN committee charged with developing 
national recommendations identified CRF as a "subjective changing experience not a 
diagnosis" (Mortimer, 2010, p.1132). Formal implementation ofthe ICD-10-CM is not 
expected until October 2013; however a code description, R530, Neoplastic (Malignant) 
Related Fatigue, has been identified (CDC, 2011). 
Early studies on fatigue assessment and management primarily targeted 
individuals undergoing cancer treatment (Passik, Kirsh, Donaghy, Holtsclaw, & 
Theobald, et aI., 2002; Curt et aI., 2000). Late onset fatigue was less likely to be 
identified and addressed by health care professionals after cancer treatment concludes 
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(Curt et aI., 2000; Carlson et aI., 2004, Stone et aI., 2003). Failure to identify and 
address CRF is a complex problem for patients who may be reluctant to request 
assistance with a symptom that appears to be an expected consequence of the cancer 
experience (Passik et aI., 2002), one that patients believe has no solution (Vogelzang et 
aI., 1997), or one that is identified as a commonly experienced symptom in the general 
adult population (Cella, Lai, Chang, Peterman, & Slavin, 2002). Physicians may fail to 
assess or document fatigue, underestimate the impact of it on daily function, provide 
limited advice on fatigue management, prescribe rest as a solution or offer no 
intervention advice at all (Gerber, Stout, McGarvey, Soballe, Shieh, & Diao et aI., 2010; 
Vogelzang et aI., 1997). While physical sequelae such as hematopoiesis during or 
following treatment is more easily identified and treated by oncology teams, prolonged 
variable fatigue symptoms with an unclear etiology may not be as clearly targeted. The 
result is that individuals living with CRF may not be referred for supportive care to other 
health professionals, such as occupational and physical therapists, who might be able 
to address residual symptoms and ameliorate the impact on function and role 
performance (Watson & Mock, 2004; Taylor & Currow, 2003; Galantino, Capito, Kane, 
Ottey, & Switzer et aI., 2003). 
Barriers to effective management of fatigue in patients with cancer "include a lack 
of awareness that fatigue is the most prevalent symptom, a lack of knowledge about the 
causes of fatigue among physicians and patients, and a lack of proven methods to treat 
fatigue" (National Institutes of Health State-of-the-Science Panel, 2003, p.1113). Other 
impediments to fatigue management include a dearth of evidence-informed 
interventions offered to patients experiencing CRF by health professionals, as well as 
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patients lacking the knowledge that possible solutions exist (Passik et aI., 2002; Wu & 
McSweeney, 2001). 
One population with a demonstrated need for ongoing CRF evaluation and 
intervention is women with breast cancer, BCS in remission or those who have 
achieved disease-free states, who still experience fatigue on a daily or weekly basis. 
The Agency for Healthcare Research and Quality (Carr et aI., 2002) documented 
prevalence rates in post-treatment breast cancer survivors that ranged from 35 - 56%. 
Fatigue has a documented significant effect on reported quality of life and functional 
ability in women with breast cancer (Servaes, Verhagen, C., & Bleijenberg, 2002b; Curt 
et ai, 2000; Stone, Richardson, Ream, Smith, Kerr, & Kearney, 2000). A subset of BCS 
experience ongoing fatigue that persists much later in the treatment process (Yates et 
aI., 2005) and can continue for years or decades after treatment concludes 
(Andrykowski et aI., 1998). BCS who are considered free from disease may also 
experience CRF symptoms that interfere with daily life tasks and employment (Stone et 
aI., 2003; Curt et al., 2000; Andrykowski et aI., 1998). 
In one study, BCS reported fatigue frequency at one year post-diagnosis 
equivalent to that of newly diagnosed women (Vogelzang et aI., 1997). A study of 
disease-free BCS found that women classified by fatigue measures as severely fatigued 
or non-severely fatigued experienced greater impairment in the ability to manage and 
complete daily activities than a control group without breast cancer (Servaes, Verhagen, 
C., & Bleijenberg, 2002b). Research on this topic has addressed population 
identification, prevalence, and assessment of CRF, but concerted efforts to develop and 
research interventions for prolonged fatigue in cancer survivors remain limited. This is a 
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critical area for continued study that acknowledges the persistent nature of the fatigue 
experience and the impact on BCS and their families. 
Those stud ies with documented interventions for the management of treatment­
related or prolonged post-treatment fatigue (Yates et aI., 2005; Stanton et aI., 2005; 
Barsevick, Dudley, Beck, Sweeney, Whitmer, & Nail, 2004; Holley & Borger, 2001; 
Grant, Golant, Rivera, Dean, & Benjamin, 2000; Mustian et aI., 2004; Galantino, Capito, 
Kane, Ottey, Switzer, & Packel, 2003) have generally not incorporated an approach to 
assess the impact of fatigue on functional performance of daily life tasks, although many 
address quality of life. Only one study was identified that used an established measure 
of occupational performance for activities of daily living (ADLs) (Mallinson, Cella, Cashy, 
& Holzner, 2006). Less frequent follow-up visits for BCS once they enter the extended 
survivorship phase create barriers for women with prolonged CRF unless clinicians 
mount a concerted effort directed toward identification and monitoring of this symptom. 
Upper Extremity Function 
A separate body of research suggests that upper extremity deficits and altered 
sensory experiences following cancer surgery and treatment produce additional side 
effects that may also persist following the conclusion of surgical and adjuvant therapies 
for breast cancer. Differences in treatment options for type and stage of breast cancer, 
location of tumors, individual preferences regarding treatment and clinical expertise 
figure strongly into the physician-patient decision making process. Those decisions and 
the underlying disease processes and other patient factors can potentiate or alleviate 
development of upper extremity sequelae. 
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The literature offers insights into the impact of breast cancer surgery and adjuvant 
therapies on upper extremity physical function (Hayes, Battistutta, & Newman, 2005; 
Collins, Nash, Round, & Newman, 2004; Reitman, Dijkstra, Debreczeni, Geertzen, & 
Robinson, 2004). Upper extremities are the 'tools' that permit dynamic interaction with 
the environment, performing the majority of functions that promote participation and 
fulfillment of life roles. The consequences of reduced arm function can impair the ability 
of survivors to independently perform and complete desired activities including self-care 
tasks requiring reaching, household tasks necessitating increased demands for upper 
body strength, employment tasks and community activities (Reitman et aI., 2003; Collins 
et aI., 2004). 
The unique contributions of factors instrumental to the development of extremity 
symptoms following breast cancer surgery or intervention are multifaceted. The majority 
of the research conducted has focused primarily on lymphedema prevalence, 
assessment and intervention rather than the functional implications of those physical 
factors. Lymphedema is defined as the "swelling that occurs when protein-rich lymph 
fluid accumulates in the interstitial tissue" (NCI, 2011). In BCS, lymphedema, identified 
as a potentially distressing side effect may limit arm function, diminish participation in 
life spheres and alter body image (Reinertsen et aI., 2010; Hack et aI., 2010; Hayes, 
Rye, Battistutta, DiSipio, & Newman, 2010). It is one of the most dreaded side effects 
of breast cancer, negatively impacting the ability of the survivor to fulfill life roles and 
maintain occupational performance (Collins et aI., 2004), potentially altering or 
disfiguring physical appearance, and limiting full use of the affected extremity. 
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Generally accepted incidence figures for lymphedema indicate that 15 - 30% of BCS 
will develop lymphedema at some point following surgery and treatment (Hayes et aI., 
2008; Petrek & Heelan, 1998), with an estimated 120,000 - 600,000 BCS experiencing 
this complication (Soran et aI., 2006). A recent cross-sectional national study in 
Denmark was conducted surveyed the entire BCS population (N = 3253, 85%), 13 - 41 
months post surgery, in a country with standardized health care and defined adjuvant 
and surgical protocols (Gartner, Jensen, Kronborg, Ewertz, Kehlet, & Kroman, 2010). 
Depending upon surgical and treatment modality, the authors reported a self-perceived 
lymphedema prevalence rate of 13 - 65% with 11 - 44% of BCS also reporting 
decreased occupational performance after treatment, particularly for employment 
(Gartner et aI., 2010, p. 511). 
In a longitudinal multi-center study with complete data on 296 subjects, persistent 
edema was noted in 32% of BCS within 3 years following surgery with three times the 
risk for developing arm edema noted with every additional lymph node that was 
dissected (Paskett, Naughton, McCoy, Case & Abbot, 2007). Fifty percent of women 
reporting upper extremity edema identified diminished abilities to complete household 
chores (Reitman et aI., 2003) with 69% of BCS reporting decreases in the ability to 
complete activities of daily living due to edema (Oliveri et aI., 2008). Hayes, Battistutta, 
Parker, Hirst, & Newman (2005) reported the highest task burden was noted when 
"carrying a moderate weight, washing the upper part of the back, opening a tight jar, 
and doing up a bra" (p. 257). A subsequent study by Hayes et al. (2008) indicated that 
some women confuse typical short-term upper extremity and breast side effects of 
radiation with lymphedema, noting that self-perceived symptoms may overestimate the 
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population. It is also possible that women may perceive slight increases in limb swelling 
before mechanical measurements can detect this changes. Several validated 
measurement options are available to measure limb edema including circumferential 
tape measurements, volumetric water displacement, bioelectrical impedance analysis 
and self-report (Johannson & Branje, 2010; Norman, et aL, 2009; Hayes, Janda, 
Cornish, Battistutta, & Newman, 2008). 
The advent of sentinel node biopsy has overtaken axillary node biopsy as the 
prevailing standard of care and is the most commonly performed procedure for initial 
surgical node removal and staging (McGuire et ai, 2009), altering the landscape for 
BCS and researchers. This trend developed following more than a decade of literature 
suggesting that a significant relationship exists between the number of lymph nodes 
removed during axillary node dissection and the development of subsequent arm 
morbidity and sequelae such as lymphedema (Hack et aL, 2010). Breast conserving 
surgery with follow-up radiotherapy, chemotherapy, and hormonal therapy or 
combination therapies has accelerated the acceptance of this method of node removal 
(McGuire et aI., 2009). However, women with positive sentinel nodes on biopsy may 
require additional axillary node removal to obtain an accurate diagnosis and differentiate 
treatment choices. Therefore node removal remains a great source of concern for 
women with breast cancer and for those involved in survivorship care. 
Extensive axillary node dissection and radiation to the axilla and chest wall have 
been strongly implicated as causal agents resulting in the development of post-surgical 
extremity symptoms such as lymphedema (Rietman et aI., 2006; Tsai et aL, 2009). One 
study contradicted those findings implicating chemotherapy as causative (Paskett et aI., 
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2007). Mastectomies can produce more arm limitations and potential lymphedema than 
breast-conserving therapy, such as lumpectomies. A meta-analysis of 98 lymphedema 
studies found that women followed for three years or less who underwent mastectomy 
demonstrated the most significant correlations for lymphedema and women who 
underwent radiation therapy and axillary dissection were at the highest risk of the 
development of lymphedema (Tsai et aI., 2009). Recent evidence suggests that 
mastectomy rates have risen at major cancer centers after several years of diminishing 
percentages of women who underwent this more extensive surgery (McGuire et aI., 
2009; Katipamula et aI., 2009). Factors accounting for this unexpected rise include an 
increase in contralateral prophylactic mastectomies as genetic testing provides women 
with significant breast cancer risk factors options to prevent the development of breast 
cancer, decisions by some women to request more extensive surgery to avoid or 
decrease the use of radiation or chemotherapy, and younger women hoping to avoid 
recurrence (McGuire et aI., 2009; Katipamula et aI., 2009). The impact on the 
prevalence of lymphedema as a result of this trend is unknown. 
While arguably the most serious and visually distressing problem, swelling from 
lymphedema is not the only extremity side effect that may result from breast cancer 
surgery or treatment (Fu & Rosedale, 2009). Surgical procedures, type of node biopsy 
and notably radiation therapy may also be accompanied by other upper extremity 
sequelae including muscle weakness, numbness, pain, paresthesias, loss of shoulder 
range of motion, strength, tightening of scar tissue, and decreased hand strength and 
function (Fu & Rosedale, 2009; Karki, Simonen, Malkia, & Selfe, 2005; Stariano & 
Ragland, 1996). Pain in the upper extremity has been reported to negatively impact arm 
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function, decrease task performance, participation and quality of life (Oliveri et aI., 2008; 
Dawes, Meterissian, Goldberg & Mayo, 2008). Pain has also been linked to higher 
levels of disability (Dawes et aI., 2008). 
As the magnitude of the survivor population increases in the United States, the 
imperative to clarify and address upper extremity functional deficits expands as well. 
Interest in assessing and promoting long-term quality of life for individuals across the 
cancer care continuum must include special attention to education and management of 
the prolonged or delayed onset of arm symptoms in survivors that interfere with daily 
life. 
Purpose of the Study 
This descriptive, exploratory cross-sectional study was designed to examine perceived 
upper extremity functional status and cancer-related fatigue in breast cancer survivors 
who have achieved remission or disease-free status one (~ 12 months) to six years (:::; 
72 months) after the conclusion of surgical and adjuvant therapies. Perceived upper 
extremity functional status and cancer-related fatigue were further explored by 
examining participant differences in node dissection status, adjuvant therapies received 
and dependent caregiver responsibilities. 
Research Questions 
Four questions were guided by the literature for this study. 
1. 	 Is there a relations~lip between self-reported cancer-related fatigue and 

perceived upper extremity functional deficits in breast cancer survivors? 

2. 	 Is there a difference in perceived upper extremity function and fatigue between 
survivors who underwent sentinel node dissection and those who underwent 
axillary node dissection? 
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3. 	 Is there is a difference in perceived upper extremity function and fatigue between 
survivors who underwent differing types of adjuvant cancer therapies, including 
chemotherapy, radiation, or combination therapies? 
4. 	 Is there a difference in perceived upper extremity function and fatigue between 
survivors who have dependent caregiver responsibilities and those without 
dependent caregiver responsibilities? 
Pilot Study 
A pilot study (n =42) was conducted in early 2011 to determine the feasibility of 
the snowball recruitment methodology and to assess the ease of completion of the 
researcher designed demographic survey and standardized questionnaires. 
Conceptual and Theoretical Framework 
The capacity to fulfi" life roles and participate in the everyday activities that 
create meaning and identity in our lives is part of the experience of adulthood. Adults 
can be described as "occupational beings ... a person who is fully engaged in the world 
of activity - work, play, leisure - who is productive and feels a sense of self-worth" 
(Clark, Ennevor, & Richardson, 1996, p.374). This ability to engage in desired 
occupations has been shown to have a positive impact on health and well-being (World 
Health Organization, 2001, Clark, Ennevor, & Richardson, 1996). Occupations are 
meaningful activities that individuals choose to engage in. The term 'occupation' is not 
restricted to activities tied to employment but is defined as "daily activities that reflect 
cultural values, provide structure to living, and meaning to individuals; these activities 
meet human needs for self-care, enjoyment, and participation in society" (Crepeau et 
aI., 2003, p. 1031). 
Adults form perceptions of their identities through participation in these 
meaningful activities, acquiring skills and achieving completion of desired and required 
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tasks that are woven throughout the life narrative. Furthermore, the ability to complete 
daily occupations and routines creates opportunities for goal attainment and add 
meaning to our daily existence. Christiansen (1999) described successful goal 
achievement as resulting in feelings of efficacy and influence over the environment. Any 
illness or disability that disrupts the continuity of performance of these common 
activities can threaten beliefs about competence and therefore impact identity 
(Christiansen, 1999). 
Frank (1995) refers to this disruption as a loss of the "destination and map" that 
previously helped the person navigate through difficult periods in life. People who 
believe that they can successfully manage disruptive life challenges are better able to 
cope with the stressors that accompany life-threatening illness. Yet, Frank 
acknowledges that current health care practices do not sufficiently prepare the person 
to live in the world after biomedical intervention for the disease process has concluded 
(1995). Even occupational therapists, skilled in addressing compensatory and adaptive 
strategies for specific impairments in life skills, have not sufficiently "focused on 
assisting survivors of disability to handle the social environment with which they 
inevitably collide after hospitalization" (Clark, 1999, p. 388). 
Theoretical models. Theories of cancer survivorship are not well established 
since basic conceptual models and definitions for shared terminology are still evolving 
(Doyle, 2008). Recent efforts have centered on clinical applications, such as the 
development of survivorship care plans to manage the period of time post-treatment 
when survivors lose consistent contact with the oncology team (Hausman, Ganz, 
Sellers, & Rosenquist, 2011). Planning in advance for the acute to post-treatment 
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progression may facilitate the survivor's transition to community-based resources 
(Hausman, et aI., 2011). To adequately address survivorship needs posed by this 
burgeoning population requires a multipronged approach that includes attention and 
accessibility to medical, psychosocial, financial, employment and health care system 
resources. 
The biopsychosocial model (BPS) and International Classification of Function 
(ICF) were chosen as the framework for this project since the implementation of best 
practice using this holistic model and international taxonomy includes person and 
environmental factors leading to enhanced participation in daily life. Conjointly, it is not 
possible to discuss the post-treatment experience without reference to the staged 
survivorship model, "Seasons of Survivorship", developed by Dr. Fitzhugh Mullan 
(1985), framing his own cancer experience as a physician and cancer patient. 
Mullan (1985) aptly described the inadequacies of available services: 
"It is as if we have invented sophisticated techniques to save people from 
drowning, but once they have been pulled from the water, we leave them on the 
dock to cough and sputter on their own in the belief that we have done all that we 
can (p. 273)." 
His model was later reframed by Miller, Merry, and Miller (2008) to better reflect 
a quarter of a century of survivorship research, including awareness of the 
heterogeneity and increasing diversity of the lives of cancer survivors, many of whom 
are living well beyond the five year longevity benchmark defined in governmental 
surveillance databases. It is increasingly clear that these stages or phases of the cancer 
experience can extend for decades beyond acute medical management, further 
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supporting the paradigm shift from a biomedical, reductionistic model to one in which 
quality of life and resumption and continuation of life activities move to the forefront. 
These underlying frameworks will be discussed more fully in this section. 
Biopsychosocial Model (BPS) and the International Classification of 
Function (ICF). The biopsychosocial model (BPS) was conceptualized by George 
Engel in a seminal 1977 article arguing for the need to create a holistic framework that 
would account for the patients' perceptions of their illness experience, and 
psychological, social and biological factors encountered within the dynamics of the 
healthcare system. He hoped that an integrated model would provide guidance to 
practitioners and researchers and shift the paradigm away from the inherent mind-body 
dualism of the biomedical model (Engel, 1977). BPS was also conceptualized as an 
alternative holistic model to drive occupational therapy practice, focusing on the 
complex factors required to enhance participation in the community (Mosey, 1974). 
"Occupational therapy practitioners recognize that health is supported and maintained 
when clients are able to engage in occupations and activities that allow desired or 
needed participation in home, school, workplace, and community life (American 
Occupational Therapy Association [AOTA], 2008, p.629). A review of BPS model 
twenty-five years after Engel's publication reaffirmed the need to honor the subjective 
illness experience in clinical practice and research (Borrel-CarriG, Such man, & Epstein, 
2004). 
The World Health Organization (WHO) used the BPS model as the foundational 
theory during construction of the ICF, stating that "In order to capture the integration of 
the various perspective of functioning, a 'biopsychosocial approach is used" (WHO, 
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2001, p.20). The use of this theory fostered an integrated perspective on the biological, 
psychological, social, environmental and individual perceptions of health-related quality 
of life (HRQOL) (WHO, 2001). These alterations represented a sUbstantial shift from the 
early disablement model of the International Classification of Impairments, Disabilities 
and Handicaps (ICIDH) (WHO, 1980-1993) to one that identified health, personal and 
contextual factors as integral to function and participation. 
The ICF (WHO, 2001) is in actuality a taxonomy as opposed to a theory or 
practice model, providing an international language and systematic classification to 
facilitate communication about global health, participation and environment. The ICF 
domains describe body functions (e.g., underlying physiologic systems), structures 
(e.g., anatomical, cellular, neurochemical), activities (all daily tasks and occupations 
across the lifespan) and participation (e.g., engagement in occupation with attention to 
physical, social, and environmental factors, and economic barriers) (WHO, 2001). The 
structure identifies participation as involvement in a variety of life spheres, including 
learning and applying knowledge, general tasks and demands (handling responsibilities, 
stress and other psychological demands), communication, mobility, self-care, domestic 
life (acquisition of needed daily resources, household management. caring for personal 
and other household objects, and caregiving), interpersonal interactions and 
relationships, major life areas (work and school). and community, social, and civic life 
(recreation and leisure activities, spirituality and religious participation, and politics) 
(WHO, 2002). Research studies have documented "the positive influence on health and 
well-being" (Law, 2002, p.641) that participation in these desired and meaningful 
occupations provide. 
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Documenting the positive impact of the development of the ICF model on 
interventions, Oston, Chatterji, Kostansjek, & Bickenbach (2003) opined that the 
biological view was only one facet of the ICF, demonstrating a more comprehensive 
view of the individual and environmental factors influencing health and disability. 
Recently Huber, Sillick and Skarakis-Doyle (2010) suggested that while the ICF clearly 
references the internalized subjective experience articulated in the BPS model, these 
concerns are subsumed under contextual factors and may not be easily identified when 
viewing the actual design. Seaburn (2005) countered, proposing that it is not the design 
or model that is problematic but the adoption and application of the biopsychosocial 
approach within the current health care system. Nevertheless, researchers are 
increasingly using the ICF framework and adding health-related quality of life (HRQOL) 
measures to studies (Allan, Campbell, Buptill, Stephenson, & Campbell, 2006; Dixon, 
Johnston, McQueen, & Court-Brown, 2008). There is enhanced recognition that the 
gestalt of the person's life experience is central to understanding the trajectory though 
the illness process. Assessment of life roles, psychoemotional responses and function 
in self-care, instrumental activities of daily living, productivity, and social interactions 
offer rich insights that enhance patient care (Ryff & Singer, 2000). Addressing these 
areas, particularly psychoemotional functioning, is helpful for individuals with chronic 
diseases where cure is not the clear objective (Ryff & Singer, 2000). van Dijk (2000) 
described quality of life "as degree of goodness of daily living" (p. 104). envisioned as 
the meaningfulness of the transaction between the person and life contexts in which 
activities take place. Well-being incorporates role performance, productivity and daily 
function (Ryff & Singer, 2000). Internalized perceptions of capacity and quality of 
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performance compose the individual's understanding of their HRQOL (Huber et aI., 
2010). The focus on the subjective lived experience of cancer is an essential 
component of HRQOL, and serves as the core of conceptual models of survivorship. 
Stages of survivorship. Some survivors experience cure following completion 
of all medical interventions, others live with partial or complete remission, encounter 
recurrence, or will continue with ongoing treatment to address maintenance needs or 
secondary complications from the cancer. Additionally, psychological, cognitive, or 
physical sequelae may persist. Fears of recurrence may resurface across the survivor's 
lifespan at critical junctures for medical tests or follow-up visits. The lived experience of 
survivors, noted through personal identification of subjective well-being, focuses on 
completion of daily activities that are meaningful or desirable. 
Mullan (1985), additionally cited in a CDC document on cancer survivorship 
(2005), described a three-stage model of acute, extended and permanent events that 
support the identification of changes in daily occupations based on patient experiences 
of cancer. The acute stage encompasses the initial diagnostic process (Mullan, 1985; 
CDC, 2005, p.3). During the extended stage, described as a hypervigilant state which 
begins when treatment is completed or remission occurs; the individual begins to 
consider the potential for recurrence, and realizes that there are still residual daily 
symptoms that must be addressed (Mullan, 1985; CDC, 2005, p.3 - 4). The permanent 
stage occurs when the medical status of the cancer is deemed to be very stable, but the 
survivor is still facing sequelae of cancer treatment including persistent symptoms and 
socioeconomic concerns (Mullan, 1985; CDC, 2005, p.4). 
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This oft cited model was later reframed by Miller et al. (2008) to better reflect the 
increasing diversity of cancer survivors, many of whom are living well beyond the five 
year benchmark. The definition of the acute survivorship stage remained unchanged 
from Mullan's original conceptualization. Transitional survivorship was added to 
correspond to the time when either "watchful waiting" or maintenance therapies may be 
present, but the survivor and family are readjusting to the consequences of the cancer 
experience (Miller et aI., 2008, p.372). Extended survivorship, described by Mullan 
(1985) and augmented by Miller et al. (2008), highlights the ambivalent 
psychoemotional responses and heterogeneity of the post-treatment experience, 
whereby some individuals may be in remission while others continue ongoing 
maintenance treatment with potential side effects. Life for those individuals vacillates 
between "'regular life' and 'the ups and downs' of living with cancer and its treatment" 
(Miller et a!., 2008, p.372). Expansion of the permanent survivorship stage, also viewed 
as a heterogeneous experience, was divided into "individuals who are cancer free and 
free of cancer"; those who are "cancer free, but not free of cancer" (Miller et aI., 2008, p. 
372); those with "secondary cancers" resulting from adjuvant therapies; and those with 
new "second cancers" whose lives revert to the acute survivorship phase (p. 373). The 
expanded stages offer further direction to researchers seeking to explore the diverse 
and variable lived experiences of cancer survivors. 
For the purpose of this study, individuals participating in the study were 
conceptualized as falling into the permanent survival stage - specifically "cancer-free 
and free of cancer" or "cancer free but not free of cancer" (Miller et aI., 2008, p. 372), 
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focusing on women who had concluded all adjuvant therapies and surgery a minimum 
of one year prior to completing the survey. 
Survivorship and Breast Cancer 
Prolonged symptoms, such as cancer-related fatigue and upper extremity 
morbidity, resulting from the cancer experience are noteworthy due to the disruption 
they cause to typically predictable daily routines and occupations. These symptom 
complexes profoundly impact the ability of BCS to continue desired occupations, 
especially targeting instrumental activities of daily living (IADLs), work, leisure, and 
socialization. It is noteworthy that basic self-care or activities of daily living (ADLs) are 
not typically identified in the literature as problematic for BCS, except for those with 
significant lymphedema (Fu & Rosedale, 2009). IADLs are defined as "essential self­
maintenance activities which are necessary for independent living that are not 
considered basic ADL, or self-care tasks" (Christiansen & Baum, 2004, p.598). These 
include activities such as home maintenance, shopping, meal preparation, caregiving, 
communication device use, financial management, health management and 
maintenance, and community mobility (Christiansen & Matuska, 2004). Difficulties in 
these more complex daily activities have been reported in cancer survivors with physical 
comorbidities, such as fatigue and pain, resulting from the cancer and subsequent 
interventions (Miller et aI., 2008). 
For the majority of BCS, symptoms resolve after treatment and adjuvant 
therapies such as surgery, cytotoxic chemotherapy, radiation, or a combination of 
modalities concludes. However, a proportion of this population will be impacted by 
prolonged, persistent symptoms that may continue for years or even decades after the 
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cessation of treatment, impairing participation in life-performance arenas for those 
individuals. Previously learned coping strategies may be ineffective when confronting a 
variable condition such as CRF or arm morbidity and may leave the survivor unable to 
resolve encountered occupational dilemmas. 
The changeable nature of fatigue alters the ability to be an active participant in all 
of the life spheres described by the ICF, disrupting daily routines and life roles that 
functioning adults take for granted. A systematic review documenting qualitative 
comments gleaned from 26 cancer fatigue studies concluded that the severity of the 
impact of fatigue on daily task performance was far more damaging to survivors than 
the actual physical feelings of fatigue (Scott, Lasch, Barsevick, & Piault-Louis, 2011). 
Therefore, CRF that interferes with daily performance constitutes a disability that 
negatively impacts participation in occupations. Law (2002) stated that the presence of 
such a disability potentially increases social isolation resulting in less diversified 
participation in activities in society. Past strategies that were developed for acute 
fatigue resulting from overexertion or stress are not responsive to the prolonged and 
daily variability of cancer-related fatigue. New strategies must be conceived and 
implemented to address management of this symptom. A WHO report (2002) on 
Innovative Care for Chronic Conditions (ICCC), designed to improve management and 
prevention of chronic conditions, cites the need to develop innovations in relaxation 
techniques, coping skills training, and problem solving to decrease cancer-related 
symptoms such as fatigue (p.95). 
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Summary 
A national panel convened by the Centers for Disease Control (CDC) to study 
issues of survivorship concluded that survivorship research and intervention is a priority 
for all cancer patients, confirming the paradigm shift that envisions the long-term post­
intervention needs of cancer survivors as a chronic disease state (Centers for Disease 
Control [CDC], 2009). Studies that explore the perceived functional impact of persistent 
symptoms resulting from cancer, surgery, or adjuvant therapies are needed. Framed 
within the ICF and BPS theory, this project examines body structures (upper extremity 
use), body functions (fatigue), and self-perceptions of activity execution, limitations and 
participation restrictions. The increasing emphasis on survivorship by federal agencies 
and healthcare organizations addressing the needs of this population affords us the 
opportunity to better understand the impact of perceived persistent symptoms on the 
lives of BCS. 
The potentiality of a relationship between CRF and upper extremity morbidity, 
two entities that may continue to challenge breast cancer survivors after treatment 
concludes, is not well described in the literature. It is not known whether these two 
underreported and under-diagnosed symptom complexes (Paskett et aI., 2007; Stone et 
aI., 2003; Stone, Richardson, Ream, Smith, Kerr, & Kearney, N., 2000) indeed 
represent separate concerns, or if a subset of the larger BCS population experiences 
both sets of symptoms. Understanding these relationships may enable healthcare 
practitioners to determine which women require further screening, monitoring or referral 
for interventions to address CRF or upper extremity dysfunction. 
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No studies were located exploring whether there is a relationship between 
cancer-related fatigue and upper extremity morbidity, despite prevalence statistics that 
conservatively suggest that approximately 30% or more of breast cancer survivors may 
experience either syndrome (Lash & Silliman, 2002; Hayes et aI., 2008). Current 
research remains compartmentalized, focused on upper extremity morbidity and 
lymphedema, or cancer-related fatigue. The profound negative impact on occupational 
performance of desired activities and tasks is well documented for both concerns. 
Additionally, these two symptom complexes may appear long after adjuvant therapies 
conclude or continue permanently, thus altering quality of life. The International 
Classification of Function (lCF) Core Sets for Breast Cancer categorize the activities 
and tasks deemed critical to this population, based on the ICF from the World Health 
Organization, and include specific reference to addressing hand and arm use, activities 
of daily living, instrumental activities of daily living, employment, leisure and 
socialization (Brach et aI., 2004). 
Statements from the National Comprehensive Cancer Network [NCCN] Practice 
Guidelines in Oncology, additionally confirm the "necessity to develop interventions that 
focus on fatigue as a primary endpoint for research" (NCCN, 2009, p. MS-10), further 
supporting the need for research on CRF. Without knowledge of how these two 
fundamental constructs may be linked, it will be difficult to fully address the needs of 
breast cancer survivors or develop targeted interventions. The extended lifespan 
estimates for this population support further examination and explication of prolonged 
symptoms that interfere with daily life. There is a preSSing need to explore the potential 
relationship between CRF and upper extremity functional deficits in order to begin to 
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ascertain how best to monitor and address survivors' desires to remain full and active 
participants in desired and required life tasks. This exploratory study may offer an 
alternative vantage point from which to begin to view prolonged symptoms, assisting 
clinicians to design screening tools and educational models to address BCS concerns, 
as well as laying the groundwork for future studies to help determine which women are 
at highest risk for prolonged effects from breast cancer interventions. 
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CHAPTER II 

REVIEW OF LITERATURE 

This chapter provides a review of the relevant literature on cancer-related fatigue 
(CRF) and upper extremity function in breast cancer survivors (BCS), including the 
impact of symptoms on activities of daily living (ADLs), instrumental activities of daily 
living (IADLs), employment, and caregiver status. Biological and physical contributors 
to fatigue and upper extremity deficits resulting from surgical interventions to the breast 
or adjuvant cancer therapies that impact daily function will also be explored. 
Furthermore, identification of current research trends, knowledge gaps and study 
limitations in the literature that provided the basis for this study and formulation of the 
study hypotheses will be reported. 
Cancer-Related Fatigue (CRF) 
Fatigue has long been recognized as one of the most common and significant 
cancer symptoms resulting from the cancer disease process, surgical intervention, 
chemotherapy, radiation, combined treatment interventions, immunotherapy, or marrow 
transplantation (Portenoy & Itri, 1999; Cella, Davis, Breitbart, & Curt, 2001; Sadler et aI., 
2002). It is also one of the most frequently researched symptoms across the cancer 
trajectory. Fatigue can produce undesirable consequences that diminish concentration 
and attention to tasks, result in sleep dysfunction, psychological distress, depression or 
anxiety (Sadler et aI., 2002) or bring about physical weakness and diminished energy 
(Portenoy & Itri, 1999; Cella et aI., 2001). The subjective experience of CRF can be 
characterized by a multiplicity of attributes including fatigue severity, duration, intensity, 
and variability, and exacerbating and remitting factors that potentially contribute to a 
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negative impact on occupational performance, socialization, and participation in the 
community (Bower, Ganz, Desmond, Rowland, Meyerowitz, & Belin, 2000; Curt et aI., 
2000; Portenoy & Itri, 1999). 
The following section describes and defines CRF, known etiologies, prevalence 
rates, and patient and practitioner awareness of the frequency of CRF and potential 
interventions. The section further explicates the physical and emotional symptoms 
associated with CRF. 
Definitions, Etiology and Prevalence 
Cancer-related fatigue [CRF] is a distinct phenomenon with differential 
presenting symptoms that distinguish it from the acute fatigue experience typified by 
activity overexertion, a single poor night's sleep or the presence of stressful events. 
Acute fatigue symptoms are characterized by a connection to particular activities or 
events, responding to rest or cessation of activities and resolving within a reasonable 
time period to permit resumption of typical functional capacity. Conversely, the 
individual with CRF experiences a more persistent chronic form of fatigue that does not 
resolve with periods of rest, and may interfere with the performance of life tasks 
including employment (Spelten et aI., 2003). The National Comprehensive Cancer 
Network (NCCN) defines CRF as a "distressing, persistent, subjective sense of 
physical, emotional and/or cognitive tiredness or exhaustion related to cancer or cancer 
treatment that is not proportional to recent activity and interferes with usual functioning" 
(2012, p. FT-1). Fatigue has been shown to negatively impact occupational 
performance in instrumental activities of daily living (Curt et aI., 2000), and negatively 
impact the ability to return to work (Spelten et aI., 2003). 
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Portenoy and Itri (1999) speculated that CRF may "represent a final common 
pathway to which many predisposing factors or etiological factors contribute" (p.2). 
Potential contributors to the etiology include anemia, decreased cytokine or antibody 
responses, underlying metastatic disease, abnormalities of energy metabolism, 
neurophysiologic changes of skeletal muscle, chronic stress response. hormonal 
changes, adjuvant therapies. comorbid systemic diseases, sleep disorders, immobility 
and lack of exercise, use of pain medications. and psychosocial variables such as 
depression and anxiety (Stasi et aI., 2003; Portenoy & Itri, 1999). Identifiable disorder­
based symptoms such as anemia, metabolic or hormonal dysfunction may be 
adequately addressed or alleviated through medical intervention. thus allowing those 
individuals to experience reduction or resolution of their CRF symptoms. For other 
patients, the frequency of the fatigue experience combined with an elusive defined 
etiology is commonplace, particularly in survivors who have already completed the 
acute phase of cancer treatment. 
In a study by Stone et al. (2000). patients identified fatigue as the most poorly 
controlled symptom in their cancer experience (p < .0001). They suggested that the 
population of individuals with cancer-related fatigue might be under-represented in 
current prevalence statistics due to the failure of patients to report their CRF symptoms, 
and the failure of health professionals to request detailed information about fatigue 
experiences during patient visits (Stone et aI., 2000). A cross-sectional. questionnaire­
based survey was used to investigate perceptions of cancer-related fatigue and the 
impact on quality of life on 576 patients and 576 caregivers (Stone et aI., 2000). Fatigue 
was identified as the most significant symptom (P < .0001) resulting from patient cancer 
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experiences with 82% experiencing it at least a few days over a month-long period, 56% 
experienced it on most days or every day, with only 7% not reporting any fatigue (Stone 
et aI., 2000, p.972). 
CRF and Adjuvant Therapies 
Research on CRF over the past decade predominantly detailed the impact of 
fatigue on recently diagnosed oncology patients undergoing treatment with adjuvant 
therapies. Cancer treatment, particularly chemotherapy and radiation therapy, has been 
implicated as a potential cause for CRF. Reported results have been contradictory with 
CRF correlated with chemotherapy in some studies (Broeckel et aL, 1998; Bower et aL, 
2000), with radiation therapy in others (Lee et aL, 2007), and with combined adjuvant 
therapies in still others (Jacobsen, Donovan, Small, Jim, Munster, & Andrykowski, 2007; 
Bower et aL, 2006). Patients who receive cyclic chemotherapy usually experience 
fatigue within a few days of treatment, which then declines until the next treatment cycle 
is initiated (Portenoy & Itri, 1999). For patients undergoing radiation therapy, fatigue 
appears to be cumulative, potentially increasing with time in treatment (Portenoy & Itri, 
1999). 
Prevalence rates vary dramatically in the research literature providing confusing 
estimates of the scope of this problematic symptom. In a 2002 review of 54 articles on 
cancer fatigue prevalence, Servaes, Verhagen, C., & Bleijenberg (2002a) identified a 
prevalence range of 25 - 99% in the literature. Some discrepancies appear to be 
population dependent, with expanded sampling along the continuum of the cancer 
experience trajectory accounting for some of the variation, and the operational definition 
of fatigue used in a particular study accounting for additional variance (Servaes et aI., 
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2002a). If patients were asked if they were fatigued and responded affirmatively without 
further delineation for a fatigue diagnosis, then the prevalence rates appeared to be 
higher and may be artificially inflated (Cella et aI., 2001; Servaes et al., 2002a). Patients 
who are in the process of undergoing adjuvant therapies almost universally report 
fatigue at some point in time during treatment. These prevalence numbers are 
substantially reduced when only post-treatment survivors are examined. Overall 
prevalence rates in disease-free survivors are estimated at between 17 - 30% of the 
total cancer survivor population (Servaes et aI., 2002a). These numbers are further 
reduced when the more stringent proposed ICD-10 neoplastic related fatigue diagnostic 
criteria are applied. 
Broeckel et aL (1998) authored one of the original studies supporting the 
persistence of CRF after adjuvant therapies concluded. The investigators completed a 
cross-sectional questionnaire-based survey combined with a researcher-conducted 
phone survey in 61 BCS who were 3 - 36 months post chemotherapy treatment and 
compared them to peer-matched controls (8roeckel et al.). Univariate analysis revealed 
that patients treated with chemotherapy agents reported more severe fatigue (P < .05) 
at 1.5 times the level of the controls, and higher levels of current fatigue (P < .05) 
(8roeckel et al.). Other studies have not SUbstantiated the impact of cancer treatment 
modality on the development of CRF in off-treatment populations (Reinertsen, 2010). 
In a later study, Bower et aL (2000) surveyed two large independent samples of 
breast cancer survivors to examine fatigue in survivors of breast cancer. Two centers, 
one in Los Angles and one in Washington, D.C. (N =1957) recruited women to examine 
health-related quality of life, depression, sleep and vasomotor symptoms. All survivors 
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were between 1 - 5 years post diagnosis and had completed all medical treatment for 
breast cancer. Data results were compared with two national sets of norms; one for 
general population scores on the Medical Outcomes Short-Form 36 (SF-36) as well as 
against baseline data from a large (N = 9,749) prevention trial for women at high risk for 
breast cancer (Bower et aL, 2000). 
Women with increased fatigue rated health-related quality of life as lower than 
women who had higher scores on the energy/fatigue scale (Bower et aL, 2000). 
Fatigued women were younger, less likely to be married, less affluent (p < 0.05), and 
more likely to have received combination treatment (Bower et aL, 2000). The results 
documented improvements in energy levels until the second year post-adjuvant 
therapies when gains stabilized; however, one-third of the women surveyed 
experienced persistent moderate to severe fatigue beyond the expected two years post­
diagnosis (Bower et aL, 2000). 
Bower et aL (2006) continued the aforementioned research study, conducting a 
longitudinal assessment of 817 disease-free BCS to evaluate the persistence of CRF 
five to ten years post-diagnosis, finding persistent fatigue in sixty-three percent of the 
women who were classified as fatigued in the original study (p.754). Fatigue prevalence 
rates for in both studies was 21 % with income as the only significant fatigue correlate in 
the second study (P = 0.05) (Bower et aL, 2006). 
Another longitudinal study examined predictors, prevalence and correlates of 
CRF in 317 long-term BCS at two time points: 2.5 - 7 years post-treatment, and 2.5 - 3 
years following initial data collection (Reinertsen et aL, 2010). Twenty-three percent of 
the sample documented CRF at both data collection points, a small sample 
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demonstrated resolution of initial fatigue (10%), and 16% exhibited new CRF at the 
second data collection point (Reinertsen et aL, 2010). This study was of interest not only 
for the length of time the participants were followed, but because the authors provided 
support for the development of new cases of CRF long after diagnosis and treatment 
conclude. 
The ICD-10 diagnostic criteria was applied to a nationally representative sample 
of 379 cancer patients living in the United States, the majority of whom were between 1 
- 5 years post-diagnosis (Cella et aL, 2001). Seventy-nine percent reported significant 
fatigue as the most common symptom, versus 21 % who reported no fatigue during the 
continuum of pre- to post-treatment (Cella et aL, 2001). When the CRF criteria were 
applied, only 17% ofthe sample satisfied the diagnostic criteria (Cella et aL, 2001). This 
is particularly significant because the ICD-10 criteria, as opposed to some other 
measures of cancer fatigue, specifically requests confirmation that the patient 
experiences dysfunction in areas of occupational performance for daily tasks as a result 
of CRF. The authors note that the prevalence rate obtained would appear to be more 
accurate for off-treatment survivors, but cautioned that these figures may still 
underestimate the population (Cella et aL, 2001). Persistence of the prevalence figures 
was demonstrated when 1 year off-treatment survivors were compared to 5-year off­
treatment survivors (Cella et aL, 2001) indicating that fatigue symptoms in the subset of 
individuals meeting the ICD-10 criteria do not easily resolve over time and may leave 
the survivor with persistent functional deficits. 
Prevalence rates in off-treatment survivors are sufficiently high to warrant 
continued research into the potential factors that underlie this common symptom. The 
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need for practitioners and survivors to attend to the potential serious ramifications of 
fatigue symptoms was underscored in a study by Groenvald et al. (2007). The authors 
conducted a longitudinal study (median follow-up 12.9 years) of 1,588 patients with 
breast-cancer in Denmark examining how self-perceived fatigue and other quality of life 
health measures might impact long-term survival and recurrence rates (Groenvald et aI., 
2007). The reported results indicated that fatigue was the only significant predictor of 
breast cancer recurrence (risk ratio 1.45, confidence interval 1.04 - 2.04, P =0.030), 
whereas emotional function emerged as the only predictor of overall survival (Groenvald 
et ai., 2007). Using psychoneuroimmunologic theory linking emotional distress and 
immune function, they concluded that mind-body interventions should be designed to 
decrease fatigue in order to exert an influence on recurrence, but could not conclude 
that potential interventions would ultimately alter survival rates (Groenvald et aI., 2007). 
Patient and Practitioner Awareness of CRF 
Awareness of cancer-related fatigue has increased as published research 
studies with an emphasis on quality of life in cancer patients become known, but 
practitioner and patient awareness of the pervasiveness of CRF remains a significant 
problem in clinical practice. As recently as 2010, Escalante, Kallen, Valdres, Morrow, 
and Manzullo noted that CRF remains an enigma to patients and providers alike, 
acknowledging that persistent CRF that develops into a chronic condition for a subset of 
survivors requires the focused attention of a dedicated multidisciplinary team of 
providers. 
An early study by Stone et al. (2000) demonstrated that patients experiencing 
fatigue attempted to discuss fatigue with their physician during most appointments 
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(25%) or at least once (43%) in a cross-sectional randomized survey. A startling 52% of 
the overall sample in the study had never discussed CRF with their physician (Stone et 
aI., 2000). The authors posited a potential explanation for this lack of identification as 
stemming from patient values and beliefs about their cancer experience. Forty-three 
percent of respondents surveyed felt that fatigue was an inevitable side effect of cancer 
treatment or the actual disease process, 34% thought it was unimportant, and 27% 
thought it was untreatable (Stone et aI., 2000). Only 22% believed that the fatigue 
symptoms could be controlled by some kind of intervention (Stone et aI., 2000). The 
authors concluded that patients did not discuss what they felt could not be ameliorated. 
Prevalence rates may therefore not be reflective of the total population of individuals 
with CRF, since patients who fail to report symptoms might not be included in data 
surveys that rely on health providers for identification of this population. 
In a nationally randomized study that assessed perceptions about CRF and 
prevalence rates in 419 patients, 200 patient-nominated caregivers, and 205 
oncologists, Vogelzang et al. (1997) reported that 78% of patients reported the 
experience of fatigue during the cancer treatment experience. The mean prevalence of 
daily fatigue for all groups was 32%, with younger adult patients experiencing more 
fatigue (45%), women experiencing more daily fatigue (36%) and one-year post­
diagnosis rates similar to those recently diagnosed (Vogelzang et aI., 1997, p.6). One 
third of patients reported that fatigue significantly impacted daily activities and routines, 
limited their ability to work, engage in social activities (57%). and participate in 
community mobility (48%) (Vogelzang et aI., 1997). Fatigue resulted in slowed task 
completion (69%), reduced task completion (49%). or rendered them unable to care for 
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their families (Vogelzang et aI., 1997). Sixty-one percent reported that fatigue was the 
primary symptom affecting daily life with younger patients and working patients 
reporting that fatigue impacted life functions more than pain (Vogelzang et aI., 1997, 
p.6). Patients did not view fatigue as manageable with only 50% of patients in this study 
reported ever bringing this concern to the attention of their treating physician 
(Vogelzang et aI., 1997). Seventy-three percent of respondents who vocalized about 
the fatigue symptoms to their oncologist reported that they were told this was "a 
symptom to be endured" (Vogelzang et aI., 1997, p.8). Primary recommendations from 
the surveyed oncologists identified rest as the potential solution to these symptoms 
(Vogelzang et aI., 1997). Patients and oncologists reported few prescriptions or ideas 
for treating fatigue, with oncologist most often advising rest (68%), medication (42%), 
diet or nutrition (30%) and infrequently, exercise (7%) (Vogelzang et aI., p.9). Dimeo, 
Stieglitz, Novelli-Fischer, Fetscher, & Keul (1999) suggested that during adjuvant 
therapies, patients altered activity choices in an attempt to self-modulate fatigue and 
"down-regulate their level of activity" secondary to deconditioning, thus furthering a self­
perpetuating cycle that led to the need for increased rest (p.2274). Vogelzang et al. 
concluded that patients who received specific treatment for CRF felt that it was a 
controllable symptom and provided some relief (66%); however surveyed oncologists 
only believed that attempted treatment successfully impacted 17% of patients with CRF 
(1997, p.9). 
Mortimer et al. (2010) documented an exploratory study to examine patient 
descriptions of the functional impact of fatigue on function utilizing 26 articles from a 
literature search of previously published research. The patients documented functional 
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limitations in activities of daily living, instrumental activities of daily living and 
socialization and indicated that survivors begin to self-limit daily tasks and decrease 
expectations of task accomplishment (p. E197 -199). 
Fatigue and Other Symptomatology 
Additional cancer-related or treatment-related symptoms have been correlated 
with CRF in numerous research studies. Of specific concern is the ongoing controversy 
in the literature surrounding the meaning or presence of depressive symptoms in 
individuals experiencing CRF. Twenty-five percent of patients with a cancer diagnosis 
are also diagnosed with a major depressive episode at some time during the course of 
their illness, with highest risk for depression in those with advanced disease, 
uncontrolled cancer-related symptoms such as pain, or a prior history of a mood 
disorder (Bower et aI., 2000; Portenoy & Itri, 1999). The importance of understanding 
the presence of depression is highlighted when reviewing the anticipated ICD-10 CRF 
diagnostic criteria which denote the need to rule out major affective disorders or other 
comorbid psychiatric disorders in order to assign a diagnosis of CRF (CDC, 2007; Cella 
et aI., 2001). 
In a previously referenced study by Broeckel et al. (1998), the presence of a prior 
psychiatric disorder was not statistically significant in determining CRF; only a current 
disorder accompanying the breast cancer emerged as significant lending credence to 
the idea that CRF contributes to depression and not vice versa. Spelten et al. (2003) 
found statistically significant results demonstrating decreases in fatigue, physical 
complaints and psychological distress from the first to last data collection in a 
prospective inception cohort study with 12 months follow-up of 195 previously employed 
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patients with a primary recent (4-6 months) cancer diagnosis (Spelten et aI., 2003). 
Upon baseline assessment, fatigue and depression were correlated (r =0.54), as were 
fatigue and physical complaints (r =0.61), sleep problems (r =0.33), and emotional 
distress (r =0.32) (Spelten et aI., 2003). Physical complaints were related to 
depression and sleep (r =0.50) and depression was related to psychological distress (r 
> 0.50) (Spelten et aI., 2003). 
Fatigued women also reported greater frequency and number of menopausal 
symptoms than non-fatigued women, and identified more depressive symptoms (Bower 
et aI., 2000). The predictive model described by the latter was significant (P =0.0001) 
with depression (p = 0.001) and pain (p =0.001) emerging as the strongest predictors of 
CRF (Bower et aI., 2000). Bower et al. (2000) concluded that even though their results 
demonstrated that depression was the strongest predictor of fatigue, there was no 
causal relationship citing the reciprocal nature of fatigue symptoms such as diminished 
occupational functioning preceding depressive mood or depressive mood causing 
fatigue. In a 2006 study, Bower, Ganz, & Desmond et al. affirmed their previous 
findings. Fatigued women were more depressed, had increased comorbid pain, higher 
fear of cancer recurrence, and were more likely to have undergone both chemotherapy 
and radiation than non-fatigued women (Bower et aI., 2006). 
Sadler et al. (2002) found that increased reporting of depressive symptoms were 
higher in individuals meeting the ICO-10 criteria (P = 0.02). Since decreased energy is a 
significant symptom in individuals meeting the DSV-IV-TR criteria for a depressive 
mood disorder, this might argue in favor of CRF as a manifestation of an underlying 
mood disorder. However, Sadler et al. concluded that the ICD-10 CRF criteria are 
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designed to specifically eliminate those individuals with an underlying mood disorder 
before the criteria can be accurately applied (2002). 
Researchers have also explored the potential for CRF existing as part of a 
defined symptom cluster. Dodd, Miaskowski, & Paul (2001) investigated linkages 
between fatigue, pain, and sleep dysfunction in a longitudinal study with 93 participants 
who had recently completed chemotherapy. The Karnofsky Performance Scale (KPS), a 
clinical assessment tool used to classify patients based on the extent of medical 
intervention needed, patient disease prognosis, and a measure of functional 
performance, revealed the emergence of fatigue as the highest rated predictor for 
changes in KPS scoring, with pain emerging as a secondary predictor (Dodd et aL, 
2001). The study's findings refuted their hypothesis that fatigue, pain, and sleep 
constituted a cluster, and lends credence to the view of cancer-related fatigue as a 
multi-faceted single entity (Dodd et aL, 2001). 
Cancer-Related Fatigue Instrumentation 
A gOld-standard measurement tool for CRF has yet to be identified. Over 25 self­
perception tools assessing CRF, ranging from single item to complex multifaceted 
scales, are available for use with varying psychometric reliability and validity (Mortimer 
et aL, 2010). Previous research studies have validated instruments capable of defining 
aspects of CRF, but none have emerged in either research or clinical settings as the 
outcome measure of choice. Difficulties in measurement are directly attributable to the 
problem of defining the parameters of this multidimensional construct. For example, 
instruments that are capable of measuring the physical attributes of fatigue, may not 
record the undesirable consequences that interfere with daily life. Attempts to refine the 
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CRF construct and discriminate it from other forms of fatigue have resulted in the 
development of ICD-1 0 diagnostic criteria. 
The development of the proposed diagnostic category for CRF for the next 
10thpublication of the International Classification of Disease, edition, Clinical 
Modification (ICD-10 CM) (Sadler et aL, 2002; Portenoy, & Itri, 1999), should assist 
clinicians in the identification of patients experiencing CRF. The proposed criteria have 
been studied to validate the symptom list and determine prevalence rates (Young & 
White, 2006). For researchers, a formal diagnosis of neoplastic related fatigue offers the 
potential to identify and target interventions meeting the needs of severely fatigued 
patients living with cancer; however the criteria poses the risk of excluding individuals 
with fairly significant fatigue who may fall short of the required six symptoms for 
diagnosis. 
Young and White (2006) utilized the ICD-10 criteria to estimate prevalence rates 
of CRF in 69 disease-free BCS in Scotland and to further validate the draft criteria due 
to concerns regarding discrepancies in the literature between higher reported 
prevalence rates when self-perceived fatigue questionnaires were used with cancer 
survivors versus prevalence when the new criteria was applied. Twenty-three percent of 
participants met symptoms criteria, while 18.8% met the determination of interference 
with daily function (Young & White, 2006, p.33). Those meeting the criteria reported 
daily fatigue patterns that worsened as the day progressed, had received more types of 
adjuvant therapy, and experienced higher psychological distress (Young & White, 
2006). They also reported a broader fatigue experience that impacted daily life tasks, 
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experiencing fatigue an average of 2.7 more days per week and reported increased 
anxiety, depression, and psychological distress (Young & White, 2006, p.35) 
Sadler et al. (2002) evaluated off-treatment fatigue in 51 individuals who had 
previously undergone autologous or allogenic blood or marrow transplantation to 
establish validity for a structured CRF interview based on the P-ICD-10 CM. Results 
indicated that the interview discriminated between fatigued and non-fatigued 
populations, identifying 43% of the sample (n = 22) experiencing fatigue daily or nearly 
every day during at least two weeks within the past month (p. 409),77% of those who 
were fatigued perceived the need to struggle to overcome activity, and 36% reporting 
that they had difficulty completing daily tasks due to fatigue (Sadler et aI., 2002, p.410). 
Twenty-one percent of the sample (n = 11) met at least 6 of the 11 symptoms in the 
criteria, defined as the cut-off for a diagnosis of CRF (Sadler et aI., 2002, p. 410). 
A Belgian study of 834 cancer patients established cut-off scores for the ICD-10 
for the purposes of diagnosis (Van Belle et aI., 2005). Descriptive statistics revealed that 
79% of fatigue-positive patients documented "difficulty completing daily tasks attributed 
to feeling fatigued" versus 24% of non-fatigued patients, and 65% of fatigue-positive 
patients reported "decreased motivation or interest in engaging in usual activities" 
versus 24% of non-fatigued patients (Van Belle et aI., 2005, p.249). 
In a randomized representative sample of U.S. households with individuals with 
cancer (Cella et aI., 2001) the prevalence of CRF was found in 17% of 379 individuals 
evaluated using the guidelines for symptoms and functional impact of the ICD-10 
criteria. Committees of researchers working to refine the definition of CRF have 
suggested that the ICD-10 diagnosis for CRF include four criteria: "the presence of CRF 
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for 2 or more weeks, significant distress or impairment, consequence of cancer or its 
treatment, and absence of comorbid psychiatric disturbance (Mortimer et aI., 2010, p. 
1332)." 
The F ACIT -fatigue scale was used to assess a population of cancer patients with 
and without anemia compared to a general U.S. sample population (Cella, Lai, et aI., 
2002). The general population, as expected, reported lower levels of fatigue than cancer 
survivors regardless of anemia status (p < .0001). Using a cut-off score of 43, the 
FACIT-fatigue was capable of distinguishing between the general population and cancer 
survivor with and without anemia (sensitivity 0.92; specificity 0.68). 
Functional Assessment of Cancer Therapy - Fatigue Subscale (FACT-F). 
Based on prior studies and psychometric stability, the Functional Assessment of Cancer 
Therapies (FACT) was chosen as the fatigue scale for this study. FACT is a system of 
well-researched self-report questionnaires designed to evaluate various QOL impact of 
cancer therapies on individuals living with cancer (Yellen et aI., 1997). The FACT is a 
subset of the larger Functional Assessment of Chronic Illness Therapy (FACIT) system, 
a vast test bank of questions designed for a variety of health-based conditions and 
translated into 43 languages (Stasi et aI., 2003). Subsumed, as part of the FACT 
system, is a tool that was designed to assess anemia (FACT-An) in individuals 
undergoing treatment for cancer. Contained within the FACT-An is a 13-item subscale 
designed to assess cancer-related fatigue since fatigue is foremost among symptoms of 
anemia. Subsequent research validated the FACT -F as a separate assessment 
instrument from the FACT-An questionnaire that can be used across the cancer 
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spectrum to assess fatigue-based symptoms (Van Belle et aI., 2005; Hwang, Chang, 
Rue, & Kasimis, 2003; Passik et aI., 2002; Yellen et aI., 1997). 
The FACT -F is composed of the same 13-item fatigue subscale described in the 
FACT-An, as well as questions from the FACT-G on information related to the impact of 
fatigue on quality of life concerns such as physical, social, emotional, and functional 
status (Cella, Eton, Jin-Shei, Peterman, & Merkel, 2002; Yellen et aL, 1997). Each item 
retrospectively assesses the experience of fatigue over the past seven days and is 
rated on a 5-point Likert scale, from 0 "not at all" to 4 "very much so" (Cella, Lai et aL, 
2002; Van Belle et aI., 2005). Higher scores are indicative of better functioning (Yellen 
et aI., 1997). Estimated completion time for the complete FACT-F is 10 minutes; the 13­
item subscale would therefore take less than 10 minutes to complete. The FACT system 
has a reading level of 6.0, making it suitable for a range of populations and can be 
administered via verbal interview or questionnaire (Yellen et aI., 1997). The FACT-F has 
been documented as a suitable measure of self-perceived fatigue in populations with 
cancer (Mustian et aI., 2004; Bennett, Goldstein, Lloyd, Davenport, & Hickie, 2004; 
Stasi et aL, 2003; Yellen et aI., 1997). Van Belle et at confirmed the validity in the 
FACT-F subscale and unidimensional measure of fatigue for systematized assessment 
of fatigue in individuals with cancer (2005). 
Another study delineated a cut-off score of 37 out of the 52 possible points on the 
FACT-F subscale as constituting moderate to significant fatigue in a population of 
women with breast cancer undergoing and following radiation therapy (Wratten et aI., 
2004), but the sample size of 52 was small. In this study, baseline fatigue subscale 
scores, along with neutrophil and red blood count, were found to be predictive of 
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membership in fatigued versus non-fatigued groups at 6-week post-treatment (Wratten 
et aI., 2004). The cut-off score was chosen based on an earlier study which 
extrapolated this test score from high correlation scores between the FACT-F and Brief 
Fatigue Inventory (BFI). The relationship between the FACT-F and BFI was supported 
by the work of Hwang et al. (2003) who found that a factor analysis yielded 91% of the 
variance through loading on one factor between the FACT-F and BFt. Van Belle et al. 
(2005) established that a cut-off score of 34 allowed for prediction of ICO-1 0 status in 
93% of 470 patients (sensitivity 0.91, specificity 0.75) (p.251). For this proposed study, 
the Van Belle cut-off score of 34 will be considered to define significant fatigue on the 
FACT-F. 
CRF Summary 
The exigent circumstances that surround the imperative to develop interventions 
for CRF are noted as the BCS population grows in response to early detection with 
increasing survival statistics. These women remain at risk for the development of 
secondary morbidities such as fatigue and upper extremity deficits after adjuvant 
therapies conclude directly impacting occupational performance in all spheres of life. 
The majority of the research literature has focused on defining the parameters of the 
construct and determining prevalence rates. There is still a paucity of intervention 
research addressing CRF and functional status. The potential for long-standing health 
deficits and functional limitations that spiral from the persistent experience of CRF, 
including the potential for cancer recurrence, supports concerted efforts directed toward 
furthering our understanding of CRF and its impact on daily life. 
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Upper Extremity Function 
The range of deficits and impairments found in the upper extremity secondary to 
breast cancer diagnosis, surgery, or adjuvant therapies is broad, thus defining the 
impact of these symptoms depends upon the research variables of interest, definitions 
of function, instrumentation choices and when data is obtained. There is a sizable body 
of literature describing the impact of breast cancer surgery and adjuvant therapies on 
upper extremity physical function (Hayes et aI., 2005; Collins et aI., 2004; Rietman et 
aI., 2004), but less is known about the impact of residual symptoms on function in BCS. 
Incidence rates for all problems vary from 7 - 80%, with pain and sensory deficit 
estimates ranging from 9 - 68%, lymphedema from 2 - 17%, and decreases in range of 
motion from 3 - 73% (Hack et aI., 2010). Lymphedema of the ipsilateral extremity is a 
potential complication of breast cancer surgery and treatment, with differing incidence 
and prevalence numbers reported due to variations in research study parameters, 
impacting 15 - 20% of BCS (Petrek & Heelan, 1998). Hack and colleagues documented 
that multiple treatment and demographic factors, often in combination, influence 
persistent symptoms including pain, lymphedema, and ROM on the results of a 
Canadian multi-center assessment of persistent arm dysfunction in 316 BCS (2010). 
A focal point for recent literature has compared the significance on upper 
extremity function resulting from axillary lymph node dissection [ALNO] or sentinel 
lymph node biopsy [SLNB] during the diagnostic process (Rietman et aI., 2006). Node 
biopsy and particularly radiation therapy may be accompanied by upper extremity 
sequelae including muscle weakness, numbness. pain, paresthesias, loss of shoulder 
range of motion, tightening of scar tissue, and risk for or exacerbation of lymphedema 
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(Karki et aI., 2005). These resulting deficits can further complicate hand function in the 
affected extremity (Karki et aI., 2005). The consequences of reduced physical function 
in the upper extremity and hand directly impact occupational performance in all areas of 
occupation (Collins et aI., 2004). The upper extremities typically provide the means 
through which performance of most activities of daily living and instrumental activities of 
daily living take place. Therefore, marked impairment in upper extremity function will 
likely also impact life role fulfillment and quality of life. 
Surprisingly, research on CRF has not explored the interrelationships between 
upper extremity deficits resulting from surgery or adjuvant therapies on energy usage 
and the experience of fatigue. Linkages within the CRF body of literature clearly identify 
occupational performance deficits resulting from the fatigue experience (Ashbury, 
Findlay, Reynolds, & McKerracher, 1998). It is also acknowledged that both CRF and 
upper extremity limitations are commonly experienced by many BCS and diminish 
quality of life. These two distinctive impediments place an undue burden on survivors' 
abilities to perform IADLs, work-related tasks, leisure and socialization, and in turn 
impact family relationships (Hayes et aI., 2005; Taylor & Currow, 2003). 
In light of the emphasis on engagement and partiCipation in all life spheres 
emphasized by the World Health Organization (2001), this section stresses the 
importance of the impact of upper extremity function on occupational performance in life 
tasks and roles. Definitions for terminology related to functional performance and study 
variables are located in Appendix A. It concludes with a description of the research 
literature supporting the use of the Disability of the Shoulder, Arm, and Hand (DASH) as 
an outcome measurement tool for this proposed study. 
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Impact of Breast Cancer on Upper Extremity Physical Parameters 
Hladiuk, Huchcroft, Temple, & Schnurr (1992) reported results from a pilot study 
to examine objective measures of upper extremity function when compared with the 
contralateral extremity in a sample of 57 BCS who underwent ALND alone or in 
combination with surgical tumor resection, describing follow-up from 6 - 15 months 
post-surgery. The most improvement in range of motion occurred by month 6 and 
roughly stabilized thereafter, with external rotation demonstrating the highest level of 
residual limitations in 12% of the participants (Hladiuk et aI., 1992). Of particular interest 
in this study was the finding that 42% of the women experienced ongoing, measurable, 
diminished function after one year post-surgery (Hladiuk et al., 1992). Diminished grip 
strength was documented in 16% of the participants, with a reduction of 12 -18% when 
compared to grip strength of the non-surgical arm, although arm dominance was not 
related to recovery of physical function (Hladiuk et aI., 1992, p.49). Women who 
continued to follow the typical health professional BCS guidelines for post-surgical 
upper extremity exercise a year following surgery documented a trend toward less 
impaired grip strength, but the small population size and the decision of the authors to 
alter the alpha level to 0.25 brings the results into question (Hladiuk et aI., 1992). 
The impact of dominance and treatment side is a critical issue when examining 
functional performance resulting from upper extremity deficits after adjuvant treatment 
concludes and is another area of breast cancer morbidity that has been underreported. 
Hayes et al. (2005) examined the relationships between objective upper body function 
and subjective questionnaires on quality of life measures in Australian BCS under the 
age of 75 using the Disability of Arm, Shoulder, and Hand (DASH) questionnaire, the 
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Functional Assessment of Cancer Therapy, Breast (FACT-B), and upper body strength, 
range of motion, and grip strength as objective measures. Radiation therapy emerged 
as the only adjuvant treatment associated with decreased flexibility, but only when the 
non-dominant side was treated (Hayes et aI., 2005). When the dominant side was 
treated, participants consistently demonstrated greater objective upper body function for 
strength, endurance, and grip strength (p < .001), but simultaneously reported lower 
quality of life (Hayes et aI., 2005). Similar findings were observed for the IADL task of 
childcare which was positively correlated with hand grip strength, but negatively 
associated to self-perceived function (Hayes et aI., 2005, p.3-4). Income. extensive 
axillary node dissection, and lymphedema were all associated with factor with 
decreased upper body function (Hayes et aI., 2005, p.4). This unexpected finding that 
the dominant treatment side demonstrated increased function was first identified in an 
earlier study by Swedborg and Wallgren (1981). The authors reported higher grip 
strength scores and more degrees of external rotation on the dominant affected side, 
with 34 - 44% of BCS demonstrating better grip strength and 40 - 48% with improved 
range of motion (Swedborg & Wallgren, 1981). The authors conjectured that women 
whose dominant side was affected still needed to use the arm functionally resulting in 
increased objective measures, but greater recognition of subtle losses in function 
resulted in less satisfaction in performance (Hayes et aI., 2005). 
Node Dissection and Adjuvant Therapy Impact to the Upper Extremity 
It was previously mentioned that the methodology used for the staging of breast 
cancer frequently involves dissection of the lymphatic nodes in the axilla. Historically, 
ALND was the standard of care for decades with multiple nodes removed for biopsy 
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often at the same time as surgical resection of solid breast tumors. This procedure is 
identified as "the most prognostic variable in patients with breast cancer "(Rietman et 
aI., 2003, p.229). However, ALND has been associated with the development of upper 
limb dysfunction in BCS (Rietman et al., 2006; Rietman et aI., 2003). Nodal staging 
during the last decade has been supplanted by SLNB (McGuire et aI., 2009, p. 2682). 
Breast conserving surgery with follow-up radiotherapy, chemotherapy, hormonal or 
combination therapies further accelerated the acceptance of this method of node 
removal. However, many women with positive sentinel nodes on biopsy will require 
further axillary node removal to obtain an accurate diagnosis and differentiate treatment 
choices. Therefore node removal remains a great source of concern for women with 
breast cancer. 
The advent of SLNB, as opposed to ALND, as the prevailing standard of care for 
initial surgical node removal and diagnosis has altered the landscape for BCS and 
researchers. The National Cancer Institute describes sentinel node biopsy as the 
process of locating and systematically examining the most likely lymph nodes to be 
affected by cancer cells from the primary tumor (2005). Radioactive dye is used via 
Iymphoscintigraphy, followed by the use of a gamma probe to identify the sentinel 
nodes for surgical biopsy (Rietman et aI., 2006). Typical ALND regional clearance of 
many or most nodes may not be necessary if the sentinel nodes, once examined by 
pathologists, are clear of metastasized cancer cells (NCI, 2005). SLNB is usually 
performed as a separate procedure from breast tumor resection; therefore women may 
need to undergo more than one invasive procedure. Removing fewer lymph nodes for 
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staging and diagnostic purposes has the potential to cause less arm morbidity; however 
current research has not fully established this link (NCI, 2005). 
A decade of literature suggests that a significant relationship exists between the 
number of lymph nodes removed and the development of subsequent arm morbidity 
and sequelae such as lymphedema (Hack et aI., 2010). While SLNB has become an 
alternative diagnostic procedure resulting in lower numbers of removed nodes, research 
has not yet established this techniques' accuracy in enhancing survival rates or 
identifying cancer recurrence (NCI, 2005). 
There is also recent evidence that mastectomy rates are increasing again after 
years of diminishing percentages of women undergoing this more extensive surgery 
(McGuire et aI., 2009; Katipamula et aI., 2009). Identified factors accounting for this 
unexpected rise include an increase in contralateral prophylactic mastectomies followed 
by reconstruction as genetic testing provides women with increased information that 
may alter collaborative decision-making with the oncology team, as well as decisions of 
women to request more extensive surgery in order to try to avoid or decrease radiation 
or chemotherapy (McGuire et aI., 2009). 
The impact of SLNB on upper extremity function and self-perceived occupational 
performance and quality of life was the focus of a study of 181 BCS in the Netherlands 
in a pretest-posttest design examining upper limb, function-based, and quality of life 
assessments from the day before surgery to a second time period two years post­
surgery (Rietman et aI., 2006). ALND was predictive of negative adverse effects two 
years after treatment concluded in objective physical measures including decreased 
grip strength, decreased shoulder abduction and some diminished aspects of ADL 
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status and quality of life (Rietman et aI., 2006). Individuals who had undergone radiation 
therapy further demonstrated diminished range of motion and increased arm swelling 
(Rietman et aI., 2006). Women who underwent SLNB experienced less adverse effects 
in all areas measured (Rietman et aI., 2006). 
Radiation therapy was also implicated as a contributing factor in upper extremity 
morbidity in a much earlier study of 475 BCS who underwent modified radical 
mastectomies in Stockholm, and were randomized to pre-surgical radiation therapy, 
post-surgical radiation, or no radiation therapy (Swedborg & Wallgren, 1981). One 
hundred sixty of the original cohort underwent further physical evaluation for volumetric 
lymphedema measurement, shoulder range of motion, and grip strength (Swedborg & 
Wallgren, 1981). Following surgery and/or radiation, it was noted that BCS who did not 
undergo radiation therapy experienced less edema, had increased mobility, and a trend 
toward increased grip strength in the affected upper extremity, but with no significant 
differences for the two radiation therapy groups (Swedborg & Wallgren, 1981). 
Conflicting results on the role of chemotherapy in the development of 
lymphedema and functional impairments have been reported. Rietman et al. (2004) 
found that radiotherapy was the most significant predictor of loss of range of motion, 
with chemotherapy contributing only minor predictive interest. Paskett et al. (2007) 
focused on the prevalence of lymphedema and resulting impact to quality of life in a 
sample of 627 women recruited from four nationally recognized cancer centers. Lymph 
node removal was the most significant factor in the development of lymphedema (P = 
0.003) with hazard equations demonstrating an increasing risk of 2.2% for every 
additional node removed (Paskett et aI., 2007, p.779). The unexpected finding was the 
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high risk of lymphedema in those receiving chemotherapy (76%), as well as increased 
risk in married women. Paskett et al. conjectured that increased lymphedema risk for 
married women might be related to more frequent engagement in IADL tasks (2007). 
ADL and Upper Extremity Instrumentation 
The predicament of how to measure fatigue outcomes is echoed by the same 
difficulties when comparing studies that measure occupational performance or upper 
extremity function. Rietman et al. (2003) conducted a literature search yielding 15 
studies that met their criteria to explore the effects of late morbidity on function and 
quality of life. They documented the lack of uniformity, documented criteria, and 
psychometrically sound assessment tools to measure ADL and IADL function, as well 
as in tools those chosen to measure upper extremity dysfunction. For the proposed 
study, one measure has been chosen to assess self-perceived ADUIADL function and 
upper body symptoms. The Disabilities of the Arm, Shoulder, and Hand (DASH) was 
chosen due to its reliable and validated psychometric properties with a variety of 
patients with upper extremity dysfunction (Jester, Harth, Wind, Germann, & Sauerbeir, 
2005; Beaton, Katz, Fossell, Wright, & Tarasuk, 2001; SooHoo, McDonald, Seiler, & 
McGillivary, 2002; Hudak, Amadio, Bombardier, & Upper Extremity Collaborative Group 
[UECG], 1996). 
Disabilities of the Arm, Shoulder, and Hand (DASH). Developed by the 
Institute for Work and Health in Toronto, Canada, and the American Academy of 
Orthopedic Surgeons in 1996, the Disabilities of the Arm, Shoulder, and Hand 
questionnaire (www.dash.iwh.on.ca/index.htm) is a standardized quality of life outcomes 
measure designed to assess patient perceptions of upper extremity musculoskeletal 
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disability causing limitations in ADL and IADL tasks, as well as perceived extremity­
related symptoms such as pain or weakness (Hudak et aI., 1996; Kennedy, Beaton, 
Solway, McConnell, & Bombardier, 2011). It consists of a 30-item questionnaire asking 
patients to assess their ability to perform common ADL and IADL tasks within the prior 
week using a 5-point Likert scale with answers ranging from "not at all" to "extremely." 
The instrument has been translated into 17 different languages resulting in an 
increasing body of international literature on upper extremity musculoskeletal disorders 
to support the use of this instrument in assessing perceived disability, as well as health 
burden (Gummesson, Atroshi, & Ekdahl, 2003). 
Normative data in the DASH from a United States random population sample 
using the National Family Opinion's household panel database matched to the U.S. 
census has been documented (Hunsaker, Cioffi, Amadio, Wright, & Caughlin, 2002). In 
this nationally representative sample, the DASH exhibited Cronbach's alpha ranging 
from 0.94 to 0.98, Pearson correlations of 0.49 to 0.87, and item internal consistency of 
100 (Hunsaker et aI., 2002, p.213). Mean scale scores for global function on the DASH 
(n =1706) was 10.10 (SO 14.68); Sports optional scale (n =1113) 9.75 (SO 22.72); and 
Work optional scale (n =1610) 8.81 (SO 18.37) (Hunsaker et aI., p.211, 2002). 
Reliability of the DASH was demonstrated in this population with a Cronbach's alpha 
coefficient above 0.9 (Gummesson, 2003, p.4). 
Construct validity of the DASH as an extremity specific quality of life outcome 
measure was supported by data from SooHoo, McDonald, Seiler, and McGillivary 
(2002) in a study examining correlations of the DASH to the Medical Outcomes Study 
Short-Form 36 (SF-36), a well established quality of life outcome measure with available 
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standardized normative scores for the U.S. population. The hypotheses were confirmed 
with moderate correlations observed ranging from 0.36 for the general health subscale 
to .62 for the role emotional subscale (SooHoo et al., 2002). 
Beaton et at (2001) also assessed the psychometric properties of the DASH, 
examining within-subject responsiveness, reliability and validity in a study sample of 172 
patients from major hospital centers in Toronto (n = 109) and Boston (n = 91) engaged 
in treatment for a variety of upper extremity disorders. Working patients demonstrated 
lower DASH disability scores than those who were unable to work due to upper 
extremity dysfunction, demonstrating statistically significant discriminative validity (26.8 
vs. 50.7, t =-7.51, P < .0001) between these groups, as well as between those 
diagnosed with shoulder vs. hand conditions (Beaton, 2001, p.135). Reliability of the 
DASH as measured by Cronbach's alpha was reported as 0.97 (Beaton et aI., p.140) 
during baseline data collection and is further supported by data from Gummesson et al. 
(2003), documenting Cronbach's alpha levels above 0.90. 
Convergent construct validity was also found in Pearson correlations exceeding 
0.70 between the DASH and joint-specific measures, the Shoulder Pain and Disability 
Index (SPADI) and the Brigham questionnaire for hand and wrist dysfunction (Beaton, 
2001, p.135). Pearson correlation using data over the course of 3 - 5 days from 56 
subjects, indicating that they had no change in deficits during that time period, was 0.96 
and Spearman ranked correlation was 0.96 at the 95% CI (Beaton et aI., 2001) 
indicating high test-retest reliability. The ICC was 0.96 (95% CI) and the SEM of 4.6 
points provided a minimally detectable change (MIDC) of 12.75 on the 100-point scale 
or 10.7 of 100-points using a 90% MIDC (Beaton, 2001, p.135). This is also consistent 
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with the 10 point MIDC described by Gummesson et aL (2003) and Hunsaker et aL 
(2002). Results indicate that the DASH is a valid, reliable, and responsive tool for single 
or multiple disorders in the upper extremities. 
One dissenting study from Australia questioned the discriminative validity of the 
instrument. Dowrick, Gabbe, Williamson and Cameron (2006) evaluated the use of the 
Short Musculoskeletal Functional Assessment (SMFA) and the DASH comparing three 
groups of individuals with upper extremity injuries, lower extremity injuries, and a control 
group. Reported data supported previous DASH validation studies to identify upper 
extremity dysfunction, but noted that the lower extremity group demonstrated higher 
scores on the DASH than the control group (z =-7.1, P < .001) (Dowrick et aL, 2006, 
p.526). While this finding was not supported by other research, identification of some 
lower limb disability using the DASH provides support for the complexities inherent in 
ADl and IADl tasks. If certain ADl and IADl tasks delineated on the DASH were 
subjected to an activity analysis, they might not solely be comprised of upper quadrant 
requirements as these tasks are typically performed by adults in daily life. The authors 
cautioned that investigators should attempt to insure that only upper extremity disorders 
exist when choosing the DASH as an upper quadrant outcome measure (Dowrick et aI., 
2006). In that study, the Dowrick et al. altered the instructions to request information 
about lower extremity function. The standardized instructions developed by the DASH 
developers will be used since all subjects in this study have experienced some type of 
medical intervention in one breast that has the potential to impact upper quadrant 
function. 
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One study was located describing the use of the DASH as a measure of 
perceived upper extremity function for research on recovery advice given to women with 
breast cancer (Round et aI., 2006). All of the research studies previously described 
(Beaton et aI., 2001; SooHoo et aI., 2002; Gummesson et aI., 2003) support the use of 
the DASH as an outcomes measurement with established psychometric properties that 
can be used to assess upper quadrant dysfunction, including upper extremity function in 
women with breast cancer. 
Impact of Fatigue and Upper Extremity Dysfunction on Occupational Performance 
The consequences of cancer-related fatigue are disturbing, but the negative 
impact of fatigue on occupational performance highlights the need to further define the 
functional implications. Occupational performance of IADLs suffered most from the 
impact of CRF in the daily lives of survivors, however ADLs that involve lifting, pushing, 
carrying, or tasks that demand increased shoulder range of motion can be affected as 
well (Hayes et aI., 2005; Stariano & Ragland, 1996). Patients with advanced stage 
cancer reported more significant ADL deficits that increased as the disease process 
progressed (Taylor & Currow, 2003). In 1998, Ashbury et al. surveyed 913 Canadian 
cancer survivors to assess the perceived relationship between fatigue and function. 
Seventy-eight percent of the respondents reported moderate to severe interference with 
occupational performance (P < .0001) with work, socialization, family relationships, and 
personal finances highlighted as the most affected activities. In the 2000 study by 
Stone et aI., the authors also documented specific areas of occupational performance 
that were most frequently impacted. These included work-related functions, the ability to 
enjoy life, and sexual relations (Stone et aI., 2000). Broeckel et al. (1998) documented 
74 
the negative impact on employment by fatigue symptoms (P < .05). Aside from the 
emotional factors that accompany the ability to work, the economic impact of loss of 
work is large with 75% of survivors and 40% of caregivers noting changes in the status 
of their employment attributable to fatigue (Spelten et aI., 2003). 
Servaes, Verhagen, S., & Bleijenberg (2002) compared a sample of 150 younger 
disease-free pre-menopausal BCS in the Netherlands (6 - 70 months post-adjuvant 
therapies) with 78 peer-nominated controls to assess various dimensions of the fatigue 
construct. Results indicated that 38% of the BCS met the criteria for severe fatigue on 
self-perceived fatigue measurement tools and 16% met the criteria for non-severely 
fatigued status, whereas only 11 % of the control group met the same criteria. Severely 
fatigued BCS reported more functional impairments than controls, although the authors 
found no difference in task demands or hours spent in daily tasks between the groups 
using a prospective recording form for ADL and IADL activity that was completed four 
times daily over 12 days; their findings indicated that BCS performed the same tasks as 
disease-free counterparts, but performance was more difficult due to fatigue (Servaes, 
Verghagen, S., & Bleijenberg, 2002). BCS were also employed for fewer hours per day 
than the control counterparts and fatigued BCS also reported less physical activity and 
less social functioning than controls or less-severely fatigued BCS (Servaes, 
Verghagen, S., &Bleijenberg et aI., 2002). 
Not all studies have examined CRF as a correlate to occupational performance 
deficits, yet many have clearly identified the loss of functional status in BCS from 
specific upper extremity deficits. Hayes et al. (2005) identified specific ADL and IADL 
tasks that caused difficulty for BCS, stratifying difficult tasks into those that were usually 
75 
performed more frequently to calculate which daily tasks created the greatest overall 
burden. The tasks most frequently cited were "carrying a moderate weight, washing the 
upper part of the back, opening a tight jar, and doing up a bra" (p.257). BCS also 
identified other difficulties in IADLs that included carrying, pushing or pulling tasks such 
as laundry and grocery shopping; repetitive tasks such as vacuuming, raking, or 
sweeping; and tasks that involved reaching overhead (Hayes et aI., 2005). The 
presence of lymphedema increased task burden by 15 - 21 % (Hayes et aI., 2005). 
Taylor and Currow (2003) conducted a cross-sectional prevalence survey in 104 
outpatients and 13 inpatients to identify unmet ADL and IADL needs in a mixed cancer 
population in Australia. Thirty-percent of patients identified unmet ADL and IADL needs 
that might benefit from assistance to develop alternative techniques or the use of 
adaptive equipment, with women identifying more unmet needs than men. Work, 
leisure, and driving were the most frequently cited concerns (Taylor & Currow, 2003). 
A qualitative study of twenty-four BCS in Australia confirmed previous literature 
results documented the impact of upper extremity impairments on occupational 
performance and continued complaints of upper extremity dysfunction in 50% of the 
participants six months post-surgery (Collins et aI., 2004). IADL task performance was 
impacted most once BCS had completed all surgery and adjuvant therapies, but were 
further complicated by perceived fatigue and emotional distress (Collins et aI., 2004). 
Task deficits reported in this study included "sleeping on the affected side, putting 
washing on the line, putting curtains up, washing the windows, gardening, writing, 
cutting vegetables, ironing, computer work, carrying a handbag, doing up a bra, wearing 
a bra and buying a comfortable one, and driving in a car (seatbelt wearing, putting 
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hands on the wheel and driving over bumps) (Collins et aI., 2004, p.109). Women 
expressed uncertainty, confusion, or denial about the need to include exercise as a 
component of breast cancer recovery, but women who attended a gentle exercise group 
described the benefits of the exercises and increased realization of the extent of their 
upper quadrant deficits (Collins et aI., 2004). This study was important in providing a 
detailed description of specific activities that resulted in deficits in occupational 
performance, despite the small sample size and participants who once again composed 
an educated cohort within a higher socioeconomic class. 
The heterogeneity of breast cancer survivors has been described throughout the 
literature. Individual variability in fatigue throughout the day was explored by Dhruva et 
al. (2010), in a repeated-measures study of 73 BC patients examining patterns of 
fatigue throughout and following radiation therapy. This study confirmed the variability of 
idiosyncratic fatigue experiences and identified differences in predictive factors for 
morning and evening fatigue. Two occupational performance variables, specifically 
caregiving for children and employment, emerged as predictive for evening fatigue 
(Dhruva et al., 2010). 
Fatigue and Arm Function Symptoms 
No studies have specifically examined the relationship between cancer-related 
fatigue and physical symptoms in the ipsilateral extremity, but a few have documented 
findings that suggest that factors related to limb function and CRF may interact In a 
large study (n =1,933) conducted in Korea that examined prevalence rates and 
relationships between CRF! depression and QOL in BCS, Kim et al. (2008) documented 
five risk factors for developing CRF and depression: dyspnea, sleep disturbance, 
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appetite loss, constipation, arm symptoms, and lower monthly income. Further details 
about arm symptoms, which were assessed as part of a larger quality of life measure, 
were not explored. A recent study by Gerber et al. (2010) reported significant correlates 
of biological and behavioral factors to persistent fatigue in 44 BCS nine months post­
diagnosis, identifying higher levels of fatigue in women with increased body mass index 
(BMI), WBC counts > 8,000, increased ipsilateral limb size, and decreased levels of 
physical activity. Their findings indicated the presence of a predictive relationship 
between defined symptoms of upper body morbidity, lifestyle factors, and cancer fatigue 
in breast cancer survivors (Gerber et aI., 2010). Significant fatigue was found in 25% of 
the study sample using a single item 0 - 10 point numeric rating scale (Gerber et aI., 
2010). Several studies have also identified pain, although not always specified as 
related to upper limb function, as a contributing factor in CRF. Reinertsen et al. (2010) 
noted this relationship in a longitudinal study of off-treatment long-term BCS described 
earlier in this section, reporting statistically significant pain and discomfort on the side of 
the body treated for cancer (p < .001). 
Impact of CRF and Arm Function on Employment 
Women spend a great deal of their daily life at work when usual economic 
conditions prevail, and additional time performing household maintenance tasks and 
child care. The United States unemployment rate for 2011, the time period during which 
data was collected for this study, was 7.9% for adult women (U.S. Bureau of Labor 
Statistics, 2012). Time use studies on the U.S. population documented that employed 
and non-working women between ages 20 - 64 spent a mean of 20.9 - 27.3 hours per 
week in work related tasks, a mean of 10 - 18.3 hours on household tasks and a mean 
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of 27.4 - 36.2 on leisure activities (U.S. Bureau of Labor Statistics, 2010). Women with 
more education devoted more weekly hours to employment, whereas women with less 
education spent more hours on household tasks (U.S. Bureau of Labor Statistics, 2010). 
For BCS under retirement age, employment during or following treatment for 
breast cancer is often a desirable outcome and some may view the return to work as a 
hallmark of successful management of the disease process (Spelten et at, 2003). 
Persistent symptoms resulting from the cancer or subsequent surgical or adjuvant 
therapy interventions may alter the trajectory of employment for BCS, particularly since 
nearly half of all cancer survivors are under retirement age (de Boer et aI., 2009). 
However persistent symptom burden resulting from the disease process or treatment 
may negatively impact employment status (Hansen, Feurerstein, Calvio, & Olsen, 
2008). Employment was a secondary area of interest for this exploratory study; several 
questions were formulated in the demographic survey to survey potential changes in 
employment resulting from the breast cancer itself or current United States economic 
conditions, as well as to understand the current employment profile for the study 
sample. In addition, data from the Disability of the Arm Shoulder Hand (DASH) Optional 
Work Module was collected to try to ascertain perceived interference from upper 
extremity symptoms on physical work-related tasks. 
A review of the cancer survivor literature revealed that the majority of studies on 
employment were conducted on individuals who were still receiving cancer treatment 
during data collection. de Boer et al. (2009) conducted a meta-analysis and meta­
regression analysis of 26 articles compiling results from 26 stUdies to ascertain key 
factors that may predispose survivors to employment risk. Breast cancer survivors were 
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found to be 1.28 times more likely to be unemployed than comparable healthy controls 
(35.6% vs. 31.7%) (de Boer, 2009, p. 757). Limitations in physical status or persistent 
residual cancer symptomatology were identified as key factors contributing to 
unemployment in all cancer survivors, although not inclusive to BGS (de Boer, 2009). A 
longitudinal study examined physical and cognitive task requirements for job 
performance in 447 BGS and 267 prostate cancer survivors at 12 and 18 months post­
diagnosis demonstrated that there was a subset of survivors that continue to experience 
work-related problems secondary to physical limitations even though many survivors do 
well following the conclusion of treatment (Obserst, Bradley, Gardiner, Schenk, & Given, 
2010). At one year post-diagnosis, they found that 71 % of the BGS reported the need to 
perform physical job task demands and almost universal agreement on the requirement 
for cognitive task demands at work (Obserst et aI., 2010). More women reported 
physical disability at one year that limited work performance (60%) with improvement at 
18 months (36%; p < .01), but employment decreased for women with disabling residual 
physical limitations at both time points compared with BGS without these limitations 
(Obserst et aI., 2010, p. 326). 
Hansen et al. (2008) captured information regarding residual symptom burden in 
a study of 100 working BGS who were an average of four years post-treatment and a 
healthy comparison group responding to an online survey. The authors found that 
fatigue was significantly higher in BGS than the comparison group (p < .001), as were 
symptoms of depression, anxiety and cognitive limitations, with fatigue accounting for 
71 % of the total symptom burden (p. 781). The study did not examine the impact of 
residual arm symptoms in the BGS, although pain was noted to be a non-significant 
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contributor as was tumor stage and cancer treatment. It is difficult to compare these 
studies since Obserst et al. (2010) examined actual task demands and Hansen et al. 
(2008) reported on a range of symptoms, but did not address the actual work tasks 
performed by the respondents. The impact of going to work every day with persistent 
symptoms should not be underestimated. Studies researching the economic burden of 
survivorship indicate that when time post-treatment is included as a variable, working 
survivors still experience more functional limitations and variability in employment status 
than individuals without cancer (Yabroff, Lund, Kepka, & Mariotto, 2011). 
Literature Summary 
The imperative to address the needs of breast cancer survivors is repeatedly 
affirmed in the literature and throughout government agencies focused on cancer 
survivorship. Cancer-related fatigue [CRF] has been shown to contribute to decreased 
quality of life and reductions in occupational performance in BCS and persists as a long­
standing symptom in a subset of women after adjuvant therapies conclude. In addition, 
upper extremity deficits resulting from the cancer disease process, surgical excision of 
tumors and single or combination adjuvant therapies also negatively affect occupational 
performance and quality of life. The loss of functional status in specific tasks related to 
IADLs, work, and social participation are oft cited for the physical parameters 
associated with upper extremity dysfunction, as well as those resulting from fatigue 
sequelae. 
CRF is regarded as a complex multi-dimensional construct measured most 
accurately by self-report and by noticeable effects on occupational performance of life 
tasks. Research is necessary to contribute to the growing body of evidence that 
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supports acknowledgement and interventions for these disruptive symptoms and 
prevention of secondary morbidities resulting from surgical intervention and adjuvant 
therapies. A desirable goal must be to assist BCS to return to full participation in all daily 
occupations, including the performance of ADLs, IADLs, work, leisure, and socialization 
activities. 
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CHAPTER III 

METHODS 

Introduction 
This study describes the relationship between perceived cancer-related fatigue 
and upper extremity functional status in breast cancer survivors a minimum of one year 
(> 12 months) to a maximum of 6 years « 72 months) following the conclusion of 
surgical and adjuvant therapies. Perceptions of cancer-related fatigue and upper 
extremity functional abilities were additionally explored by examining participant 
differences in node dissection status, adjuvant therapies received and caregiving 
responsibilities. This chapter details the methodology for the study including design, 
subject criteria and sampling methodology, an overview of the psychometrics related to 
the outcome variables of interest, and administrative procedures. 
Design 
The study is an exploratory, cross-sectional descriptive design. A correlational 
study was chosen since the relationship between the two main constructs of interest, 
cancer-related fatigue and upper extremity function, have not been explored in the 
literature. This type of study can be used to generate other research hypotheses and 
further describe the variables of interest (Polit & Hungler, 1995; Portnoy & Watkins, 
1993). A series of self-report instruments were provided to obtain demographic and 
health data, and to assess perceived cancer-related fatigue and upper extremity 
function. On-line convenience-sample survey methodology was employed to recruit the 
sample and collect data. 
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Research Questions and Hypotheses 
There were four research questions for this study. 
RQ1. Is there a relationship between self-reported cancer-related fatigue and 
perceived upper extremity functional deficits in breast cancer survivors (BCS)? 
Ha.1. There is a relationship between self-reported cancer-related fatigue 
and perceived upper extremity functional deficits in BCS 
RQ2. Is there a difference in perceived upper extremity function and fatigue between 
breast cancer survivors (BCS) who underwent sentinel node dissection and those 
who underwent axillary node dissection? 
Ha.2.1: There is a difference in perceived upper extremity function 
between BCS who underwent various node dissection procedures, 
including axillary node dissection, sentinel node dissection and both 
axillary and sentinel node dissection. 
Ha.2.2: There is a difference in perceived cancer-related fatigue between 
BCS who underwent various node dissection procedures, including 
axillary node dissection, sentinel node dissection and both axillary and 
sentinel node dissection. 
RQ3. Is there is a difference in perceived upper extremity function and fatigue 
between breast cancer survivors (BCS) who underwent differing types of adjuvant 
cancer therapies, including chemotherapy, radiation, or combination therapies? 
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Ha3.1: There is a difference in perceived upper extremity function 

between BCS who underwent chemotherapy, radiation, immunotherapy, 

hormone therapy or combination therapies. 

Ha3.2: There is a difference in perceived cancer-related fatigue between 

BCS who underwent chemotherapy, radiation, immunotherapy, hormone 

therapy or combination therapies. 

RQ4. Is there a difference in perceived upper extremity function and fatigue between 
breast cancer survivors (BCS) who have dependent caregiver responsibilities and 
those without dependent caregiver responsibilities? 
Ha4.1: There is a difference in perceived upper extremity function 
between BCS who have dependent caregiver responsibilities and those 
without dependent caregiver responsibilities. 
Ha4.2: There is a difference in perceived cancer-related fatigue between 
BCS who have dependent caregiver responsibilities and those without 
dependent caregiver responsibilities. 
Description of Participants 
Women were eligible to participate in the study if they (1) were between 21 - 65 
years of age (2) could read English; (3) had a confirmed diagnosis of breast cancer, 
Stage 0 to III (And rykowski , Curran, & Lightner, 1998); (4) had received and completed 
required surgical intervention, adjuvant chemotherapy and/or radiotherapy treatment for 
breast cancer a minimum of 1 year (>12 months) and a maximum of 6 years «72 
months) prior to participation in the study (Curran, Beacham, & Andrykowski, 2004; 
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Young & White, 2006), (5) were currently in remission or considered to be disease-free, 
(6) had access to the internet; (7) were willing to complete on-line questionnaires and a 
demographic survey and (8) resided in the United States. Women who were not in 
rernission or considered to be disease-free, were in Stage IV (metastasis), were still 
undergoing active cancer treatment or surgical intervention, did not have internet 
access, resided outside the United States, or whose diagnostic and treatment 
completion parameters did not fall within the designated time parameters, were 
excluded. No compensation or incentives were offered to participants who volunteered 
to complete the study. 
Pilot data was obtained from February 2011 through April 2011. Active 
recruitment for the final data sample occurred from October 2011 through January 
2012. 
Sample Size Estimate. An a priori sample size of 268 participants was 
estimated using G*Power, version 3.1, based on a medium effect size of 0.30, an alpha 
level of 0.05 (two-tailed) and 0.80 power (Faul, Erdfelder, Lang, &Buchner, 2007). 
Sampling Method 
An internet snowball sampling strategy was chosen due to the exploratory nature 
of the study. Locating an adequate sampling frame for participants within the narrowly 
defined inclusionary criteria was anticipated to be difficult without a broader recruitment 
effort. Snowball recruitment has been found to be less expensive than mail recruitment 
methods, time efficient for respondents and uses increasingly available informal and 
social networking to bolster recruitment efforts (Ritter, Lorig, Laurent, & Matthews, 
2004). This methodology has been used to recruit populations that are difficult to access 
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by other means, including for studies that must request sensitive health or personal 
information (Sadler, Lee, Lim, & Fullerton, 2010). This sampling schema originated in 
'''contact tracing' in public health in which one individual names all other individuals who 
were associated with a specific event" (Sadler et aI., 2010, p. 370), or as one researcher 
euphemistically described, using the social equivalent of "six degrees of separation" 
between contact groups (Gruppetta, 2005, p.8). 
Research is limited on internet use patterns for women with breast cancer. Fogel, 
Albert, Schnabel, Ditkoff, and Neugut (2002) conducted a cross-sectional study, using a 
mailed questionnaire, to examine the use of the internet for breast cancer-related 
concerns by 188 BCS in New York City who were under the age of 65 and within three 
years of diagnosis. They found that 41.5% of the sample reported utilizing the web for 
information, finding that users were more educated, had higher socioeconomic status, 
were more likely to be Caucasian, and trended toward younger ages (Fogel et aI., 
2002). They further noted that minority participants demonstrated a trend toward less 
use of the internet for health-related concerns (Fogel et aI., 2002). This is consistent 
with other studies that continue to report the existence of a digital divide in computer 
and internet access. 
A 2011 survey by the Pew Research Center's Internet and American Life Project 
documented the use of the internet by 78% of adults residing in the United States, with 
59% of all adult users researching health-related information (Fox, 2011, p.5). The 
largest percentage of health information seekers, 66%, searched for specific medical 
conditions with women seeking health information (83%) more often than men (73%) 
(Fox, 2011, p.9). White users (70%; N =1267) comprised the largest group of 
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individuals who sought information on health problems regardless of gender, followed 
by Latino users (58%; N = 285) and Black users (54%; N = 356) (Fox, 2011, p.23), 
although the Pew Foundation noted that increasing access to mobile devices, such as 
cell pll0nes, may continue to positively alter user percentages in rninority populations 
over time (Fox, 2011, p.3). Limitations in the sampling and recruitment method are 
discussed in Chapter V. 
Breast cancer survivors constitute the largest percentage of cancer survivors in 
the United States, but are a heterogeneous group. Women may not participate in virtual 
or in-person support group networks or return to clinical sites for follow-up on a time 
table that permits cost-effective and timely recruitment efforts for research. The 
parameters for this study were further limited to a narrow sector of the overall population 
of breast cancer survivors living in the United States. Since community-dwelling BCS 
who had completed all initial treatment were the target population, it was felt that a 
general snowball recruitment effort would result in sufficient subject self-selection to 
meet the a priori population estimate. Additionally, recruitment efforts for the final 
sample were initiated at the beginning of October during Breast Cancer Awareness 
Month, typically a time of focused attention on this population in popular media and 
NGO educational and fundraising directives. Unlike snowball recruitment using mail 
surveys, participant anonymity was maintained and researcher blinding was not 
required since it was not necessary for the investigator to contact an identified potential 
respondent in order to forward the survey. This type of recruitment is, however, 
considered to be non-probability sampling and typically does not produce a random 
sample or reduce all recruitment bias (Sadler et aI., 2010; Etter & Perneger, 2000). 
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Study Sample Recruitment. Faculty, Staff, and Students in the School of Health 
and Medical Sciences (SHMS) as well as professional and personal contacts received 
the pilot e-mail snowball recruitment announcement requesting voluntary participation in 
the study for eligible BCS, or asked the recipient to forward the e-mail to other 
individuals who might be eligible. Distinct collectors, for example, 'Faculty and Staff 
were identified by the investigator using the collector function in Survey Monkey prior to 
deployment of the survey. Each collector was automatically assigned a unique URL 
address by the software package that was individually pasted into the e-mail request for 
participation in order to assess the responsiveness of selected groups to recruitment 
efforts. Anonymity was maintained since collectors only covered broad categories of 
potential respondent pools. Pilot sample snowball recruitment invitations were sent to 7 
administrators, 8 staff, 41 faculty (N. Blaszka, personal communication, February 23, 
2012), and 428 students in the School of Health and Medical Sciences at Seton Hall 
University (D. Verderosa, personal communication, February 23,2012), along with 7 
personal contacts, an oncology nurse specializing in breast cancer and two oncology 
social workers. 
Final sample recruitment included 506 administrators, 341 staff, and 455 faculty 
on the South Orange Campus, and 43 administrators, 42 staff, and 81 faculty at the 
Newark Law School Campus (M.J. Hudson, personal communication, February 23, 
2012). Additionally, 5300 undergraduate students and 4400 graduate students on the 
Seton Hall University South Orange Campus (SHU.edu, 2011) received the e-mail 
invitation to participate or forward the study information. An additional 21,495 Seton Hall 
University alumni also served as initial contact sources (D.P. Nugent, personal 
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communication, February 16, 2012), along with 300 personal and professional contacts, 
solicitation of cancer support organizations serving breast cancer survivors, and three 
physician practices willing to forward the survey information or place IRB approved 
recruitment fliers in their offices. In December 2011 , a second request for participation 
was forwarded to the South Orange Campus only through the Seton Hall University 
Campus Digest, a university news and event e-newsletter that replaced the Broadcast 
e-mail system for non-administrative contact with faculty, staff and students. The e-mail 
and paper recruitment letters included an e-mail address and phone number in the 
event that contact with the investigator was desired, as well as IRB contact information. 
Procedures 
Institutional Review Board approval was obtained for the pilot study and for 
clarification in the wording for selected items on the demographic survey questions prior 
to final data collection to facilitate ease of completion by respondents. Moreover, a 
sentence was added to the recruitment invitation asking BCS who completed the pilot 
survey to refrain from responding to the survey a second time. Modifications in 
demographic survey questions included the following alterations: 
Question 1 was changed from "What is your date of birth?" to "What is your 
age?" since the exact date of birth was not required for data analysis. An additional 
response option, "Asian" was added to Question 3, "How do you identify yourself?", as 
this variable was inadvertently omitted from the pilot study demographic questionnaire. 
An open-ended response option permitted respondents to self-identify in whatever 
manner they deemed appropriate and was available for pilot and final data collection 
surveys; no individuals in the pilot survey self-identified as Asian. Question 13, "Have 
you had more than one episode (recurrence) of breast cancer (yes, no)? Right or Left 
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side?" was added to the final data collection after two respondents in the pilot study 
indicated that they developed recurrence of breast cancer during the inclusionary time 
period of 12 to 72 months post-treatment. The exclusionary criteria eliminated BCS 
diagnosed with metastasis, but did not request incidence information about recurrence. 
It was felt that recurrence data should be captured for accuracy in data analysis and 
reporting of results. 
Question 14 was amended from "What type of surgery did you have? (Choice of 
none, lumpectomy, partial mastectomy, total mastectomy, reconstruction - can select 
more than one response)" to "What type of surgery did you have? (Choice of none, 
lumpectomy, mastectomy, reconstruction - can select more than one response). Pilot 
data collection indicated that participants may have had difficulty understanding the 
medical terminology used to describe mastectomy procedures. Definitions were not 
provided during the pilot study, therefore simplifying the terminology to a single category 
of 'Iumpectomy' for breast conserving surgery and 'mastectomy' was deemed to be less 
confusing to respondents. The research hypotheses for this study did not require further 
delineation of the specific type of lumpectomy. mastectomy or reconstructive surgery 
procedure. 
Two optional open-ended questions, "Are there any other daily activities that 
have been impacted by having fatigue (list)?" and "Are there any other daily activities 
that have been impacted by problems with arm function (list)?" were added to the 
survey following pilot data collection. Functional activities identified in the FACIT-F or 
DASH surveys might not capture the full range of performance deficits in tasks that BCS 
encounter on a daily basis. Questions 33 and 34 permitted the respondent to describe 
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other activities impacted by fatigue or problems with arm function, unimpeded by the 
assumptions of the validated instruments or investigator-generated questions. 
Broadcast e-mails through Seton Hall University, e-mails to cancer support 
groups, selected community organizations, professional and personal contacts were 
used to recruit participants. Snowball recruitment methodology was utilized. All 
individuals who received the initial recruitment request were asked to forward, 
"snowball", the e-mail to women they knew who might be interested in participating in 
the study or individuals who might be willing to forward the request to others. Women 
interested in participating were directed to click on a link to a unique URL address on 
Survey Monkey, allowing them to view and complete the self-administered survey. 
Seven unique URLs were assigned to the final survey during data collection to identify 
collector sources, e.g., professional contacts, in order to assess the snowball 
recruitment methodology during data analysis. A brief summary of the research study, 
inclusionary and exclusionary criteria and informed consent information was posted on 
the initial e-mail. In addition, a paper version of the recruitment e-mail solicitation was 
approved by the Institutional Review Board for distribution, but survey completion was 
only available through the Survey Monkey internet-based site. 
The survey was conducted via Survey Monkey, an internet-based survey 
company providing server and encryption security to ensure data protection. According 
to company information, Survey Monkey is one of the most frequerltly used web survey 
platform tools available on the internet (surveymonkey.com, 2009). Prospective 
participants or individuals who might know potential respondents received an e-mail 
invitation to participate and were then provided with a URL address specific to this 
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survey if they are eligible and willing to participate. Confidentiality of participants was 
maintained by the automatic assigning of unique numeric codes to each participant 
during data downloads into SPSS from the survey site. 
Survey Monkey parameters were set to cue participants, through highlighted text, 
to complete any unanswered questions on the demographic surveyor assessment tools 
prior to allowing respondents to submit that section of the surveyor questionnaire in an 
attempt to obtain complete information and reduce missing data points. Data obtained 
from participants was secured in a locked file cabinet in the School of Health and 
Medical Education on the Seton Hall University South Orange campus. 
Assessments were administered in the same order to all participants: 
demographic information and health history, Functional Assessment of Cancer Therapy 
Fatigue Scale (FACT-F), Disabilities of the Arm, Shoulder, and Hand (DASH), Optional 
Work Module of the DASH, and two optional open-ended questions, Q32 and Q33, 
inquiring about other daily activities that have been impacted by having fatigue or 
problems with arm function respectively. 
Instrumentation 
Demographic Survey. Demographic information collected included ICF 
Personal Factors (age, state of residence, race, marital status, number of dependent 
children, and highest level of education achieved (WHO, 2001), ICF Work and 
Employment Factors (current occupation collected as part of the Disability of the Arm 
Shoulder Hand [DASH] Optional Work Module) and employment status) and ICF 
Environmental Factors ascertaining whether employment status was impacted by the 
breast cancer or the current state of the U.S. economy respectively (WHO, 2001). 
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Participant-reported health history included ICF Body Functions and Structures (hand 
dominance, side of tumor location, year and stage at diagnosis, type of surgery 
including reconstruction, adjuvant therapies received, and lymphedema diagnosis, 
treatment or management, including the preventative wearing of compression sleeves) 
(WHO, 2001). 
Respondents also answered an investigator developed set of questions for 
cancer-related fatigue that corresponded to the major ICF Activities and Participation 
categories of self-care [Self-care], care of others [Assisting Others], household tasks 
[Domestic Life], shopping or errands [Domestic Life], work [Work and Employment], 
leisure or relaxation [Community, Social and Civic Life], and socialization [Interpersonal 
Interactions and Relationships] (World Health Organization [WHO], 2001). Perceptions 
of the impact of fatigue on these functional activities were not addressed in items on the 
Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F). The questions also 
corresponded to the Occupational Therapy Practice Framework, 2nd edition, delineating 
the domains of practice for the profession of occupational therapy (AOTA, 2008). They 
were added to the survey to provide a better descriptive understanding of the impact of 
fatigue on daily function. 
Disabilities of the Arm, Shoulder, and Hand (DASH). Developed by the 
Institute for Work and Health in Toronto, Canada, and the American Academy of 
Orthopedic Surgeons in 1996, the Disabilities of the Arm, Shoulder, and Hand 
questionnaire [DASH] (Kennedy et aI., 2011) is a standardized health-related quality of 
life (HRQOL) outcomes measure designed to assess patient perceptions of upper 
extremity function resulting in limitations in ADL and IADL tasks, as well as perceived 
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extremity-related symptoms such as pain or weakness. It consists of a 30-item 
questionnaire asking patients to assess their ability to perform common ADL and IADL 
tasks, noting the level of disruption to function and musculoskeletal symptoms within the 
prior week using a 5-point Likert scale with answers ranging from "not at all" to 
"extremely" (Kennedy et aI., Beaton, Solway, McConnell, & Bombardier, 2011). The 
questionnaire is designed to be self-administered. It requests responses to several 
different facets of upper quadrant function. The composition of the questionnaire details 
21 questions about the respondent's ability to complete specific activities of daily living 
such as washing one's back or cutting food, and instrumental activities of daily living, 
including items asking for ability to complete heavy housework, meal preparation or 
changing a light bulb (Kennedy et aI., 2011). Five questions assess physical symptoms 
such as pain, tingling and weakness, and four questions request information on 
socialization, global ability to complete tasks, sleep, and feelings of overall confidence in 
the ability to complete daily tasks (Kennedy et al., 2011). 
The DASH was chosen due to its reliable and validated psychometric properties 
with a variety of patients with upper extremity dysfunction, including employed and 
disabled workers (Kennedy et aI., 2011; Jester et aI., 2005; Bot et aI., 2004; SooHoo, 
McDonald, Seiler, & McGillivary, 2002; Beaton et al., 2001; Hudak et aI., 1996). The 
instrument has also been used to research perceived upper body function in breast 
cancer survivors, with and without lymphedema (Smoot et al., 2010; Koh & Morrison, 
2009; Dawes et aI., 2008; Hayes et aI., 2005). It is also one of the few measurement 
tools for the upper extremity that focuses on the functional activity outcomes resulting 
from whole arm movement patterns, rather than attending to single joints. It has been 
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also been studied relative to its fit with the ICF structure (Dixon et aL, 2008), 
demonstrating the ability to measure ICF outcomes at the impairment, activity, and 
participation level and is thus consistent with the theoretical framework that supports 
this study. 
In 2002, the scoring for the DASH was revised, now calculated by adding the 
sums of the item responses divided by the number of completed items, subtracting 1, 
and multiplying by 25 (Kennedy et aL, 2011). This produces a transformed value 
ranging from "0" or no perceived disability, to "100", a greater level of perceived 
disability. Greater than three missing item responses results in an inability to score the 
questionnaire (Kennedy et aL, 2011). Up to three missing items can be addressed by 
replacing those values with "the mean value of the responses to the other items before 
summing" (Beaton et aL, 2001, p.129). The DASH takes an estimated 6 minutes to 
complete and 3 minutes to score (Michener & Leggin, 2001). 
There are also two optional DASH modules recording the self-perceived impact 
of upper extremity dysfunction on work and on sports/performing arts. Either or both 
modules may be used to obtain additional information. Each optional module consists of 
4 questions rated on a 5-point Likert scale ranging from "no difficulty" to "unable" 
(Kennedyet aL, 2011). Each module is scored separately by adding the values for each 
response, dividing by 4, subtracting 1 and multiplying by 25 (Kennedy et aL, 2011). All 
four questions on each module must be answered in order to obtain the summary score. 
For the purpose of this study, only the optional work module was used since 
employment is a key concern of cancer survivors and is often the benchmark by which 
survivors measure their return to prior life activities (Maunsell et al., 2004). The DASH 
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Work Module has only four items and is designed to assess the level of physical 
difficulty the person has performing employment activities, including performing tasks in 
a similar manner as before illness and performing at usual levels (Kennedy et aL, 2011). 
It does not assess or question other aspects of work performance, but does have an 
open response question asking the respondent to list their current job. Chronbach's 
alpha for this optional module is 0.89 (Tang, Pitts, Solway, & Beaton, 2009). It has been 
shown to discriminate differences in some diagnostic groups as well as by the number 
of upper quadrant regions impacted, resulting in increased levels of disability (Fan, 
2008). There was only one study located that specifically cited the use of the optional 
work module with a sample of 18 individuals who had undergone latissimus dorsi "flap 
reconstruction, including 4 BCS who underwent reconstruction following mastectomy 
(Koh &Morrison, 2009). 
In a nationally representative sample in the United States, the DASH exhibited 
Cronbach's alpha ranging from 0.94 to 0.98, Pearson correlations of 0.49 to 0.87, and 
item internal consistency of 100 (Hunsaker et aL, 2002, p.213). Mean scale scores for 
global function on the DASH (n = 1706) was 10.10 (SD 14.68) and 8.81 (SD 18.37) on 
the Work Optional Scale (n =1610) (Hunsaker et aL, p.211). The Institute for Work & 
Health 3rd edition of the DASH user's guide enumerates normative values for women in 
the general U.S. population (N =1008), with a mean of 11.96 for the DASH and 9.44 for 
the DASH Optional Work Module (Kennedy et aI., 2011, p.143). These values, rather 
than those delineated in the earlier publication by Hunsaker et aI., were chosen for 
comparison with the study sample due to the ability to isolate gender-based scores. 
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Construct validity of the DASH as an extremity specific quality of life outcome 
measure was supported by data from SooHoo et aI., (2002) in a study examining 
correlations of the DASH to the Medical Outcomes Study Short-Form 36 (SF-36), a well 
established quality of life outcome measure with available standardized normative 
scores for the U.S. population. The hypotheses were confirmed with moderate 
correlations observed ranging from 0.36 for the general health subscale to .62 for the 
role emotional subscale (SooHoo et aI., 2002). Beaton, et al. (2001) also assessed the 
psychometric properties of the DASH, examining within-subject responsiveness, 
reliability and validity in a study sample of 172 patients from major hospital centers in 
Toronto (n = 109) and Boston (n = 91) engaged in treatment for a variety of upper 
extremity disorders. Discriminative validity was established between employed patients 
and those on disability, as well as between individuals diagnosed with shoulder versus 
hand conditions (26.8 vs. 50.7, t = -7.51, P < .0001) (Beaton, 2001, p. 135). Reliability of 
the DASH as measured by Cronbach's alpha was reported as 0.97 (Beaton, p.140) 
during baseline data collection and is further supported by data from Gummesson et al. 
(2003) documenting Cronbach's alpha levels above 0.90. 
Convergent construct validity was also found in Pearson correlations exceeding 
0.70 between the DASH and joint-specific measures, the Shoulder Pain and Disability 
Index (SPADI) and the Brigham questionnaire for hand and wrist dysfunction (Beaton, 
2001, p.135). Pearson correlation using data over the course of 3 - 5 days from 56 
subjects reporting that they had no change in deficits during that time period was 0.96 
and Spearman ranked correlation was 0.96 at the 95% CI (Beaton et aI., 2001) 
indicating high test-retest reliability. 
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Prior research supports the use of the DASH as a valid, reliable, and responsive 
HRQOL tool for single or multiple musculoskeletal disorders in the upper extremities. A 
review of the literature did not reveal any articles documenting computer-based self­
administration of this instrument. Permission was granted from the Institute for Work 
and Health in Toronto, Canada, to use the DASH and to place the instrument in an on­
line environment in Survey Monkey for participants (G. Palloo, personal communication, 
January 10, 2010). 
Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F): Fatigue 
Subscale. The Functional Assessment of Cancer Therapy (FACT) is a system of self­
report questionnaires designed to evaluate various QOL impact of cancer therapies on 
individuals living with cancer (Yellen et aI., 1997). The FACT is a subset of the larger 
Functional Assessment of Chronic Illness Therapy (FACIT) system, a vast test bank of 
validated questionnaires designed for a variety of health-based conditions and 
translated into 43 languages (Stasi et aI., 2003). Subsumed as part of the FACIT 
system, is a tool that was designed to assess anemia (FACT-An) in individuals 
undergoing treatment for cancer. Contained within the FACT-An is a 13-item subscale 
designed to assess cancer-related fatigue since fatigue is a foremost distinguishing 
symptom of anemia. Subsequent research validated the FACT -F as a separate 
assessment instrument from the FACT-An questionnaire that can be used across the 
cancer spectrum to assess fatigue-based symptoms (Van Belle et aI., 2005; Hwang et 
aI., 2003; Passik et aI., 2002; Yellen et aI., 1997). The 4th version of the 13-item scale, 
titled the FACIT-Fatigue on the publisher's site is also referred to as the FACT-F in 
research studies (Santana et aI., 2009). For the purpose of consistency within this 
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project, the tool will be referred to as the FACIT-F, except when describing other 
research studies that utilized the original FACT-F label. 
The FACIT-F is composed of the same 13-item fatigue subscale described in the 
FACT-An, as well as in questions from the FACT-G on information related to the impact 
of fatigue on quality of life concerns such as physical, socia.!, emotional, and functional 
status (Cella, Eton, et aI., 2002; Yellen et aI., 1997). Each item retrospectively assesses 
the experience of fatigue over the past seven days and is rated on a 5-point Likert 
scale, from 0 "not at all" to 4 "very much so" (Cella, Eton et aI., 2002; Van Belle et aI., 
2005). Scores range from 0 to 52; during data analysis items are reverse coded, 
therefore higher scores are indicative of better health and less fatigue, and lower scores 
indicate more fatigue and lower HRQOL (Yellen et aI., 1997; FACIT.org, 2012). 
Estimated completion time for the FACIT-F is 2-3 minutes (FACIT.org, 2012). It has a 
reading level of 4.0, making it suitable for a range of populations and can be self­
administered using computer-based testing (Yellen et al.; FACIT.org, 2012). The 
FACIT-F has been documented as a suitable measure of self-perceived fatigue in 
populations with cancer, including cancer survivors (Mustian et aI., 2004; Bennett et aI., 
2004; Stasi et aI., 2003; Yellen et aI., 1997). Permission was granted by the FACIT 
organization to use this tool and place the questionnaire on a Survey Monkey web­
based platform. The organization noted that the FACIT-F has been utilized in previous 
studies in virtual environments for linguistic validation and research (J. Bredle, personal 
communication, January 9,2009) 
Yellen et aI., found that the FACT-F fatigue subscale demonstrates validity as an 
independent measure of cancer fatigue, construct validity, good test-retest reliability 
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over a 7-day period (r =0.90) and internal consistency (alphas =0.93 and 0.95) (p.68), 
with discriminative validity for hemoglobin levels and better functional performance 
(1997, p.71). Higher scores in the FACT-F, which indicate higher functioning, were 
correlated with higher quality of life scores (Yellen et aI., 1997). Bennett et al. (2004) 
found internal consistency for the FACT-F, demonstrated a Cronbach's alpha coefficient 
of 0.94. 
Cella and Eton et al. (2002) evaluated the reliability of the FACT-F, finding that 
scores demonstrated high internal consistency in three different population samples (> 
0.85), good test-retest stability in Sample 1 (n = 50) over a 7-day time period (r> 0.80) 
and good stability for intraclass correlation coefficients (ICC) of at least 0.85 in all 
samples (Cella, Eton et aI., 2002, p.553). The likely MICD, based on the mean 
differences for the three populations when retested on the fatigue scale, was 2.7 points 
(Cella, Eton et aI., 2002, p.557). This is the scoring difference that would need to be 
achieved in order to estimate whether an intervention demonstrated a clinically relevant 
score change. It was further recommended that a conservative estimate of MICD for the 
FACT-F be rounded to the nearest whole number, or 3 points (Cella, Eton et aI., 2002, 
p.559). 
Van Belle et al. (2005) established that a cut-off score of 34 allowed for 
prediction of P-ICD-10 status in 93% of 470 patients (sensitivity 0.91, specificity 0.75) to 
define significant fatigue on the FACT-F (2011, p.251). This score meets the criteria for 
the diagnostic classification of neoplastic related fatigue in the ICD-10 (Van Belle et aI., 
2005). Normative values were also established for the FACIT-F for the general United 
States population using randomized digital dialing sampling methods and compared to 
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FACIT-F responses from anemic and non-anemic patients with cancer (Cella, Lai et aI., 
2002). The mean score for the general population (n = 1010) was 43.6 +/- 9.4; 40.0 +/­
9.8 for the non-anemic patients with cancer, and 23.9 +/- 12.6 for the anemic patients 
with cancer (Cella, Lai et aI., 2002, p. 533). Using the findings from this study, a cut-off 
score of 43 was used to compare the study sample to the general U.S. population, as 
this provides "sensitivity of 0.92 and a specificity of 0.69", accurately predicting 84% of 
group assignment (Cella, Lai et aI., 2002, p. 537). Both these values, 43 (Cella, Lai et 
aI., 2002) and 34 (Van Belle et aI., 2005), were used to compare the study sample to 
the normative values in order to assess the relationship of the sample to normative and 
diagnostic criteria. Webster, Cella, and Yost (2003) also reported that the FACIT-F 
could be self-administered via computer. 
Data Analysis 
Data analysis was conducted using SPSS version 18.0 software for Windows. 
Data was downloaded from Survey Monkey into SPSS software, coded and analyzed. 
Examination and analysis of the pilot and final data sample populations indicated that 
the pilot data for women meeting the inclusionary criteria could be safely aggregated 
with the larger sample of eligible respondents and is described in Chapter IV. All 
statistical tests were two-sided and a P value of < .05 was deemed to be statistically 
significant, unless otherwise stated. Confidence intervals of 95% were also computed 
by SPSS where appropriate. 
Descriptive statistics, including frequencies, percentages, means and standard 
deviations were computed to describe the study population characteristics and assess 
variability in demographic and self-reported health data. Categorical demographic data 
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(race, marital status, education, employment status, impact of the economy), health 
factors (hand dominance, breast tumor location, surgical intervention, node dissection 
status, cancer treatment received, lymphedema di~gnosis and treatment, use of 
compression sleeves), and activity and participation factors (perceived impact of fatigue 
on daily function and participation, and caregiver status for dependent children) were 
analyzed using frequencies and percentages. Participant age, tumor stage at diagnosis, 
year of treatment completion, and ages of dependent children were analyzed using 
frequencies, percentages, means, and standard deviations. 
An evaluation of the relationship between perceived fatigue and perceived upper 
extremity function was measured using Pearson's correlation. Pearson's was chosen 
since normative data on the United States population was available for the FACIT­
fatigue and the DASH, as well as cut-points to examine the relationship between the 
study sample and the population norms, as well as normative data for cancer survivors 
with and without anemia. One sample Student's t-tests were performed to test the 
hypotheses that the means of the normative scores for the FACIT-fatigue and the DASH 
respectively were not significantly different from the study sample means. 
A Kruskal-Wallis was used to test the hypothesis that there were no differences 
on average in perceived CRF and perceived upper extremity function respectively 
between BCS who underwent sentinel node biopsy, axillary node biopsy or both types 
of node biopsy. Relationships between the FACT-fatigue, DASH, and continuous 
demographic data were explored using Pearson's product-moment correlation 
coefficient for normally distributed data. Statistically significant results from the 
correlational analysis were analyzed using regression analysis to determine the 
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presence of any predictive models. Categorical demographic data was analyzed using 
chi-square analysis. Ordinal non-normally distributed data was analyzed using Mann­
Whitney U tests, and ratio level demographic data was analyzed using t-tests. An 
analysis was conducted using a Kruskal-Wallis to assess the difference in perceived 
upper extremity function and fatigue between survivors who underwent radiation, 
chemotherapy or combination adjuvant cancer therapies. An analysis was also 
conducted using an independent sample t-test was used to assess the difference in 
perceived upper extremity function and fatigue between survivors with dependents living 
at home and those without dependents living at home. Independent sample t-tests were 
also used to compare the results on the DASH and FACIT-F scores with the U.S. 
population or cancer-specific normative values. 
Additional Questions 
The Optional Work Module of the DASH was used in the survey as a brief 
measure of perceived physical function in the workplace. Independent sample t-tests 
were used to compare the results of the DASH Optional Work Module with the U.S. 
population normative values. Employment information was collected in the demographic 
survey. In addition, two questions on the demographic survey questioned participants 
about whether their employment situation had changed as a result of the breast cancer, 
and whether their employment status had changed as a result of the U.S. economy. 
Primary work roles described by participants as part of the DASH Work module were 
coded and stratified using the Standard Occupational Classification (SOC) system, a 
U.S. Department of Labor categorization system designed for the compilation and 
dissemination of employment-based data (U.S. Department of Labor, 2010). Descriptive 
104 
statistics for categorical variables including frequencies and percentages were used for 
analysis of demographic data. 
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Chapter IV 

RESULTS 

Sample and Participant Selection 
For the pilot study, 494 initial e-mail requests to participate were forwarded, 
asking individuals who received the e-mail to forward the study invitation to potential 
respondents if they were not eligible. Additional information directed specifically toward 
BCS was included in the same e-mail. Invitations were sent to 7 Seton Hall University 
administrators, 8 staff, 41 faculty (N. Blazka, personal communication, February 23, 
2012), and 428 students through department secretaries. An additional 7 personal 
contacts, an oncology nurse specializing in breast cancer and two oncology social 
workers were also contacted. Fifty-two BCS responded to the invitation and completed 
the on-line survey for a response rate of 10.5%. Forty-two BCS met the inclusionary 
criteria and completed sufficient data points for data analysis. 
For the second data collection, 32,663 initial e-mail requests were sent asking 
individuals to forward the survey information to other personal and professional 
contacts, resulting in 133 respondents for a .4% response rate. Snowball recruitment 
invitations were sent to 506 administrators, 341 staff, and 455 faculty on the Seton Hall 
University South Orange Campus, and 43 administrators, 42 staff, and 81 faculty at the 
Newark Law School Campus (M.J. Hudson, personal communication, February 23, 
2012). Additionally, 5300 undergraduate students and 4400 graduate students on the 
South Orange Campus received the e-mail invitation to forward study information or 
participate if eligible. An additional 21 ,495 Seton Hall University alumni also served as 
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initial contact sources (D.P. Nugent, personal communication, February 16, 2012), 
along with 300 personal and professional contacts, solicitation of cancer support 
organizations serving breast cancer survivors, and three physician practices willing to 
forward the survey information or place the IRB approved paper recruitment flyers in 
their offices. In December 2011, a second request for participation was forwarded to the 
South Orange Campus only through the Seton Hall University Campus Digest, a 
university news and event e-newsletter that replaced the Broadcast e-mail system for 
non-administrative contact with faculty, staff and students. The e-mail and paper 
recruitment letters included an e-mail address and phone number in the event that 
contact with the PI or IRB was desired. 
In order to protect the anonymity of the participants as approved by the Seton 
Hall University Institutional Review Board (lRB), no contact data was collected from 
individuals who forwarded the e-mail invitation to other contacts or from survey 
respondents, therefore it was not possible to contact participants who did not complete 
the entire survey in order to request clarification of responses. The mean time for survey 
completion time was 15.29 (N = 185) minutes. 
Data from eligible respondents in the pilot study was compared to data from 
eligible respondents from the final data collection sample. No statistically significant 
differences were found between the two groups on general demographic or health­
related variables. Due to the lack of significance on any of these variables, the decision 
was made to aggregate the data from the pilot study and the final data collection sample 
since it was believed that both samples were drawn from the same larger population of 
BCS meeting the inclusionary criteria. Data from the aggregated sample population of 
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185 BCS from the aggregated sample was then reviewed for eligibility. Twenty-one 
participants with completed surveys were ineligible based on number of years since 
diagnosis; 6 were diagnosed in 2011 and 21 were diagnosed before 2004. Final data 
analysis was conducted on 158 eligible respondents. 
Changes that were made in the demographic and health-related variables 
following the pilot study, as described in Chapter III, were designed to ease respondent 
burden but the information obtained was unchanged between the two data collection 
periods. Only one additional question added to the demographic survey following pilot 
data collection, asking about breast cancer recurrence within the eligible time period. 
Only 6 respondents from the second data collection point (n =113) indicated that they 
had recurrence; 5 (3.2%) on the ipsilateral side and 1 (.6%) on the contralateral side of 
the original BC (n = 113). The question was eliminated from further data analysis due to 
the lack of data for the entire sample. The two open-ended questions inquiring about the 
impact on other daily activities on fatigue and upper extremity function were not asked 
during the pilot data collection. This question was optional for respondents in the 
second data collection. Data analysis from those responses is detailed later in this 
chapter. 
Demographics 
The average age of the participants was 52 (N =158, SD 8.08), ranging in age 
from 32 to 65. Eleven respondents were between ages 32 - 39 (7.1 %), 45 respondents 
were between 40 - 49 years of age (28.4%), 72 were between 50 - 59 (45.5%), and 30 
were between 60 - 65 (36.1 %). Respondents were more likely to be highly educated 
with 71 respondents holding a graduate degree (44.9%), married (n = 112, 70.9%), 
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employed full-time;:: 35 hours per week (n =98, 62.0%), and Caucasian (n =147, 93%). 
Table 1 presents the demographic characteristics of the BCS. 
Table 1 

.-Earficipan(Characteristics (N =158) 
n Percent 
Race 
White/Caucasian 
Black/African American 
Hispanic/Latino 
Asian 
Education 
Graduate degree or higher 
College degree 
Associate's degree/some college 
High school degree 
Marital Status 
Married 
Never married/single 
Widowed 
Divorced 
Living with a significant other 
Separated 
Employment Status 
FUll-time employed (~ 35 hours) 
Part-time employed « 35 hours) 
Full-time homemaker 
Retired 
Unemployed 
Leave of absence 
On disability 
Full-time student 
Part-time student 
147 

5 

5 

1 

71 

52 

21 

14 

112 

15 

13 

11 

4 

3 

98 

21 

16 

11 

6 

2 

2 

1 

1 

93.0 
3.2 
3.2 
0.6 
44.9 
32.9 
13.3 
8.9 
70.9 
9.5 
8.2 
7.0 
2.5 
1.9 
62.0 
13.3 
10.1 
7.0 
3.8 
1.3 
1.3 
0.6 
0.6 
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Table 2 
Region and State a (N =158) 
n Percent 
Middle Atlantic (NJ, NY, PA) 104 66.2 
South Atlantic (DC, FL, GA, MD, NC, VA) 23 14.7 
New England (CN, MA, NH, Vi) 10 6.3 
Pacific (CA, OR, WA) 11 6.9 
East North Central (IL, OH) 4 2.5 
West North Central (MN) 2 1.3 
Mountain (AZ, NV) 2 1.2 
East South Central (MS) 1 0.6 
Unknown 1 0.6 
a Respondents by U.S. Census Bureau Regions (n.d.) 
Respondents identified 21 states of residency plus the District of Columbia, with 
the majority living on the East coast of the United States (n =127,80.9%) in the Middle 
and South Atlantic regions (U.S. Census, n.d.). The largest number of respondents 
lived in NJ (n =74, 47.1 %), NY (n =24, 15.3%), and CA (n =9, 5.7%) (Table 2). 
Health and treatment demographics. The majority of respondents were right-
dominant (n =146,92.4%). As data collection took place over the course of 13 months, 
year of diagnosis ranged from 2004 - 2010 (Table 3). Tumor stage at diagnosis was 
most likely to be Stage I (n = 60, 38.0%) or Stage II (n = 49, 31.0%). There were equal 
numbers of BCS identifying the original tumor location as right versus left sided with 6 
BCS identifying bilateral tumor identification at diagnosis (3.8%). Eighty-six participants 
(54.4%, N =158) listed the number of nodes removed during diagnostic procedures for 
tumor staging. The average number of nodes removed was 8.87 (S.D. 8.122, range 1 ­
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33) (Table 4). Sentinel node dissection was the most frequent staging procedure 
identified by a ratio of 4.5:1. 
Table 3 
Year of Diagnosis (N =158) 
n Percent 
2004 
2005 
2006 
2007 
2008 
2009 
2010 
18 
20 
20 
39 
35 
19 
11.4 
12.7 
12.7 
24.7 
22.2 
12.0 
Table 4 
Type of Node Dissection (N =_1_5_8-,-)__________--=-___ 
n Percent 
None 19 12.0 
Axillary Node 18 11.4 
Sentinel Node 81 51.3 
Both 30 19.0 
Do not know 10 6.3 
Additional health and treatment characteristics are presented in Table 5. Of the 
69 BCS who underwent lumpectomies (43.7%), none had reconstructive surgery. Of the 
68 respondents who underwent mastectomies (36.7%), 45 had undergone 
reconstructive surgery (66.1 %). Twenty BCS had lumpectomies and mastectomies 
(12.6%). Of those BCS who underwent both procedures, 15 had reconstruction (75%). 
Twenty-five women identified a diagnosis of lymphedema (15.8%); 7 (39%) BCS 
with axillary node dissection, 12 (15%) BCS with sentinel node biopsy, 4 (13%) BCS 
who underwent both types of node biopsies and 2 (20%) BCS who did not know the 
type of node biopsies they received. Ten (6.4%) were receiving treatment for the 
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lymphedema from an occupational or physical therapist at the time of survey 
completion; 4 (40%) with axillary node dissection, 4 (40%) with sentinel node biopsy 
and 2 (20%) with both types of node biopsies. Eleven (7.2%) BCS used compression 
wrapping to treat the lymphedema. 
Additional questions were asked about the use of compression garments 
(sleeve) during daily tasks to manage or prevent lymphedema. Compression sleeves 
were worn by 33 BCS during air travel (n =98, 33.7%), by 12 participants (n =82, 
14.6%) while exercising, by 14 (n =86, 16.3%) when performing heavy housework, and 
4 wore the compression garment at all times (n = 76, 5.3%). Of the 25 BCS reporting 
diagnosed lymphedema, 86% wore their garment during air travel, 75% during exercise, 
71 % during heavy housework, and 40% at all times. 
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Table 5 
Health and Treatment Characteristics (N =158) 
n Percent 
Hand dominance (n =158) 
Right 
Left 
146 
12 
92.4 
7.6 
Tumor location (n =158) 
Right 
Left 
75 
75 
47.5 
47.5 
Both sides 
Tumor stage at diagnosis (n =158) 
0 
6 
25 
3.8 
15.8 
I 60 38.0 
II 49 31.0 
III 22 13.9 
Do not know 2 1.3 
Type of surgery (n =158) 
Lumpectomy 
Mastectomy 
Both 
69 
68 
20 
43.7 
36.7 
12.7 
Breast reconstruction 65 41.4 
None 1 0.6 
Diagnosed with Lymphedema (n =157) 
Yes 25 15.8 
No 132 83.5 
Receiving treatment for lymphedema (n =157) 
Yes 10 6.4 
No 147 93.6 
Compression wrap lymphedema bandages 
(n =153) 
Yes 11 7.2 
No 142 92.8 
Childcare responsibilities. Respondents were asked to list the ages of children 
living in the household who were dependent upon them for assistance with daily life 
activities, including self-care, chores, school activities or play. Ninety-eight respondents 
(N = 158,60.8%) had at least one child who depended upon them for assistance with 
daily tasks. The mean ages for all dependent children are described in Table 6. Sixty­
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one BCS had one child; 15 were s; 10 years of age, 37 were between 11 and 20, 8 were 
between 21 and 30, and 1 was younger than 40. Thirty BCS had 2 children; 14 were S; 
10 years of age and 16 were between 11 and 20. Six BCS had 3 children; 3 were S; 10 
years of age and 2 were between ages 11 and 20. One BCS had four children; that 
child was between 11 and 20 years of age. 
Table 6 
Number of Children Dependent on BCS for Daily Activities (n = 98) 
n Percent Mean Age SO 
Child 1 61 62.9 14.64 6.86 
Child 2 30 30.9 11.64 4.87 
Child 3 6 6.2 9.2 4.75 
Child 4 1 1.0 14.0 o 
Fatigue during daily activities. The FACIT-F focuses on the perceived 
experience of fatigue, however the impact of fatigue on specific daily activities with the 
exception of eating, sleep, "usual activities" (Yellen et aI., 1997), and socialization are 
not delineated. Investigator designed questions on the demographic portion of the 
survey therefore queried respondents about the following using categories from the 
International Classification of Function [ICF] (WHO, 2001) and the Occupational 
Therapy Practice Framework [OTPF], 2nd edition (AOT A, 2008): "Do you have fatigue (a 
tired feeling) at least twice a week that keeps you from completing any or all of these 
daily activities?" Fatigue was reported most often while performing household tasks (56 
BCS, n = 157, 35.7%), when attempting to socialize with friends and family (38 BCS, n 
= 154, 24.7%), while shopping or running errands (45 BCS, n = 154, 29.2%), during 
leisure or socialization (33 BCS, n = 150,22%), at work (26 BCS, n = 148, 17.6%), 
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while taking care of others (25 BCS, n = 153, 16.3%), and least often during self-care 
(16 BCS, n =151,10.6%). 
Outcome of Cancer-Related Fatigue and Upper Extremity Function 
RQ1. Is there a relationship between self-reported cancer-related fatigue and 
perceived upper extremity functional deficits in breast cancer survivors (BCS)? 
Ha.1. There is a relationship between self-reported cancer-related fatigue 
and perceived upper extremity functional deficits in BCS 
An analysis using Pearson's correlation coefficient demonstrated that there was 
a moderate statistically significant inverse relationship between CRF and upper 
extremity function, r =-.661 (two-tailed), p < .001, such that women who had low scores 
on the FACIT-F (more disability or decreased health-related quality of life [HRQOLD had 
higher scores on the DASH (more disability or decreased HRQOL). For these data, the 
FACIT-F mean score was 41.25 (SD = 10.419, n = 157), and the DASH mean score 
was 11.77, SD 13.850, n = 153). 
A simple linear regression analysis was used to further determine if the overall 
model was predictive. The regression model was negative and significant F(1, 150) = 
116.617, P < .001, with 43.4% of the variance in fatigue accounted for by perceived 
upper extremity function. The model indicated that as DASH scores increased by 1 
point, indicating higher levels offunctional disability in the extremity, FACIT-F scores 
decreased by .05 points, also indicative of higher levels of fatigue and disability (f3 = 
.504, t = -10.799, P < .001). 
A one-sample student t-test compared the study sample to the FACIT-F 
normative score for the general United States population using the raw cut-off score of S 
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43 established by Cella, Lai et al. (2002). The study sample, on average, was 
significantly more fatigued than the expected fatigue level for the general U.S. 
population (M =41.25, SO =10.41), t (156) =-2.10, P =.037 (two-tailed). A one-sample 
student t-test was also used to compare the study sample to the cut-off raw score of 5 
34 defined by Van Belle et al. (2005) as the score on the FACIT-F that would meet the 
proposed diagnostic ICD-10 criteria for cancer-related fatigue. The BCS, on average, 
exceeded the proposed diagnostic score (t(156) =8.724, P < .001), indicating that on 
average the study sample had less fatigue than those individuals who would meet the 
ICD-10 diagnostic cut score. However, a subset of the population, 22.3% (n =25), 
demonstrated scores of 34 or less, thus meeting the criteria for a diagnosis of CRF. 
A one-sample student t-test used to compare the DASH scores for the study 
sample (n =153, M =11.77, SO =13.85) to the general U.S. population of women using 
a cut-score of 2:11.96 (Kennedy et aI., 2011), found that on average, BCS in the study 
sample experienced less disability than the U.S. normative sample, t(153) =7.953, P < 
.0001 (two-tailed) for upper extremity function. It is noteworthy that of the 22.3% of BCS 
who scored below or equal to 34 on the FACIT-F thus meeting the diagnostic criteria for 
CRF, 45.5% also had higher DASH scores indicating that this subset of the study 
sample exhibited greater disability or lower HRQOL on both measures (Figure 1). 
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Figure 1 
BCS with Increased CRF and Upper Extremity Disability 
(N=158) 
Not Selected Selected 
FACITFscore <= 34 (FILTER) 
Outcome of Node Dissection Status 
DASHscOfe 
100. >= 11.96 
(FILTER) 
.Not Selected 
• Selected 
so. 
60. 
40. 
~o. 
RQ2. Is there a difference in perceived upper extremity function and fatigue 
between breast cancer survivors (BCS) who underwent sentinel node dissection 
and those who underwent axillary node dissection? 
Ha.2.1: There is a difference in perceived upper extremity function 
between BCS who underwent various node dissection procedures, 
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including axillary node dissection, sentinel node dissection and both 
axillary and sentinel node dissection. 
Ha.2.2: There is a difference in perceived cancer-related fatigue between 
BCS who underwent various node dissection procedures, including 
axillary node dissection, sentinel node dissection and both axillary and 
sentinel node dissection. 
A nonparametric Kruskal Wallis test was used to test for differences in node 
dissection status and perceived upper extremity function and cancer-related fatigue 
respectively because normality was questionable and unequal sample sizes violated the 
use of an ANOVA. The equality of the reported node dissection procedures was skewed 
with 51.3% of BCS undergoing 'sentinel node biopsy. Results indicated that there was 
not a statistically significant difference in the distribution of the fatigue scores of BCS 
undergoing various node dissection procedures l(2) =2.46, p =.292). There was also 
not significant in the distribution of scores measuring upper extremity function l(2) = 
4.67, p =.097). Node dissection status in this sample was not related to perceived 
fatigue or upper extremity function. 
Outcome of Adjuvant Cancer Therapies 
RQ3. Is there is a difference in perceived upper extremity function and fatigue 
between breast cancer survivors (BCS) who underwent differing types of 
adjuvant cancer therapies, including chemotherapy, radiation, or combination 
therapies? 
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Ha3.1: There is a difference in perceived upper extremity function 

between BCS who underwent chemotherapy, radiation, immunotherapy, 

hormone therapy or combination therapies. 

Ha3.2: There is a difference in perceived cancer-related fatigue between 

BCS who underwent chemotherapy, radiation, immunotherapy, hormone 

therapy or combination therapies. 

One hundred and forty-five BCS reported receiving adjuvant treatment, with 13 
women recording no adjuvant therapies following diagnosis and surgical intervention 
(Table 7). A nonparametric Kruskal Wallis test was used to test for differences in cancer 
treatment and perceived upper extremity function due to violations of the distribution 
across all adjuvant therapies resulting in non-normality of the sample. Results indicate 
that there was not a statistically significant difference in upper extremity function in BCS 
who received adjuvant cancer therapies, X2 (2) =1.057 and p =.590. The Kruskal 
Wallis analysis indicated that there was also not a statistically significant difference in 
the distribution of the fatigue scores of BCS undergoing various adjuvant therapy 
procedures l(2) =.558, p =.757). 
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Table 7 
Number and Type ofAdjuvant Cancer Therapies (N = 158) 
oModalities (no treatment) (N = 13)a 
1 Modality (N = 44)a 
Radiation 
Chemotherapy 
Hormone Therapy 
2 Modalities (N =75)a 
Chemotherapy + Radiation 
Radiation + Hormone Therapy 
Chemotherapy + Hormone Therapy 
Chemotherapy + Immunotherapy 
3 Modalities (N = 25)a 
Chemotherapy + Radiation + Hormone 
Chemotherapy + Radiation + 
Immunotherapy 
Chemotherapy + Immunotherapy + 
Hormone 
4 Modalities (N =1)a 
Chemotherapy + Radiation + 
Immunotherapy + Hormone therapy 
n Percent 
13 8.2 
21 13.3 
12 7.5 
11 7.0 
43 27.3 
16 10.1 
15 9.5 
1 0.6 
20 12.7 
3 1.8 
2 1.3 
1 0.6 
a Percentages based on total respondents 
Outcome of Dependent Caregiver Responsibilities 
RQ4. Is there a difference in perceived upper extremity function and fatigue 
between breast cancer survivors (BCS) who have dependent caregiver 
responsibilities and those without dependent caregiver responsibilities? 
Ha4.1: There is a difference in perceived upper extremity function 
between BCS who have dependent caregiver responsibilities and those 
without dependent caregiver responsibilities. 
An independent sample t-test was used to assess the difference in upper 
extremity function and fatigue in BCS with and without caregiver responsibilities. On 
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average, women with at least one child experienced slightly higher upper extremity 
disability (M = 13.87, SE = 1.945) than those without children (M = 10.41, SE = 
1.338), however the results were not statistically significant, t(df =151) = -1.515, p = 
.132). 
Ha4.2: There is a difference in perceived cancer-related fatigue between 
BCS who have dependent caregiver responsibilities and those without 
dependent caregiver responsibilities. 
On average, BCS who had at least one child experienced greater fatigue than 
women without children, t (df = 155) =2.089, p =.038. Mean fatigue values were lower 
for women with children (M = 39.10, SE =1.453) than those without children (M = 42.63, 
SE =.979), signifying greater disability or decreased HRQOL. 
Impact of Upper Extremity Function and Fatigue on Other Activities 
Twenty-two BCS (N = 133, 16.5%) responded to the optional question, "Are there 
any other daily activities that have been impacted by problems with arm function 
(Please list)?" The most frequent impact (n = 11, 8.3%) was related to physical 
symptoms such as pain, diminished strength particularly when performing heavy tasks, 
decreased speed of performance, and swelling. Addition impact was found in IADLS (n 
= 7, 5.3%), including caregiving of young and adult disabled children, and work-related 
tasks (n =6, 4.5%). The least frequent impact statements were in sleep and leisure. 
See Table 10, Appendix C for a complete listing of verbatim comments detailed 
according to ICF (WHO, 2001) and OTPF (AOTA, 2008) classifications. 
Twenty-nine BCS in the second data collection (n = 133, 21.8%) responded to 
the optional question, "Are there any other daily activities that have been impacted by 
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having fatigue (Please list)?" with one respondent indicating no other activities impacted 
by fatigue. The most frequent impact from fatigue reported by the respondents involved 
generalized feelings of fatigue that interfered with the timing and completion of a 
multitude of tasks (n =9, 6.8%), exercise (n =5, 3.8%), work (n =4, 3.0%), sleep and 
IADL activities, including caregiving (n =3 respectively, 2.3%). The least frequently 
mentioned daily activities impacted by fatigue involved ADL activities (self-care) and 
socialization. See Table 11, Appendix C for a complete listing of verbatim comments 
detailed according to ICF (WHO, 2001) and OTPF (AOTA, 2008) classifications. 
Outcome of Employment 
Although employment was not the primary area of focus of this study, several 
questions were asked regarding work status in order to more fully understand the 
impact of breast cancer survivorship on this critical area of occupation. Respondents 
were asked, "Has your work situation changed as a result of problems from your breast 
cancer?" Twenty-two BCS (N =158,13.9%) reported that there had been employment 
changes following breast cancer. Respondents were also asked, "Has your work 
situation changed as a result of the economy?" Twenty-three BCS (N =158, 14.6%) 
identified changes in their employment as a result of the current state of the U.S. 
economy, although only 6 women (3.8%) were unemployed. 
A one-sample student t-test used to compare the DASH Optional Work Module 
(DASH-W) scores for the study sample (n = 134, M = 7.99, SO = 15.45) to the general 
U.S. population of women using a cut-score of ~11.96 (Kennedy et aI., 2011), found that 
on average, BCS in the study sample experienced less disability than the U.S. 
normative sample, t(133) = - 2.974, P =.003 (two-tailed) for upper extremity function. 
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Data from the DASH Optional Work Module (DASH-W) was analyzed relative to 
node dissection status and number of adjuvant therapies received. A nonparametric 
Kruskal Wallis test was used to test for differences in the type of node dissection 
performed during diagnosis and perceived ability to complete work-related tasks due to 
violations of the distribution across node dissection categories, resulting in non­
normality of the data, as well as non-normality of the DASH-W data. Results indicated 
that there was no significant difference in perceived physical abilities during work based 
on node dissection status, n =111, x2 (2) =3.88, P =.14. 
A non parametric Kruskal Wallis test was used to test for differences in number of 
adjuvant cancer treatments and perceived physical ability to complete work-related 
tasks due to violations of the distribution across node dissection categories, resulting in 
the non-normality of the data. Results indicated that there was a positive trend in the 
data, but not a statistically significant difference in perceived physical abilities during 
work in BCS who received adjuvant cancer therapies, n =122, X2 (3) =7.81 and p =.05. 
Job classification by SOC category. The Standard Occupational Classification 
System (SOC) (U.S. Department of Labor, 2010) was used to categorize responses 
from participants to the Optional Work Module of the DASH. The question, "please 
indicate what your work/job is" precedes the four DASH questions assessing perceived 
impact of arm function on work activities. The SOC is the preferred job classification 
system used by federal agencies to aggregate job-related statistical data (U.S. 
Department of Labor, 2010). The 23 major classifications and 97 minor classification 
categories were used to sort participant responses into meaningful occupational 
categories. 
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Seventeen participants (14.5%, n =117) were employed in Management 
Occupations (11-0000): 2 in Top Executive positions; 4 in Management Occupations; 3 
in Advertising, Marketing, Promotions, PR, or Sales Manager positions; 4 as Operations 
Specialties Managers; and 4 in Other Management Occupations. 
Five participants (4.2 %, n = 117) were employed in Business and Finance 
Operations Occupations (13-0000): 3 as Business Operations Specialists; and 2 as 
Financial Specialists. Three participants (2.5%, n =117) were employed in Computer 
and Mathematical Operations (15-000); all were employed in Computer Occupations. 
Four participants were employed in Life, Physical, and Social Science Occupations (19­
000); all were employed as Social Scientists and Related Workers. Five participants 
were employed in Community and Social Service Occupations: all were employed as 
Counselors, Social Workers, and Other Community and Social Service Specialists. One 
participant (.8%, n =117) was employed in Occupations (23-000); that participant was 
employed under Lawyers, Judges, and Related Workers. 
Twenty participants (17.1%, n =117) were employed in Education, Training, and 
Library Occupations (25-000): 2 as Postsecondary Teachers; 10 as Preschool, Primary, 
Secondary, and Special Education Teachers; 4 as Other Teachers and Instructors; 3 as 
Librarians, Curators, and Archivists; and 1 as Other Education, Training, and Library 
Occupations. Seven participants were employed in the Arts, Design, Entertainment, 
Sports, and Media Occupations (27-000): 2 as Arts and Design Workers; 1 in 
Entertainers, Performers, Sports, Sports and Related Workers; and 4 as Media and 
Communications Workers. 
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Sixteen BCS (13.7%, n =117) were employed in Healthcare Practitioners and 
Technical Occupations (29-000); all were employed in Health Diagnosing and Treating 
Practitioners. Five participants (4%, n =117) were employed in Personal Care and 
Service Occupations (39-000): 3 were employed as Personal Appearance Workers, and 
2 were employed as Other Personal Care and Service Workers. 
Seven participants were employed under Sales and Related Occupations (41­
000): 1 was employed as a Supervisor of Sales Workers; 2 were employed as Sales 
Representatives, Services; and 4 were employed as Other Sales and Related Workers. 
Twenty participants (17%, n =117) were employed as Office and Administrative 
Support Workers (43-000): 3 as Supervisors of Office and Administrative Support 
Workers; 1 in Financial Clerks; 1 in Information and Record Clerks; 9 in Secretaries and 
Administrative Assistants; and 6 in Other Office and Administrative Support Workers 
positions. 
One person (.8, n = 117) could not be formally classified since she listed her 
employment as "consulting", a descriptor that falls within numerous SOC categories. Six 
women (5.1 %) listed their primary occupation as homemaker, an appropriate response 
for the DASH Optional Work Module but not one that can be classified using SOC 
categories. 
Ceiling and Floor Effects of Instrumentation 
Ceiling and floor effects were examined. Twenty-one BCS (n =153, 13.7%) 
reached the ceiling on the DASH, producing a score of 0, indicating maximum upper 
quadrant functioning or least disability, although none reached the floor indicating 
maximum disability. On the DASH-W, the Optional Work Module, 88 BCS (n =134, 
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55.7%) scored at the ceiling indicating no disability during physical tasks at work, with 
none reaching the floor indicating maximum disability performing physical work tasks. 
The FACIT-F scores revealed only 6 BCS (3.8%) who scored at the ceiling, indicating 
least fatigue and no participants scored at the floor indicating maximum fatigue. 
Summary 
The data revealed a statistically significant inverse relationship between CRF and 

upper extremity function in a bivariate correlational analysis. This result indicated that 

BCS in this sample who perceived higher levels of CRF, indicating higher levels of 

disability or decreased HRQOL, also perceived higher levels of disability or decreased 

HRQOL in upper extremity function. The simple regression model was predictive, 

finding that an increase of 1 point in perceived upper extremity function as measured by 

the DASH, indicating higher levels of disability, results in a decrease on the FACIT-F of 

.05, indicating higher levels of fatigue and increased disability. In addition, BCS who had 

I at least one child dependent on them for caregiving tasks reported higher levels of 

I 
 fatigue than respondents who did not have dependent children living at home. 

When compared to normative national cut-off scores for fatigue using the FACIT­
F, the study sample exhibited statistically significant higher scores than the general U.S. 
population, although they exhibited better perceived arm function than the general 
population of women on the DASH. There was a subgroup of 22.3% BCS (n =25) who 
exhibited increased fatigue, meeting the ICD-10 diagnostic criteria for CRF. Of this 
subgroup, 45.5% (n =11) also had higher DASH scores indicating there was a small 
group of BCS who exhibited greater disability or lower HRQOL on both measures. 
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There were no significant differences in fatigue or upper extremity function 
between node dissection status or adjuvant therapies received during cancer treatment. 
DASH-Work scores did not identify significant differences in fatigue or upper extremity 
function between node dissection status or number of adjuvant therapies received 
during cancer treatment, although there was a positive trend (p = .05) toward 
impairment in perceived function during physical work tasks with an increasing number 
of adjuvant cancer modalities. 
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Chapter V 
DISCUSSION 
Upper extremity functional deficits and cancer-related fatigue, the two most 
common symptom complexes facing women following breast cancer diagnosis and 
treatment, have the potential to limit performance of daily tasks and resumption of life 
roles. Both problems can challenge the daily lives of BCS, however it is not known if 
these two underreported and underdiagnosed concerns indeed represent separate 
entities as described in the majority of the literature, or if some women perceive late 
effects from both symptoms complexes. Breast cancer survivorship is accompanied by 
a myriad of unique challenges across the trajectory of the survivor's lifespan, including 
potential physical, psychosocial and economic consequences. Diagnostic procedures 
and treatment may result in late or persistent problems that continue to impact the 
survivor for years or decades after surgery or the conclusion of adjuvant therapies 
(CDC, 2012; Sadler et aI., 2002, Portenoy & Itri, 1999, Andrykowski et aI., 1998). 
This exploratory cross-sectional study examined the relationship between these 
two multifaceted constructs and further examined the impact of node dissection, number 
of adjuvant therapies received, and caregiving responsibilities in a convenience sample 
of 158 BCS who completed all surgery and treatment and were between 1 year and 6 
years post-diagnosis. Additional information on the impact of fatigue and upper 
extremity morbidity was also explored by examining these key constructs in relation to 
physical work tasks. This chapter discusses the findings of the study within the broader 
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context of the biopsychosocial model, ICF, and permanent survivorship (Mullan, 1985; 
Miller et aI., 2008; WHO, 2001). 
The findings from this study appear to provide primary outcome findings for the 
first time describing a statistically significant bivariate relationship between CRF and 
upper extremity function. Survivorship numbers are increasing with population estimates 

of 18.1 million individuals by 2020 (Mariotto et aI., 2011), the majority of whom will be 

female breast cancer survivors if current trends continue. Indeed, one in eight American 

women will be diagnosed with breast cancer in her lifetime (National Cancer Institute, 

2011). Persistent problems during post-treatment survivorship can interfere with daily 

I task performance, particularly for instrumental activities of daily living, which includes 

household management and caregiving tasks, as well as impair socialization and 

employment (de Boer et aI., 2009; Obserst et aI., 2010; Stone et aI., 2000; Servaes, 

Verhagen, S., & Bleijenberg, 2002). A more thorough understanding of these two 

symptom complexes and the accompanying activity performance limitations may assist 

I 
 healthcare professionals to screen and identify BCS in need of services. 
DemographicsI 
This group exhibited demographics that were typical of respondents to other 
breast cancer studies with a high percentage of educated BCS (Collins et aI., 2004; 
Dhruva et aI., 2010). The inclusionary criteria excluded women over 65 since 
caregiving responsibilities for dependent children and employment were variables of 
interest, therefore it was anticipated and confirmed that the mean age of the sample, 52, 
would include some younger survivors. The majority of respondents were Caucasian (n 
=147,93%), educated at the graduate (n =71,44.9%) or college level (n =52, 32.9%), 
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married (n = 117, 70.9%), and employed full-time (n = 98, 62.0%). Women who 
completed the study resided in 21 different states, plus the District of Columbia. They 
resided most often in the Middle Atlantic (n = 104,66.2%) and South Atlantic (n = 23, 
14.7%) regions of the country with the largest number of respondents identifying NJ (n = 
74,47.1%), NY (n = 24, 15.3%), and CA (n = 9,5.7%) as their state of residency. 
Respondents were primarily right-dominant (n = 146,92.4%) identified the tumor 
stage at diagnosis as Stage 0 (n =25, 15.8%), Stage I (n =60, 38.0%), Stage II (n =49, 
31.0%), Stage III (n =22, 13.9%), and 2 women (1.3%) reported that they did not know 
the stage of the tumor. There were equal numbers of BCS identifying the original tumor 
location as right versus left sided (75, n = 47.5) respectively and 6 women (3.8%) 
reported bilateral tumors at diagnosis. Of the 69 BCS who underwent lumpectomies 
(43.7%), none had reconstructive surgery. Of the 68 respondents who underwent 
mastectomies (36.7%), 45 had undergone reconstructive surgery (66.1%). Twenty BCS 
had lumpectomies and mastectomies (12.6%). Of those BCS who underwent both 
procedures, 15 had reconstruction (75%), and 1 BCS had no surgery. 
Women in this study had surprisingly high rates of mastectomy compared to 
breast conserving surgery and the majority of women who underwent dual procedures, 
lumpectomies and mastectomies, had breast reconstruction. Two recent studies 
documented the increase in mastectomy rates following several years of decline 
(McGuire, 2009, Katipamula et al. 2009). Identified factors accounting for this 
unexpected rise include an increase in contralateral prophylactic mastectomies as 
genetic testing provides women with increased information that may alter their 
collaborative decision-making with the oncology team, as well as decisions by women to 
130 
request more extensive surgery in order to try to avoid or decrease radiation or 
chemotherapy (McGuire et at, 2009). It is difficult to ascertain why the mastectomy 
incidence rates were high in this sample. It is possible that the purpose of the study 
attracted respondents who had undergone more extensive surgery, as noted in the high 
number of women who reported having undergone both lumpectomies and 
mastectomies, or BCS who might experience persistent symptoms. It could be 
suggested that the higher education level of the BCS with the majority of women holding 
graduate degrees led women to make alternative decisions about surgical options, or 
that the Northeast geographic region with access to major research cancer centers may 
offer a different array of surgical and treatment options. Diagnostic information on type 
of breast cancer, exact TMN staging, number of positive lymph nodes, and potential 
genetic variations were unavailable for analysis and this might also influence decision­
making for surgical options. Despite these increased incidence numbers, mean DASH 
scores were high indicating lower levels of arm morbidity and higher reported levels of 
HRQOL. 
Lymphedema. Twenty-five women identified a diagnosis of lymphedema 
(15.8%); 7 (39%) BCS with axillary node dissection, 12 (15%) BCS with sentinel node 
biopsy, 4 (13%) BCS who underwent both types of node biopsies and 2 (20%) BCS who 
did not know the type of node biopsies they received. Ten (6.4%) were receiving 
treatment for the lymphedema from an occupational or physical therapist at the time of 
survey completion; 4 (40%) with axillary node dissection, 4 (40%) with sentinel node 
biopsy and 2 (20%) with both types of node biopsies. Eleven (7.2%) BCS used 
compression wrapping to treat the lymphedema. The findings for this sample 
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documented mean levels of self-reported lymphedema in BCS who underwent ALND, 
SLNB or both that were reported in some previous studies (Penha, Siangen, Heuts, 
Voogd, & Von Meyenfeldt, 2011; Gartner et aI., 2010). 
Prevalence statistics for lymphedema vary dramatically, depending upon whether 
lymphedema was measured through objective measures or self-report, as well as when 
in the time period post-diagnosis this information is obtained. BCS were asked whether 
they had received a diagnosis of lymphedema, rather than whether they had noted 
signs of swelling indicative of lymphedema, as have been previously documented in the 
I self-report literature on lymphedema prevalence, however as this information could not 
I be confirmed through medical records it was treated as self-report data. The self-j reported lymphedema prevalence rate of 15.8% from this study fall within the range of 8 
I - 17% reported by Pen ha et al. (2011) from a cross-sectional study of 145 BCS using j 	 multiple assessment modalities. McLaughlin et al. (2008) reported that prevalence rates 
calculated on less than 5 years of survivorship may underestimate the size of the 
population with lymphedema since lymphedema rates increase during the first few 
years post-diagnosis and treatment. Self-report rates in the literature may document 
estimated prevalence rates that exceed the objective measurements in the same study, 
possibly due to persistent sensory changes in the affected limb that alter BCS 
perceptions of arm swelling (Hayes et aI., 2008; Haid et aI., 2002), however other 
studies document reliable self-reporting in that individuals who underwent SLNB 
appropriately reported Significantly less symptoms, including swelling, than individuals 
who underwent ALND when objective measures con'firmed these results (Schrenk, 
i 	 Rieger, Shamiyeh, & Wayand, 2000). 
I 
I 
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Compression Sleeves. Compression sleeves were worn by 33 BCS during air 
travel (n = 98,33.7%), by 12 participants (n = 82, 14.6%) while exercising, by 14 (n = 
86,16.3%) when performing heavy housework, and 4 wore the compression garment at 
all times (n =76, 5.3%). Of the 25 BCS reporting diagnosed lymphedema, 86% wore 
their garment during air travel, 75% during exercise, 71 % during heavy housework, and 
40% at all times. Only one study was located describing compression sleeve use 
patterns in BCS diagnosed with lymphedema. Ridner, Dietrich, and Kidd (2011) 
documented frequencies for self-care behaviors, including compression garment use, in 
51 BCS with lymphedema in a cross-sectional study and found that 92% reported 
J wearing their compression garments during the day and 49% at night (p.634). In this 
1 study, BCS with lymphedema reported lower percentages of garment use than noted in 
1 
I j Ridner et al. (2011) in relation to garment use during specific daytime activities typically 
I associated with recommendations for BCS (National Lymphedema Network, 2012). Use 
during sleep was not queried in this study due to the focus on functional performance. 1 
Based upon these inconsistencies one must question what recommended guidelines 
were provided to previous and current study participants and what happens to use 
patterns over a period of years following initial recommendations. Results from a 
qualitative study of 24 BCS in Australia found that women were confused about 
compression sleeve use since BCS are commonly cautioned to avoid compression of 
the ipsilateral arm through tight garments, jewelry or blood pressure cuffs, and the 
compression garments are designed to provide consistent compression to the extremity 
when worn (Collins et aI., 2004). 
I 
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Compression sleeves are one aspect of self-care advice management strategies 
provided to BCS to prevent or manage lymphedema. The National Lymphedema 
I 
] 
 prevention (NLN Medical Advisory Committee, 2012) alerting BCS with lymphedema to 

follow the manufacturer's guidelines for wear and replacement with suggested use 
during "air travel, exercise and exertion" (p.2). The same organization also updated 
recommendations for those at risk of lymphedema but not yet diagnosed (Thiadens, 
2011), suggesting that compression garments, if worn, can be used for "strenuous 
activity" and "air travel" (p. 2). The organization documented a disclaimer on the site 
stating that the evidence in the research literature supporting or refuting preventive self-
care strategies is insufficient (Thiadens, 2011). Information on compliance with 
! 

I 

1 

1 

Network recently updated their risk-reduction practices information for lymphedema 
compression garment use is also lacking in the literature, although these garments are 
regularly recommended by clinicians for prevention of lymphedema. Assessed in its 
totality, the data from this and previous studies supports the importance of clinicians 
assisting survivors to continually assess and appropriately weigh the risk factors and 
evidence surrounding garment use for self-care prevention or lymphedema 
management. 
Caregiving for Dependent Children. Participation in caregiver roles were noted 
by the majority of the study sample. Ninety-seven BCS (N = 158, 61.4%) reported 
responsibilities for at least one child who was dependent upon them for assistance with 
daily life activities, 30 BCS had two children, 6 BCS had 3 children and 1 BCS had 4 
children. Mean ages for the children were from 9.2 years to 14.64 years, but ranged 
I 
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from 1 - 38. One participant reported caring for an older adult son, age 38, with a 
disability. 
While we utilized the FACIT-F to assess key information about perceived fatigue, 
1 	 it offers little insight into specific activities that are impacted by persistent fatigue 
symptoms. Categories from the International Classification of Function [ICF] (WHO, 
2001) and the Occupational Therapy Practice Framework [OTPF], 2nd edition (AOTA, I 
I 
I 
2008) support that fatigue was reported most often while performing household tasks 
(56 BCS, n = 157, 35.7%) and least often during self-care (16 BCS, n = 151, 10.6%). 
Household tasks, errands and caregiving fall under the category of instrumental 
activities of daily living (IADLs). These higher order life tasks require additional and 
more complex skill sets, including more physical capacity, to complete than self-care 
(ADL) tasks. It was surprising that reported fatigue during caregiving on the 
demographic survey was limited (25 BCS, n = 153, 16.3%) since findings from the study 
demonstrate that increased fatigue during dependent caregiving, as measured by the 
FACIT-F, was statistically significant. It is possible that BCS did not report fatigue when 
faced with the dichotomous question on caregiving on the demographic survey versus 
I 
 choosing from the potential range of responses on the Likert scale used in the FACIT-F. 
Dhruva et at 	(2010) assessed diurnal fatigue levels in BCS before and after 
radiation therapy and revealed that women with children at home and employed women 
experienced higher levels of fatigue. Their research indicated that evening fatigue in this 
population might be impacted by "behavioral factors" (Dhruva, 2010, p. 210). This was 
the only study located that examined caregiving as a predictive factor in fatigue in 
breast cancer survivors. Many of the women in this study were also employed, had 
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received radiation therapy and had dependent children at home. If behavioral factors or 
lifestyle factors are partially responsible for fatigue, it is possible that non­
pharmaceutical interventions that address energy conservation, work simplification and 
pacing could be initiated to address the fatigue. 
Occupational Performance. Rates of impairment in the ability of BCS to 
complete daily activities range from 13% - 51% (Lash &Stillman, 2002) with activities 
requiring heavy work by the upper extremity musculature most often implicated as 
problematic. The findings of this study supported results from Fu and Rosedale (2009), 
demonstrating that basic self-care was not identified as problematic by survivors. The 
impact of fatigue on specific IADL tasks is not well described in the literature (Collins et 
a!., 2004). An examination of the questions from the investigator-designed fatigue 
survey questions and the FACIT-F revealed that the FACIT-F examines more global 
aspects of fatigue and energy, whereas the investigator-designed questions queried 
participants about ICF activity categories. It is possible that perceptions of fatigue are 
not related to task-specific behavior, distinct for example from awareness of upper arm 
function where difficulties can be easily ascertained when it is not possible to open a jar 
or vacuum the house. It is possible that the investigator-generated questions may not 
have captured the key tasks that are most impacted by fatigue, despite covering major 
activity areas from the ICF that have been documented in the breast cancer core sets 
and research literature. 
CRF and Upper Extremity Function 
The first question explored the relationship between the two most common 
symptom complexes experienced by BCS; CRF and upper extremity function. Findings 
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supported the hypothesis determining that there was a moderate significant inverse 
relationship between CRF and upper extremity function, r =-.661, P< .001, such that 
BCS who perceived increased levels of fatigue, producing lower scores on the FACIT-F 
scale, also perceived increased arm dysfunction, thereby producing higher scores on 
the DASH. A simple linear regression analysis further determined that the overall model 
was negative and significant (p < .001), with 43% of the variance in fatigue accounted 
for by perceived upper extremity function. For this sample population, the model 
indicated that as DASH scores increase by 1 point, indicating higher levels of functional 
disability in the extremity, FACIT-F scores decrease by .05, also indicative of higher 
levels of fatigue and disability (p < .001). Since other key variables of interest did not 
further explain the model, it is likely that the variance is accounted for by other factors. 
The multifactorial nature of these two symptom constructs confounds efforts to 
discern the exact underlying etiologies with any certainty. Studies on CRF have 
implicated other factors in the development of CRF that were not examined in this i 
I study, such as underlying inflammatory markers including C-Reactive Protein (Alexander et aI., 2009), other immune system dysfunction, sleep dysfunction, additional , 
disease comorbidities, and medication use (Mortimer et aI., 2010; Portenoy & Itri, 1999; 
Yellen et aI., 1997). Gerber et al. (2010) noted significant correlations between fatigue 
and white blood cell values >8,000. Other co-morbidities, such as arthritis that may limit 
arm function or increase fatigue, and an increased BMI (Gerber et aI., 2010) were not 
documented for this study sample and remain a limitation of the study. 
Pain emerged in the literature as a factor in the development of CRF and upper 
extremity morbidity (Hack et at, 2010; Peuckmann et aI., 2009), however the only 
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questions regarding pain for this study were part of the DASH questionnaire which 
required retrospective examination of perceived pain over the course of one week 
located anywhere in the upper quadrant. or pain experienced during activity in the upper 
quadrant (Kennedy et aI., 2011). Despite high overall mean DASH scores that 
exceeded the national normative values indicating lower levels of disability, 47% of the 
BCS reported mild to extreme pain in the arm, shoulder, or hand during activities and 
42.8% of the sample experienced mild to severe pain in the arm, shoulder, or hand in 
general. Other upper extremity symptoms were revealed by the DASH, including 46.7% 
reporting mild to severe stiffness, 44.4% of the same sample identifying mild to extreme 
weakness in the affected extremity, and 40.8% reporting mild to extreme tingling. 
Some researchers have proposed the development of separate scales within the 
DASH to examine facets of upper quadrant function (Dixon et aI., 2008; Lehman, 
Woodbury, & Velozo, 2011). The five symptom questions, currently clustered on the 
DASH questionnaire, have the potential to be aggregated as a subscore that could be 
used by researchers to consider contributing factors to upper extremity dysfunction. As 
43% of the variance in fatigue in this sample was explained by upper extremity function, 
it is possible that perceived pain and other persistent upper extremity physical 
symptoms identified by Dixon et al. (2008) and categorized under the impairment 
construct of the ICF, contributed to perceived fatigue. 
Comparison of the study sample to the FACIT-F normative score for the general 
United States population using the raw cut-off score of S 43 established by Cella and 
Lai et al. (2002) revealed that the study sample, on average, was significantly more 
fatigued than the expected fatigue level for the general population (p =.037). Further 
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comparison of the study sample to the raw cut-off score of s 34, defined by Van Belle et 
al. (2005) as the score on the FACIT-F that would meet the proposed ICD-10 criteria for 
CRF, indicated that the study sample, on average, was significantly less fatigued than 
those cancer survivors who would meet the diagnostic definition for CRF (p < .001). 
However, a subset of the study sample, 22.3%, did meet the criteria for CRF. The 
finding of a subset of BCS experiencing higher levels of fatigue representing 
approximately one-quarter of the overall sample is consistent with the research 
literature (Bower et aI., 2006; Servaes, Verhagen, S., & Bleijenberg, 2002; Bower et aI., 
2000). These BCS do not represent outliers in the data set. They are part of a 
consistently documented subset of cancer survivors experiencing fatigue as an ongoing 
concern. While attention needs to be directed toward all survivorship concerns, it is 
imperative that this subset receive better identification and delivery of services to 
address their needs. 
In addition, the study sample responses to perceived arm function using the 
DASH were compared to established normative values for women in the U.S. 
population using a cut-score of ~ 11.96 (Kennedy et aI., 2011). This comparison found 
that, on average, the BCS in the study sample experienced significantly less disability 
than the reference sample (p < .001). Of the subset of 22.3% of the sample that met the 
criteria for CRF, it is noteworthy that 11 participants (45.5%) of the fatigued subset also 
exhibited greater disability on the DASH as well. 
The second research question examined differences in perceived upper 
extremity function or fatigue in BCS who underwent node dissection procedures, 
specifically sentinel node biopsy, axillary node biopsy, or both sentinel and axillary node 
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biopsy. The hypothesis was not supported for differences in upper extremity function or 
fatigue based on the node dissection procedures reported by the BCS. The majority, 
51.3%, of BCS underwent sentinel lymph node biopsy (n = 81) and 19% (n = 30) 
underwent both SLNB and ALND. SLNB is considered to be the standard of care for 
BCS who have negative nodes with increasing evidence that there are no differences in 
locoregional recurrence between those BCS with negative nodes who have early stage 
disease and will undergo adjuvant therapies, versus the use of ALND (Giuliano et aI., 
2010). The literature suggests that SLNB causes less upper extremity disability than 
axillary node dissection (Hack et aI., 2010; Schrenk et aI., 2000) with the result that 
SLNB is increasingly the standard of care for node dissection. The higher number of 
women who underwent sentinel node biopsy may suggest one reason why differences 
were not detected for upper extremity function since less invasive surgical procedures 
were used in the axillary region. It is also plausible that the higher number of women 
who underwent SLNB suggests a higher proportion of node-negative respondents; none 
of the women with SLNB had mastectomies also suggesting less invasive disease at 
the time of diagnosis. 
The third research question examined differences in perceived upper extremity 
function and fatigue in BCS who underwent adjuvant therapies including chemotherapy, 
radiation therapy, immunotherapy, hormone therapy or combination therapy. The 
hypothesis was not supported for differences in upper extremity function or fatigue 
based on the number of adjuvant modalities that were reported by the BCS. One 
hundred and forty-five BCS received adjuvant therapies, with 13 women reporting no 
use of adjuvant therapies following diagnosis and surgical intervention. The majority of 
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women (n = 43,27.3%) received chemotherapy and radiation, with the next most 
frequent treatment as radiation only (n =21, 13.3%), followed by chemotherapy, 
radiation and hormone therapy (n =20, 12.7%). 
The research literature examining the relationship of radiation and chemotherapy 
to upper extremity function and fatigue has been inconclusive and the results of this 
exploratory study do not further clarify these inconsistencies. Women in this study 
received a variety of adjuvant therapy combinations and the study sample was too small 
to explore the results from each adjuvant modality in relation to arm function and 
fatigue, therefore the overall number of adjuvant modalities received was examined in 
relation to CRF and upper extremity function. It is of interest that the majority of women 
(n =101) were treated with two or more adjuvant modalities, most receiving 
chemotherapy and radiotherapy (27.3%). Prior studies have indicated that radiotherapy 
is more often associated with long term sequelae in the upper extremity than 
chemotherapy (Peuckmann et al., 2009) and that chemotherapy (Broeckel et aI., 1998, 
Bower et aI., 2000), radiotherapy (Lee et aI., 2007), or combined adjuvant therapies 
(Jacobsen, Donovan et aI., 2007; Bower et aI., 2006) have been associated with higher 
levels of fatigue in early stages of the survivorship process. 
In a case-control study, 1,929 German BCS retrospectively rated fatigue and 
quality of life before, during and following adjuvant therapies approximately 6 years 
post-surgery; findings revealed slightly higher fatigue levels for women who received 
both chemotherapy and radiation among women with chemotherapy emerging with the 
highest fatigue ratings (Schmidt et aI., 2012). BCS who had more fatigue one year post­
surgery also reported more symptoms in the surgical side and affected arm, including 
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pain, and decreased overall functioning; those who had persistent fatigue up to six 
years post surgery had reduced QOL ratings and reported worse functioning in all 
dimensions (Schmidt et aI., 2012). This is one of the few studies to describe persistent 
arm morbidity in relation to CRF (Schmidt et aL, 2012) and is supported by the findings 
in this study that there is a subset of women whose combined symptoms diminish 
HRQOL This study lends credence to the idea that there are multiple trajectories for 
women who have persistent fatigue post-surgery and treatment 
The fourth research question examined differences in perceived upper extremity 
function and fatigue in BCS who reported caregiving responsibilities for dependent 
children living at home who required assistance with daily activities. The hypothesis was 
not supported for the difference in upper extremity function between women who do and 
do not have caregiving responsibilities, although mean scores on the DASH indicated 
that women with at least one child experience slightly higher upper extremity disability 
than those without children. Round, Hayes, and Newman (2006) found that women with 
children under the age of 14 reported more upper extremity disability than women 
without children using the DASH as a measure of arm function. Their findings were not 
fully supported by this study which failed to find increased upper extremity disability in 
relation to care of dependent children. Two BCS provided optional comments identifying 
difficulties with childcare responsibilities. 
"Helping my disabled son is sometimes painful, so I ask my husband for help." 
"Lifting my children, moving things." 
However, results supported the hypothesis that there is a difference in perceived 
fatigue between BCS who have dependent caregiver responsibilities and those who do 
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not (p = .038). Mean fatigue values were lower for women with children than those 
without children signifying greater disability for women with caregiver roles. Only one 
mother reported a comment in the optional query on other daily activities that are 
impacted by fatigue, noting that: 
"[It is] challenging to take care of three small children and I am exhausted driving 
them to school, extra-curricular activities, etc." 
This was an unexpected finding in the study. On average, the BCS in this sample 
experienced higher levels of fatigue than the national normative values, even though the 
majority did not reach a level that would warrant a diagnosis of CRF. Most women were 
also employed full or part-time. It is possible that the increased demand for energy 
output from responsibilities at home and at work throughout the course of the week-long 
retrospective reporting on the FACIT-F increased reports of perceived fatigue. 
Little is reported about the impact of dependent childcare responsibilities on 
fatigue and arm function after breast cancer. Research describing dependent children is 
more likely to report the psychoemotional responses of women recently diagnosed or 
undergoing adjuvant therapies in relation to talking to children about the cancer or 
concerns about mortality, rather than focusing on the impact of reduced energy or 
diminished arm function on caregiving responsibilities. Round et al. (2006) generated 
one of the few studies to document outcomes related to caregiver roles, but only 
focused on upper extremity use. Dhruva et al. (2010) focused on the impact of radiation 
therapy on diurnal fatigue noting caregiving of dependent children as a predictive factor 
for evening fatigue. 
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Employment 
Efforts to explore the experience of work in BCS were preliminary and are 
regarded as secondary findings of the study. However, work is important to BCS and 
resumption of work is often viewed as sign of recovery from cancer (Maunsell et ai, 
2004). The optional work module for the DASH, the DASH-W, was used to assess 
physical aspects of work in relation to node dissection status and number of adjuvant 
therapies received. Results indicated that there was no significant difference in 
perceived physical abilities during work based on node dissection status. However, 
results did demonstrate a positive trend in the data, but not a statistically significant 
difference, in perceived physical abilities during work in BCS who received adjuvant 
cancer therapies (n =122, P =.05). 
Cancer survivors may report changes in employment status as a result of a 
cancer diagnosis or persistent changes following cancer treatment. In this study, 22 
BCS (13.9%) reported that there had been employment changes following their breast 
cancer. Due to major changes in the U.S. economy impacting a large number of 
employed Americans, respondents were also asked if changes in the economy had 
altered their work situation. Twenty-three BCS (14.6%) identified changes in 
employment as a result of the current state of the U.S. economy, although only 6 
women (3.8%) were unemployed and only 2 (1.3%) were on disability. The U.S. jobless 
rate during the same period was 8.9% (U.S. Department of Labor, 2012), indicating that 
this study sample experienced less unemployment than the U.S. population during the 
data collection time period. It was not possible to clarify the reason for changes in 
1 
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employment secondary to the breast cancer however this is an area that requires 
additional research. 
DASH-W scores for the study sample were compared to the general U.S. 
population scores for women using a cut-off score established by Kennedy et al. (2011). 
On average, BCS in the study sample experienced less disability performing upper 
extremity physical work tasks than the U.S. normative sample (p = .003). 
Data from the DASH-W was also analyzed relative to node dissection status and 
number of adjuvant therapies received. Results indicated that there was no significant 
difference in perceived physical abilities during work based on node dissection status. 
Results examining differences in the number of adjuvant cancer treatments received 
and perceived physical ability to complete work-related tasks indicated that there was a 
positive trend in the data, but not a statistically significant difference in perceived 
physical abilities during work in BCS who received adjuvant cancer therapies (n = 122, 
p =.05). 
The first question of the DASH-W asks a general question requesting 
identification of the participant's work or job. One-hundred and seventeen responses 
were analyzed using the Standard Occupational Classification System (SOC) (2010), 
the preferred job classification system used by federal agencies to aggregate job-
related statistical data (Department of Labor, 2010). The 23 major classifications and 97 
minor classification categories were used to sort participant responses into meaningful 
occupational categories. Participants' employment situations were represented by 10 of 
the 23 major classification areas (Department of Labor, 2010): management 
occupations; business and finance operations; computer and mathematical operations; 
145 
life, physical and social science occupations; occupations (law); education, training and 
library professionals; office and administrative support work; arts, design, entertainment, 
sports, and media occupations; healthcare practitioners and technical occupations; 
sales and related professions; and one person could not be classified. 
The optional question requesting comments about other daily activities that are 
impacted by fatig ue or upper extremity yielded remarks about work-related activities 
impacted by arm function: 
"I used to take care of a patient who was semi-comatose and I had no mobility. 
Because of my diagnosis and subsequent physical limitations (could lift no more 
than 5 - 10 Ibs with my left arm), I had to leave my job." 
"Working at my desk is sometimes uncomfortable because of arm, shoulder 
pain/pins and needles." 
"Trying to close a padlock or a 3-ring binder." 
Work activities were also impacted by fatigue. 
"I am a lecturer/teacher - I tire more easily so while it does not affect work, when 
I am done. I am very tired." 
"Going out for long periods of time. Just can't. Night deliveries (babies) tire me 
out much more now." 
The comments may increase our understanding of the differences between 
perceptions of arm function versus perceived fatigue. Comments responding to the 
question about other areas impacted by changes in arm function revealed specific 
observations related to task behaviors, specific job tasks that were more difficult to 
complete. Documented remarks about fatigue appeared to express a more global 
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viewpoint about the impact of this symptom on work, i.e., impacting time spent on task 
rather than the tasks themselves and may suggest one reason why the investigator-
I designed questions on fatigue produced lower frequencies than would have been 
.~ 
I expected based on the FACIT-F scores. Insights gleaned from this information can 
] assist in the development of further research, but may also assist clinicians to ask different questions when addressing fatigue or upper extremity morbidity. 
The biopsychosocial model approaches survivorship as a complex, multifactorial 
entity unique to each survivor but identifies commonalities experienced by this 
population. The ICF Core Sets for Breast Cancer (Brach et aI., 2004) describe the 
consensus document of ICF categories specific to breast cancer survivors. Activities 
identified as critical to this population that coincided with results from this study included 
"family relationships, hand and arm use, carrying out daily routine, doing housework, 
remunerative employment and lifting and carrying objects" (Brach et aI., 2004, p. 124). 
While the majority of women in this study were able to function in multiple life spheres, 
there were others who identified mild to severe difficulties completing daily life tasks. 
This study affirms results from previous research that subsets of BCS are continuing to 
experience mild to significant problems in daily function, even long after surgery and 
adjuvant therapies conclude. Limitations at the ICF activity and participation level 
disrupt quality of life. 
Limitations 
Design and instrumentation. CRF is not a stagnant entity and therefore the 
cross-sectional design had inherent limitations in describing the fatigue experience for 
this sample of respondents. The FACIT-F captures the perceived average fatigue 
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experience over the course of one week, but does not distinguish self-reported fatigue 
variability that may occur during a given day or week. Recall error is possible since 
responses to the FACIT-F are assessed retrospectively. 
There are questions that were not asked as part of the cross-sectional design 
due to the inability to have direct contact with participants or access medical records for 
data accuracy, including body mass index (BMI), comorbidities that could impact fatigue 
or upper extremity function such as arthritis, cardiovascular disease or the influence of 
proinflammatory biomarkers. 
While self-perception is well accepted as a measurement of fatigue, research on 
upper extremity morbidity typically includes actual measurement of ROM through 
goniometry and arm circumference by tape measure, volumetric or bioimpedence 
technology although significant inconsistencies in measurement methodology limit study 
comparisons (Hayes et aI., 2008; Haid et aI., 2002; Schrenk et aI., 2000). Some studies 
found that self-report of lymphedema, for example, resulted in increased percentages of 
women reporting this condition versus actual measurement of the extremity compared 
to the unaffected limb (Hayes et aI., 2008; Haid et aI., 2002). Participants in this study 
were asked if they were diagnosed with lymphedema, rather than their opinion 
regarding the presence of lymphedema, but there was no ability to confirm the 
diagnostic information. 
Internal validity. The survey was brief with limited participant burden and was 
completed, on average, in 15 minutes. However, it is noteworthy that individuals 
answered the survey at various times of day, including in the middle of the night and 
close to typically scheduled mealtimes, and therefore BCS may have experienced 
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maturation effects due to hunger, fatigue or competing interests for their time. 
Distraction is also a potential factor in internet-based research methodology. It is not 
known if BCS were attending to other on-line or real time activities during completion of 
the survey. 
Typically, cross-sectional studies collect data at one data point. This study was 
deployed at two different times of year with the pilot study deployed in February of 2011 
and the final data collection deployed in October 2011 during Breast Cancer Awareness 
Month with data collection continuing until January 2012. While deployment during 
October was intentionally designed, it is also a consideration that individuals might have 
reached saturation from breast cancer media awareness campaigns, requests for 
donations or event participation requests that might have resulted in a negative impact 
to receipt of the study invitation. 
External validity. The potential for sampling bias must be explored. A 
convenience sample was used for this study and required access to the internet as part 
of the inclusionary criteria. It is therefore anticipated that there was sampling bias within 
the pool of respondents. The internet divide continues to be a limiting factor in internet­
based research and was a known limitation of the study at its inception. The Pew 
Research Organization recently noted that 78% of women had access to the internet as 
of August 2011, noting that significant factors in on-line use included being younger 
than 65, having a minimum of a high school education and reporting an annual 
household income of greater than $30,000 (2011). Race emerged only as an issue in 
terms of access to sufficient broadband (Pew Research Organization, 2011). They 
further noted that despite improvements over the past decade, 20% of Americans 
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choose not use the internet (Pew Research Organization, 2011), further limiting the pool 
of potential respondents in the sampling frame and potentially creating non-sampling 
bias. Therefore respondents who chose not to participate for any reason may represent 
a different facet of the larger population. 
The response rate was extremely low for the final data collection (10.4% for the 
pilot study and 0.4% for the final data collection), although this was anticipated based 
on the decision to use snowball recruitment sampling with a large non-targeted 
population as the primary contact to locate partiCipants via the study invitation. It is not 
possible to know how many BCS received the original invitation from the PI, versus how 
many received a forwarded e-mail from a second or third-level contact. It is also not 
possible to know whether individuals receiving the e-mail from a known contact 
1 influenced response rates, or how many initial contact recipients decided to forward the 
invitation to others. Individuals can also change e-mail addresses and initial forwards 
1 
may not have reached respondents, even if primary recipients of the participation 
invitation attempted to forward the information to an eligible BCS. It was also possible 
that the invitation to participate was forwarded to a spam file, thus removing the e-mail 
from an eligible respondent's mailbox. 
It was not feasible to authenticate the eligibility of the respondents since contact 
information was not obtained and additional anonymity controls, such as discarding IP 
addresses collected by SurveyMonkey immediately following data downloads, were 
practiced. Three participants contacted the investigator via e-mail with problems related 
to the link to the survey. No errors were found in the SurveyMonkey mechanism, but 
broadband differences, user error and browser conflicts could have reduced response 
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rates. It is therefore likely that there were other women who experienced difficulty and 
chose not to take the additional step to contact the investigator to receive assistance. 
Furthermore, twenty-seven participants were ineligible to participate once their 
demographic data was reviewed due to failure to meet the time-since-diagnosis 
inclusionary parameter. 
While minority access to the internet has increased, it was extremely difficult to 
recruit a representative sample of BCS approximating U.S. minority population 
estimates for this population. Only 3.2% of the study sample self-identified as 
Black/African American (n =5) or Hispanic (n =5) respectively, and only 1 person 
identified herself as Asian (0.6%). 1m and Chee (2005) in a study on internet recruitment 
for breast cancer research, reported significant difficulty recruiting BCS in minority 
communities due, in part, to the inability to establish trust since the researchers 
remained outside the organizational structure and lacked the face-to-face contact of 
traditional research methods. Experiences in recruitment for this study mirror their 
findings. Attempts to secure participants from breast cancer support groups serving 
minority communities were unsuccessful; multiple organizations in NY and NJ simply 
did not respond to outreach efforts. Anecdotally, two key stakeholders in non-profit 
organizations serving minority members told the PI that they have increasing requests 
from researchers asking for internet or direct access to their members. They further 
reported that their non-profit organizations, struggling with reduced budgets, limited staff 
and a primary mission of service delivery, do not always have time to vet requests and 
decide on the merit and benefits of a particular study to their members. The racial 
background of the researcher must be considered as well when using snowball 
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recruitment to obtain a convenience sample. The majority of the primary personal and 
professional contacts requested to forward the study invitation were Caucasian. While 
the Seton Hall recruitment announcements to the South Orange and Newark campuses 1 
reached a diverse population, it is also more likely that individuals who knew the primary J 
investigator directly or peripherally would be more responsive to forwarding the 
recruitment announcement to others. This was confirmed by examining the survey 
collectors on Survey Monkey. Individual URLs were generated by the software in 
response to naming the origin point for the collector. As an example, support groups 
from cancer organizations yielded 4 responses, whereas professional contacts known to 
the investigator yielded 36 responses. 
I It is also possible that self-selection bias occurred. The study invitation asked all ] BCS meeting the eligibility criteria to participate, regardless of whether they were 
experiencing symptoms at the time of survey completion. It is possible that women who 
experienced some difficulties now or in the recent past might have been more likely to 
complete the survey. In light of these factors, interpretation of the data must be 
considered with caution. 
The free-text comments for the optional questions could not be used to generate 
inferences about the needs of the population due to the limited number of responses but 
did provide an opportunity to obtain additional information about the impact of fatigue 
and upper extremity function on daily activities. Garcia, Evans, and Reshaw (2004) 
noted that free comments tend to contain more negative than positive statements but 
may be used to generate ideas for future research. In this study, the investigator also 
could not request clarification of responses generated in the optional questions, the 
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majority of which were single word responses. In a study designed for direct contact 
with the respondents, additional questions requesting elaboration would have been 
posed. As a result, the limited data received from the participants could only be coded 
into key ICF and OTPF categories, but the opportunity to explore these responses in 
greater depth was not possible. 
Selection-instrumentation interaction. The FACIT-F and the DASH offer well-
established psychometric properties that have been documented in other research, as 
well as nationally normative scores that are described earlier in this thesis. However, 
there are some concerns about the observation of floor and ceiling effects for the scores 
in this sample of BCS, particularly for the DASH-W, the optional work module. Ceiling 
effects result from test items or scales that are not sufficiently difficult for the 
respondents, resulting in a subset of individuals attaining the highest possible score that 
indicates maximal functional ability (Canadian Stroke Network, 2012; Polit & Hungler, 
1995; Portnoy & Watkins, 1993). Floor effects result from individuals scoring at the 
lowest possible score that indicates least functional ability (Polit & Hungler, 1995; 
Portnoy &Watkins, 1993). As noted, a Significant number of BCS reached the ceiling 
scores for the DASH (n = 21, 13.7%) and DASH-W (n = 84, 53.2%) with the least 
number of BCS reached the ceiling scores for the FACIT-F (n = 6,3.8%). Polit and 
Hungler (1995) noted that the presence of ceiling and floor scores can decrease the 
correlations between the test scores and other attributes of interest (p. 556). This was 
not observed in this study since the only correlation performed was between the FACIT­
F and DASH scores, resulting in a moderate correlation between CRF and upper 
extremity function (p < .001). However, the number of ceiling scores observed on the 
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DASH-W raises considerable questions about the ability to interpret the results for the 
optional scale. 
There are few studies that document use of the DASH Optional Work Module 
(DASH-W) beyond the publisher's website. The DASH-W has been used in one study to 
identify at-work disability, a concept that examines the impact of disability on individuals 
while they engage in work as opposed to measuring out-of-work status of individuals 
experiencing upper quadrant disability (Tang et aI., 2009). This study was of interest 
since the majority of BCS were actively employed at the time of survey completion; 98 
BCS (62.0%) were employed full-time (~35 hours), 21 (13.3%) were employed part­
time « 35 hours), and 16 (10.1%) were full-time homemakers which is considered an 
employment category under the DASH-W. 
Tang et al. examined the psychometric properties of the DASH and other at-work 
instruments in a sample of 80 injured workers employed outside the home who were 
working with adjustments to their job responsibilities or decreased working hours 
secondary to their injuries (2009). The authors noted that the DASH-W performed as 
well as two other work disability scales, the WLQ-16 (Work Limitations Questionnaire) 
and the RA-WIS (Work Instability Scale for Rheumatoid Arthritis), but they felt that its 
brevity poses a problem for the psychometric strength of the scale. Scoring is not 
possible on the DASH-W unless all items are completed, whereas the DASH can be 
scored if up to 3 responses are missing (Kennedy et aI., 2011). The limited number of 
items on the optional DASH-W, compared to the core DASH evaluation tool, posed 
interpretive challenges for this study. The small number of items, relative to the 
comprehensiveness of the global DASH, did not appear to fully capture the work 
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experiences of the respondents and ceiling effects were reached in 88 BCS (55.7%) of 
the study sample, yet work was an area that generated additional comments from the 
BCS in the optional questions. Brach et al. (2004) reported that BCS vocational and 
financial concerns are areas that are not always adequately addressed in cancer 
survivorship. 
Survivorship Surveillance 
The American Society of Clinical Oncology publishes recommended guidelines 
for surveillance of cancer survivors. Recommendations for breast cancer survivors 
include visits to a physician "every three to six months for the first three years after the 
first treatment, every six to 12 months for years four and five, and every year thereafter" 
(Cancer. Net, 2011, p.1). The guidelines focus on physician visits to monitor for 
recurrence, encourage mammography, and the development of any new breast-related 
symptoms or long term impact from adjuvant therapies. 
A retrospective chart review examining the impact of physician specialty on 
follow-up of breast cancer survivors revealed that adherence to the guidelines is 
inconsistent, particularly when examining follow-up six years after initial treatment 
concluded, and especially for patients followed for their breast cancer by primary care 
practitioners (PCP) rather than oncology teams (Hollowell et aI., 2010). Hollowell et al. 
(2010) further reported that due to increasing survivorship, it is likely that many BCS will 
have their care transferred to a PCP after five years. The ASCO guidelines are unclear 
as to the need for follow-up for any persistent symptoms resulting from the cancer or its 
treatment, such as CRF or upper extremity function or difficulties in task performance. In 
fact, the study by Hollowell et al. (2010) represented the only study available that 
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researched documented follow-up efforts for BCS. Therefore, while guidelines from the 
Fatigue Coalition, the National Cancer Institute (NCI) and others have strongly 
recommended ongoing fatigue monitoring, the monitoring of persistent problems does 
not appear to have been translated into documentation to assist patients or oncology 
teams. Longitudinal monitoring for the development of upper extremity dysfunction is 
not noted in these materials. Functional performance in critical areas of occupation is 
not even alluded to, with the primary emphasis focused on body functions and 
structures. 
Engel's biopsychosocial model (1977) and the ICF (2001) were conceptualized 
as broader holistic frameworks and taxonomies supporting health that require a 
paradigm shift away from a biological focus. There is documented recognition for this 
shift in the increasing number of published studies that integrate a HRQOL measure 
into outcome variables (Gotayet aI., 2008), but the question remains as to whether this 
recognition will be translated into clinical practice in a manner that meets the changing 
needs of survivors. 
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Chapter VI 
Summary and Conclusions 
Summary 
This cross-sectional exploratory study of 158 BCS examined the relationship 
between breast cancer survivors' perceptions of cancer-related fatigue (CRF) and upper 
extremity function one year to six years post-diagnosis. The study further sought to 
investigate the impact of multiple adjuvant therapies and node dissection procedures on 
CRF and upper extremity function. In addition, the role of caring for children living at 
home who are dependent upon the BCS for completion of daily activities was examined 
using the same key constructs. Finally, the differences in multiple adjuvant therapies 
and node dissection status on physical aspects of employment were explored. 
Cancer-related fatigue and arm morbidity constitute the two most common 
symptom complexes impacting breast cancer survivors following treatment (Sadler et 
aI., 2002; Portnoy & Itri, 1999; Vogelzang et aI., 1997; Curt et aI., 2000, Bower et aI., 
2006; Collins et aI., 2004; Reitman et aI., 2003), but these multifaceted entities have 
traditionally been researched as if they were separately occurring events in the 
survivor's recovery. Many BCS, as noted in this exploratory study. have successfully 
resumed life roles and desired activities in the years that follow the conclusion of 
surgery and adjuvant therapies. Yet some women continue to struggle with fatigue and 
arm morbidity that alter participation and quality of life. 
A subset of women identified in this study and others, constituting approximately 
17-25% of the overall population (Gerber et aI., 2010; NCCN, 2006; Young & White, 
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2006; Sadler et al., 2002, Cella et aI., 2001) and 22% in this study sample, experience 
prolonged or persistent fatigue symptoms that are significant, persistent and would fulfill 
the criteria for a diagnosis of cancer-related fatigue. Forty-five percent of the fatigued 
subset of BCS in this study also demonstrated significant limitations in upper body 
function. In addition, the overall BCS in this sample demonstrated signi'ficantly higher 
levels of fatigue when compared to a national representative sample of adults. Women 
who continue to experience persistent fatigue, upper extremity symptoms or activity 
limitations require more effective identification, follow-up and referral to facilitate 
successful navigation of post-treatment permanent survivorship. The results from this 
study support the need for additional research on the relationship between these two 
common entities, as well as development of interventions that address the needs of this 
growing population. 
Researchers and policy makers, having taken note of the increasing number of 
cancer survivors and anticipated survivorship population growth, have produced 
statements supporting the need for healthcare practitioners and community agencies to 
monitor and address the long-term needs of survivors living with persistent symptoms. 
NCCN (2006) and the CDC (2005) have statements supporting the longitudinal 
monitoring of cancer survivors as a chronic disease state. The American Society of 
Clinical Oncology, 2006 (Cancer. Net, 2011), and the National Comprehensive Cancer 
Network [NCCN] (2012) publish recommended guidelines for longitudinal clinical 
surveillance of cancer survivors. Recommendations for BCS include visits to a 
physician "every three to six months for the first three years after the first treatment, 
every six to 12 months for years four and five, and every year thereafter" (Cancer.Net, 
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2011, p.1); similarly the more recent NCCN guidelines recommend visits every "4 - 6 
months for five years, then every 12 months" (2012, p. BINV-16). Surveillance visits to 
oncologists or primary care practitioners offer a unique opportunity to identify 
underreported and underecognized symptoms, such as CRF and arm morbidity. Based 
on the results from this study, it is suggested that the goal of visits expand beyond 
monitoring BCS for recurrence of cancer to inquire about the specific impact of any 
residual symptoms on daily activities and life roles, including employment, socialization 
and community participation. Assessments could be forwarded prior to patient visits or 
completed in the waiting room and scored by trained office staff. Individuals who self­
identify or are identified by the oncology team could then be referred to appropriate 
medical services, nurse navigators, rehabilitation services such as occupational or 
physical therapy, or community-based programming. Reviewing results from 
assessments would afford the opportunity for a dialogue between the BCS and the 
team. 
The recent study by Thomas-Maclean et aL (2012) confirmed earlier findings 
(Gerber et aL, 2010; Collins et aL, 2003; Stone et aL, 2003, Passik et aL, 2002; 
Vogelzang et aL, 1997) that survivors do not discuss persistent symptoms with their 
healthcare professional or feel as though they have received sufficient information. 
Therefore it is imperative that healthcare practitioners and teams take responsibility for 
asking questions during surveillance visits. The need for continued monitoring of these 
two entities should not be viewed solely from the perspective of recording fatigue scores 
or measuring limb circumference for potential lymphedema or ongoing pain in the 
affected extremity. Moving beyond physiological and anatomical areas of concern that 
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the ICF defines under body functions and structures (WHO, 2001) can increase the 
conversation about the more pressing life concerns of BCS. It is of interest that 
Thomas-Maclean et al. reported one reason for failure of patients to raise their 
concerns with the treatment team was the "expectation that symptoms would abate if 
certain activities were ceased" (2008, p. 69). As the focus of the ICF (2001) is to enable 
individuals to increase participation in all life spheres, self-limiting activities due to 
perceived impairments may further reduce participation, diminish HRQOl and may not 
adequately address the experienced symptoms. As higher levels of self-reported 
HRQOl have been linked in some studies to breast cancer survival (Gotay, Kawamoto, 
Bottomley, & Efficace, 2008), it is important to be cognizant of women's perceptions of 
persistent symptoms and their ability to function in daily life. 
Limitations in internet recruitment, particularly the use of snowball methodology 
as the primary source to obtain the sampling frame, posed substantial challenges 
including a low response rate that left the sample vulnerable to selection bias. In order 
to further our understanding of the relationship between CRF and upper extremity 
function identified in this study, in-person population recruitment with a more diverse 
BCS population is recommended for future research. 
Clarification by expert panels is needed to identify gold standard measurement 
tools for CRF and particularly for upper extremity morbidity in order to facilitate 
comparisons between studies. Adoption of a gold standard reference tool for CRF is 
also indicated in light of the anticipated ICO-10 diagnostic criteria for Neoplastic 
(Malignant) Related Fatigue. There is a wide array of validated fatigue assessment tools 
available, including the FACIT-F, but none have emerged as the benchmark tool for use 
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with oncology patients. Unidimensional assessments such as verbal or visual 
assessment scales are arguably more efficacious in clinical practice settings, but cannot 
capture the breadth of the functional concerns of BCS or the variability of the fatigue 
experience (Butt et aI., 2008; Schwartz et aI., 2002). The fatigue screening tool recently 
developed by an expert panel at NCCN (2010) does not incorporate questions about the 
impact of fatigue on daily performance that supports participation in all life spheres. 
Similar dilemmas are found when considering standards for assessment of upper 
extremity function as there are additional concerns about whether upper extremity 
assessment for longitudinal surveillance should be measured by objective or subjective 
means. The lack of congruence noted in some studies between measured arm function 
and self-perceived function (Hack, 2010; Hayes et aI., 2010) is noteworthy. While many 
studies support the use of objective measures as the gold standard for identification of 
lymphedema, Park, Lee, & Chung (2008) posited that women may perceive changes in 
arm function before current objective measures can accurately detect subtle changes. 
The imperative to address upper arm morbidity systematically is pressing since 
lymphedema incidence rates increase in the years post-treatment and this condition, 
once acquired, cannot be cured (Park et aI., 2008). 
However these two symptoms complexes represent only two facets of survivors' 
concerns. Indeed, Huber et al. (2010) reminds us that the ICF "takes as its central tenet 
the individual's experience with illness" (p. 1955). Seaburn (2005) admonishes us to 
consider Engel's BPS model as a rationale for integrated, collaborative clinical care that 
focuses on the patient's lived experience with the illness as "a whole fabric, indivisible" 
(p. 398). Therefore to maintain a more holistic biopsychosocial approach, assessments 
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and interventions should ultimately begin with the survivor's narrative and address all 
components within a framework of the impact on daily living and participation in context. 
In addition to concerns regarding instrumentation and ongoing surveillance, the 
'findings suggest the need to further our understanding of the relationship of CRF and 
upper extremity function, including the role of adaptation and compensatory strategies 
on function. We do not yet understand the extent to which women may be 
compensating, adapting or giving up activities in order to continue to meet task 
demands and fulfill life roles. Several women indicated on the optional open-ended 
questions that they had adapted their method of completing daily tasks at home or work. 
Collins et al. (2004) noted that women reported using their contralateral extremity to 
complete tasks, such as heavy household activities and specifically notes the use of 
attempts to develop compensatory strategies in order to meet task demands. Further 
elucidation of the extent and manner in which women are adapting, compensating for, 
or eliminating desired or required occupations is indicated as this is not an area that has 
been well explored in the literature. 
Consequently, it is incumbent upon us to consider Frank's admonishment that 
current health care practices do not assist the individual to live easily in the world 
following life-threatening illness (1995). Mullan's (1985) visually compelling metaphor of 
pulling the survivor out of the water only to leave the person floundering on the dock is 
apt. There is a surfeit of core research demonstrating that CRF and arm morbidity are 
present in sufficient numbers to warrant ongoing longitudinal monitoring. Additional 
research on the development of interventions that address these problems and enhance 
participation are needed. 
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The education of BCS about CRF and arm morbidity can begin earlier in the 
diagnostic and treatment continuum and should include assessment of fatigue and arm 
function, with circumferential baseline measurements of the upper extremities before 
surgery that could permit more effective monitoring and comparisons of symptoms that 
persist over time. 
Conclusions 
Based on the review of the literature to date, this study constitutes the first 
attempt to directly explore the relationship between CRF and upper extremity function 
as a primary research outcome. A moderate significant relationship between these two 
constructs was demonstrated in this small, exploratory cross-sectional study, as well as 
an increase in perceived fatigue in women who care for dependent children. Exploration 
of CRF and upper extremity function in relation to node dissection status and number of 
adjuvant cancer modalities received resulted in insignificant findings. Exploration of the 
number of adjuvant cancer therapies received and node dissection status in relation to 
physical work tasks identified a positive trend for only the number of adjuvant cancer 
therapies received, but did not reach significance. While the results from this study 
cannot be generalized, the findings offer insights to stimulate further exploration. 
Barriers and affordances to facilitate partiCipation of BCS in all environments should be 
identified. A larger more representative sample is needed to confirm the findings and 
better understand the factors contributing to these relationships. 
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ii Definitions and Terminology 
The following operational definitions for terminology related to functional activities 
j and occupational performance were used throughout the study. 
! 
Activities of Daily Living: "Activities that are oriented toward taking care of one's own 
body (American Occupational Therapy Association [AOTA] Commission on Practice, 
2002, p.620). These activities include the following: bathing, showering, bowel and 
bladder management, dressing, eating, feeding, functional mobility, personal and 
environmental device care, personal hygiene and grooming, toileting, sexual activity, 
sleep and rest (American Occupational Therapy Association [AOTA] Commission on 
Practice, p.620). 
Functional status: "An individual'S performance of activities and tasks associated with 
life roles" (Richmond, Tang, Tulman, Fawcett, &McCorkle, 2004, p. 84). 
Instrumental Activities of Daily Living: "Essential self-maintenance activities that are 
used to measure independent living capability that are not considered as basic daily 
living activities of self-care tasks" (Jacobs, 1999, p.71). These activities include the 
following: care of others, care of pets, child-rearing, communication device use, 
community mobility, financial management, health management and maintenance, 
home establishment and management, meal preparation and clean-up, safety 
procedures and emergency responses, and shopping (American Occupational Therapy 
Association [AOTA] Commission on Practice, 2002, p.620). 
I 
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~ 
Occupational performance: 'The ability to carry out the activities of daily life. including 
activities in the areas of occupation: activities of daily living (ADL). instrumental activities I 
1 
 of daily living (lADL). education, work. play, leisure, and social participation (American 
1 
 Occupational Therapy Association [AOTA] Commission on Practice, 2002, p.617). 
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Highest Levels of Impairment 
for DASH Functional Activities and Symptoms 
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Table 8 
DASH Functional Activity Items Exhibiting Highest Levels of Perceived Impairment (N = 
153) 
Activity No Difficulty (Percent) Mild Difficulty to 
Unable (Percent) 
Open a Jar 39.2 60.8 
Recreational activities 51.0 49.0 
requiring force or impact 
Carry a heavy object (> 1 0 54.9 45.1 
Ibs) 
Heavy housework 56.9 43.1 
Garden or yard work 58.2 41.8 
Table 9 
DASH Arm Symptoms Exhibiting Highest Levels of Perceived Impairment (N = 153) 
Symptoms None (Percent) Mild to 
Severe Difficulty (Percent) 
Pain when performing 53.0 47.0 
specific activity 
Stiffness 53.3 46.7 
Weakness 55.6 44.4 
Pain 57.2 42.8 
Tingling 59.2 40.8 
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Table 10 
Optional Question: Daily Activities Impacted By Problems With Arm Function (n = 22) 
ICF and OTPF Responses 
Classifications 
Domestic Life, 
household tasks, 
Caring for household 
objects and assisting 
othersa [IADL~ 
I cannot write with a pen for more than a few sentences so I no longer 

keep a journal. 

My writing and drawing have changed. 

Gardening. Housework. 1 

Driving 

Helping my disabled son is sometimes painful, so I ask my husband 

for help. 

Lifting my children, moving things. 

Working with my dogs. 

Work & Employmenta 
[Work~ 
Since I have implants, my pectoral muscle function limits some 
manual techniques I need for work as PT, but I have modified. 
Working at my desk is sometimes uncomfortable because of arm, 
shoulder pain/pins and needles. 
Trying to close a pad lock or a 3-ring binder. 
Delivering babies - some techniques I can't do. 
I am taking anastrazole daily, and I find in the winter that I have 
occasional pain in my wrists that makes typing and working out 
somewhat uncomfortable. It comes and goes, typically indicating 
when we are going to get rain or snow. 
I used to take care of a patient who was semi-comatose and I had no 
mobility. Because of my diagnoses and subsequent physical 
limitations (could lift no more than 5 - 10 Ibs with my left arm) I had to 
leave my job. 
Recreation and Exercise (involving use of muscles across chest and heavy weights)1 
Leisurea 
[Leisureb ] Exercise - finding a type of physical activity that does not aggravate 
my arm. 
ICF classificationsa 
OTPF categoriesb 
I 
I 
~ 
j 190 
I Table 8 Optional Question: Daily Activities Impacted By Problems With Arm Function Symptoms (n ;:: 22) 
t ICF and OTPF Responses 
Classifications 
Sleep FunctionsS The tissue expanders are uncomfortable - especially if I try to lay on 
[Sleepb] my side to sleep [waiting for reconstruction] 
Body Functions and 
StructuresS [Body 
Functions and 
Structuresb] 
ICF ""1",,,,,,,,·tl,...~.1'll"\n"'Y 
OTPF categoriesb 
Strength, rotation of shoulder. 
I still do everything, but I do less of it at a time and much more slowly 

than I used to. 

Everyday, everything. The arm has lost a lot of power, strength, 

energy ... I am lucky that my affected arm is my non-dominant 
arm ... so the answers on any survey could change a bit. 

Carrying anything heavy as dead weight. I need to support the weight 

against my body or suffer increased symptoms. 

No [problems], but wearing jewelry on my left hand/arm (rings/watch) 

can be annoying depending on swelling. 

Lifting. 

Some pain in breast when opening heavy doors. 

Most noted pulling heavy door, modify with body weight. 

Cannot lift things as heavy as I used to. 

I cannot lift as heavy an object as I used to because I lost some 

muscle tone while going through treatments. I lost a lot of weight 

including muscle while in treatment and have been working to get it 

back. I'm lucky my arm function is fine. 

Very mild occasional pain around reconstruction area but this does 
not limit my activities. 
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Table 11 
Optional Question: Daily Activities Impacted By Problems With Fatigue (n =29) 

ICF and OTPF Responses 

Classifications 

Self-carea[ADLb] Trying on tops and coats. 

Getting ready in the morning takes much longer due to fatigue. 
Domestic Life, 
household tasks, 
Caring for household 
objects and aSSisting 
othersa [IADLb] 
Work &Employmenta 
[Workb] 
Getting specific things done on time. 

Challenging to take care of three small children and I am exhausted 

driving them to school, extra-curricular activities, etc. 

Cleaning my house, carrying bags or laundry. 

I am a lecturer/teacher - I tire more easily so while it does not affect 

work, when I am done, I am very tired. 

Going out for long periods of time. Just can't. Night deliveries (babies) 

tire me out much more now. 

Working. 

It impacts my work. 

Recreation and 
Leisurea 
[Leisureb] 
Exercising. 
Exercising. 
Exercise, reading. 
Trying to just sit and read a book. 
Exercise classes. 
Exercise and gym time. 
Support and Cancel scheduled appointments due to fatigue, social life is greatly 

Relationshipsa impacted by fatigue. 

[Communication and 

Social Skillsb] 

OTPF categoriesb 
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Table 11 
Optional Question: Daily Activities Impacted By Problems With Fatigue Symptoms (n = 29) 
ICF and OTPF Responses 

Classifications 

Sleep Functions8 Sleeplessness. 

[Sleepb] 
I cannot get as many things done as I used to because I get tired 
easier and I need to rest. I need more sleep, and I go to bed earlier 
than I used to, usually by 9 PM. 
J Sometimes for no reason I feel extremely exhausted. I need to nap 1 sometimes around 3 PM. I am also having trouble sleeping through 
the night. 
I Body Structuresa [Body Functions and I have slightly less energy than I used to, but it doesn't stop me from 
1 Structuresb] doing anything in particular. I'm lucky. 
1 Walking due to the numbness felt on my feet. 
This is affected by additional causes, like having a mild cold, for 
instance.1j 
HOT FLASHES. 
I 
1 Fatigue impacts everything. 
I 
I feel my fatigue is just related to working, house chores and running 
around. 
I Fatigue is only that which is normal for a 58 year old with a fast paced 
work schedule. 
1 
i I just don't have the energy to do anything. I 
I do almost anything I did prior to breast cancer however the fatigue 1 that follows often is limiting. 
ICF classificationsaI 
,• 
OTPF categoriesb 
I 
I 

IIi j 
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I 
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I 	 194 OFFICE OF INSTITUTIONAL REvIEW BOARD 
--.----.--...---...--"---,~=-~.--~~.,....,....-"­
SETON HALL UNIVERSITY1 
i 
.1 	 February 24,2010 
,
J 
I 
Meryl Picard, MSW, OTR 

31 Crest Drive 

Murray Hill, NJ 07974 
Dear Ms. Picard, f 
j 	 The Seton Hall University Institutional Review Board has reviewed your research proposal entitled "The Relationship between Cancer-Related Fatigue and Upper 
Extremity Function in Breast Cancer Survivors" and has approved it as submitted under 
exempt status. Enclosed for your records is the signed Request for Approval form. 
f 
I Please note that, where applicable, subjects must sign and must be given a copy of the 
Seton Hall University current stamped Letter of Solicitation or Consent Form before the 
I 
I 
subjects' participation: All data, as well as the investigator's copies of the signed 
Consent Forms,nlust be retained by the principal investigator for a period ofat least three 
years following the termination of the project. 
Should you wish to make changes to the IRB approved procedures, the following 
materials must be submitted for IRB review and be approved by the IRB prior to being 
instituted: 
• 	 Description of proposed revisions; 
• 	 If applicable, any new or revised materials, such as recruitment fliers, letters to 
subjects, or consent documents; and 
• Ifapplicable, updated letters of approval from cooperating institutions and IRBs. 
At the present time, there is no need for further action on your part with the IRB. 
In harmony with foderal regulations, none ofthe investigators or research staffinvolved 
in the study took part in the final decision. 
Sincerely, 
~4~>fJlJb. 
Mary F. Ruzicka, Ph.D. 

Professor 

Director, Institutional Review Board 

cc: Dr. Genevieve Pinto Zipp 
Presidents Hall· 400 South Orange Avenue • South Orange, New Jersey 07079-2641 • Tel: 973.313.6314 • Fax: 973.275.2361 
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OFFICE OF INSTITUTIONAL 
REVIEW BOARD 
SETON HALL UNIVERSITY 
September 28, 2011 
Meryl Picard, MSW, OTR 

31 Crest Drive 

Munay Hill, NJ 07974 

Dear Ms. Picard, 
The IRB hereby approves the following requested amendments to your research protocoL 
"The Relationship between Cancer-Related Fatigue and Upper Extremity Function in 
Breast Cancer Survivors": 
1. 	 to change the wording of four questions in the original survey and adding three 
new questions 
2. 	 anlending the recruitment e-email to reduce redundancies and alert potential 
respondents that they may not complete the new survey if they were participants 
in the data collection earlier this year 
3. 	 adding a paper· copy of the letter~ directed only.to breast cancer survivors, for 
lcaving flyers with interested parties such as SUppOlt groups. 
Your stamped paper recruitmellt flyer is enclosed. Make copies only of this fonn. 
I 

I Sincerely,
I ~i.11 
Mary F. RUZIcka, Ph.D.I 
Professor 

Director, Institutional Review Board 

cc: Dr. Genevieve Pinto Zipp 
/ 
Presidents Hall ". 400 South Omnge Avenue • South Orange, New Jersey 07079-2641:" Tel: 973.313.6314 • Fax:973.275.2361 
RE: 196 
Dear Breast Cancer Survivor, 
My name is Meryl Picard and I am a doctoral student at Seton Hall University in South Orange, NJ. My 
dissertation project explores the two most common problems, cancer fatigue and ann symptoms, that 
affect some women after surgery and treatment. I need your help in understanding women's experiences 
with these problems that might interfere with the ability to complete daily life activities that you want to 
do or have to do. 
At this time there is limited understanding of the relationship between these two problem areas. 
Your responses are very important, even ifyou are not experiencing any ofthese problems at the present 
time. You may participate in this research ifyou: 
• 	 Are between 18 -65 years old 
• 	 Can read English and have access to the Internet 
• 	 Have had a diagnosis ofbreast cancer, Stage 0 - ill (please, no metastasis or Stage IV) 
• 	 Completed all your surgery, radiation or chemotherapy a minimum of 1 year ago (> 12 months) 
and less than 6 years ago « 72 months). 
The questions will only take 15 minutes to complete. Your responses are completely voluntary and will 
be kept confidential. This is a completely anonymous survey. Please do not (:cmp!ete the SUlTey ~1gal11 
if yon responded earlier this year. 
Click on the link below (or cut and paste the survey link into your Internet browser) to begin. This 
research study has been approved by the Seton HalI University Institutional Review Board, which 
monitors all research studies to protect human subjects. Ifyou have any questions about your rights as a 
participant in this study, please contact the Chairperson of the IRS at (973) 313-6314. Questions about 
the research study can be answered by contacting Meryl Picard at (973) 275-2910, 
meryl.picard@shu.edu. 
Thank you for providing your valuable time to help us understand these symptoms in breast cancer 
survivors. 
Seton Hall University 
Institutional Review Board 
SEP 28 2011 
Approval Date 
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Meryl M Picard 
From: Greer Palloo [gpalloo@iwh.on.ca] 
Sent: Tuesday, January 26, 2010 12:41 PM 
To: Meryl M Picard 
Subject: DASH use permission 
Dear Meryl, 
The Institute for Work & Health is pleased to grant you permission to use its DASH Outcome Measure for your doctoral 
study in the manner described on the user profile form dated and submitted on January 22, 2010. 
We wish you all the best with your project. 
Sincerely, 
Greer 
(Ms) Greer Palloo 
Information &Events/DASH Coordinator 
Knowledge Transfer & Exchange Department 
Institute for Work &Health 
481 University Avenue, Suite 800 
Toronto, Ontario M5G 2E9 Canada 
T 416-927-2027 x 2131 F 416-927-4167 
gpatloo@iwh.on.ca 
www.iwh.on.ca 
This e-mail may contain confidential information for the sole use ofthe intended recipient. 

Any review or distribution by anyone other than the person for whom it was originally intended is prohibited. 

Ifyou have received this e-mail in error please delete all copies. 

Opinions conclusions or other information contained in this e-mail may not be that of the organization. 

1 
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Meryl M Picard 
From: FACIT [information@facit.org] 
Sent: Friday, January 13, 2012 5:29 PM 
To: Meryl MPicard 
Subject: Thank you for your enquiry 
Dear Meryl, 
Thank you for registering with FACIT! If you've registered for a translation of a FACIT 
scale, we will contact you with the questionnaire via email. If you've registered to use an 
English version but require a letter of permission, please send an email to 
information@facit.org and we will respond. If you don't hear from us within five days, please 
send an email to information@facit.org. Below is a summary of your information: 
Summary of web form submission: 
Your Name 
Meryl Picard 
Email Address 
meryl.Qicard@shu.edu 
Case Number 
3288022 
Company 
Seton Hall University 
Username 
Your record has an existing username. This will be emailed to you. [meryl.picard@shu.edu] ­
has been ignored. 
Password 
Your record has an existing password. This will be emailed to you. [nextgenot2910] - has been 
ignored. 
Work Address 
480 South Orange Avenue South Orange, NJ 87974 United States Cell Phone Number 
973-275-2910 
Terms of Use 
I Accept the Terms of Use 
Department within Company 
Occupational Therapy 
Study Type 
Cancer-Related Fatigue 
Study Title 
CANCER-RELATED FATIGUE AND UPPER EXTREMITY FUNCTION IN BREAST CANCER SURVIVORS Funding Source 
None Total expected or actual number of study participants 
Questionnaire(s) 
FACIT-F, DASH 
Countries or Language(s) 
United States 
Do you require a letter of permission? 
1 
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Meryl M Picard 
From: Jason Bredle Ubredle@facit.org] 

Sent: Wednesday, September 02, 2009 1 :54 PM 

To: Meryl M Picard 

Subject: RE: copyright and permission question 

Hi Meryl .. 

That's totally fine. In fact .. we've used survey monkey in the past to carry out some 

linguistic validation. 

Thanks .. 

Jason 

Jason Bredle 

FACIT.org 

+1. 773.807.9094 

From: Meryl M Picard [Meryl.Picard@shu.edu] 

Sent: Wednesday.. September 02.. 2009 12:32 PM 

To: 'information@facit.org' 

Subject: copyright and permission question 

Dear FACIT.org: 

I wrote to you one year ago and received permission to use the FACIT-fatigue for a 

dissertation study on cancer-related fatigue and breast cancer survivors. Unfortunately.. the 

original RCT is now in the process of revision due to poor recruitment response for the 

clinical trial after the U.S. economy collapsed. 

Before I complete the new user profile request.. I wanted to ask if your organization would 

permit the use of the FACT-fatigue as part of on-line survey research. I will use Survey 

Monkey (surveymonkey.com) as the platform to host the dissertation study. The FACT-fatigue 

would only be available to study volunteers who respond to a participation invitation.. and 

are then directed to a designated URL link established for my research. In other words .. the 

FACT-fatigue would not be placed on a publically available website that anyone could access. 

Survey Monkey will also permit me to design the research survey to permit copyright credit of 

the FACT-fatigue on the actual survey site. 

Please advise as to whether this is possible. 

Sincerely.. 

Meryl Marger Picard.. MSW.. OTR 

Assistant Professor 

Department of Occupational Therapy 

School of Health and Medical Sciences 

Seton Hall University 

400 South Orange Avenue 

South Orange.. New Jersey 07079 

(973) 275-2910 
meryl.picard@shu.edu 
1 
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Appendix G 
Demographic Survey Questions 
*1. What is your age? 
I I 
*2. What state do you live in? 
State: 
*3. How do you identify yourself? 
o Black/African American 
o Hispanicllatino 
o Native Hawaiian/Pacific Islander 
o Asian 
o White/Caucasian 
Other (please specify) 
*4. What is your marital status? 
o Never married 
o Single 
o Married 
o living with a significant other 
o Widowed 
o Divorced 
o Separated 
*5. What is your highest level of education? 
o Some high school 
o High school degree 
o Associate's degree or some college 
o College degree 
o Graduate degree or higher 
204 
Breast Cancer Survivors Fatigue and Arm Function Survey 
*6. Which term BEST describes your current work situation? 
o Unemployed 
o Full-time employed (35 or more hours per week) 
o Part-time employed «35 hours per week) 
o Leave of absence 
o On disability 
o FUll-time student 
o Part-time student 
o Full-time homemaker 
o Retired 
*7. Has your work situation changed as a result of problems from your breast cancer? 
ONO 
o Yes 
8. Has your work situation changed as a result of the economy? 
ONO 
o Yes 
9. Which hand do you use to write? 
o Right hand 
o Left hand 
*1O. What year were you diagnosed? 
Four digit year 
11. Which side was your breast tumor located? 
o Right side 
o Left side 
o Both sides 
*12. Have you had more than one episode (recurrence) of breast cancer? 
ONO 
o Same side as first episode 
o Opposite side of firsl episode 
Breast Cancer Survivors Fatigue and Arm Function Survey 
*13. What was the tumor stage when you were diagnosed? 205 
0 0 
01 

011 

Om 

o Do not know 
*14. What type of surgery did you have (Check all that apply)? 
DNone 

D Lumpectomy 

D Mastectomy 

DBreast reconstruction 

*15. What type of node dissection did you have to determine the cancer diagnosis? 
o None 
o Axillary node dissection 
o Sentinel node dissection 
o Both 
o Do not know 
If you had node dissection, how many nodes were removed? 
*16. What type of cancer treatment did you receive after your surgery? (Select all that 
apply.) 
D None 

D Chemotherapy 

D Radiation 

D Immunotherapy 

D Hormone therapy 

*17. Have you ever been diagnosed with lymphedema? 
ONO 
o Yes 
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*18. Are you currently receiving treatment for your arm from an occupational or physical 
therapist? 
ONO 

Oves 
*19. Do you wear a compression sleeve? 
Ves No 
Never 0 o 
While exercising 0 o 
While doing heavy 0 o 
household work (laundry, 
vacuuming, raking) 
When I fly on a plane 0 o 
Always 0 o 
*20. Do you perform compression wrapping with lymphedema bandages? 
ONO 

Oves 
*21. Do you have fatigue (a tired feeling) at least twice a week that keeps you from 
completing any or all of these daily activities? 
Ves No 
Self-care 0 0 

Care of others 0 0 

Household tasks such as 0 0 

cooking, cleaning or yard 
wor1< 
Shopping or errands 0 0 

Doing your job at work 0 0 

leisure or relaxation 0 0 

Socializing with friends and 0 0 

family 
22. List the ages of children living in your house that depend on you to help them to 
complete daily life activities, including self-care, chores, school activities or play: 
Age of child 1 
Age of child 2 
Age of child 3 
Age of child 4 
Age of child 5 
